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ABSTRACT 
 
Humans have a unique evolutionary trajectory that allows life past reproductive 
viability. Antagonistic pleiotropy and resource economics lead to the deterioration of 
physiological processes once beyond years in which natural selection is effective. As individuals 
age, bone becomes increasingly fragile and prone to fracture. Due to heterogeneity in human 
aging patterns, bone aging is a highly variable process. The ability to predict, diagnose, and 
treat age-related bone fragility has become an area of major focus in medical research, 
however, there is little consensus in the field as to the mechanisms behind bone aging. The lack 
of clarity in the causes of bone aging makes individualized medical approaches difficult. Studies 
of these mechanisms are complicated by the inherent variability in human biology and 
environment. The use of murine models provides greater experimental control but has 
previously not recognized the presence of variability in aging. 
This work provides evidence for the utility of multiple inbred mouse strains in aging 
research. This approach provides high level of control but also allows investigation into the 
causes behind variable aging outcomes. The first aim of this project establishes differences in 
bone aging in the femora of four inbred mouse strains to demonstrate the range of intraspecies 
variability in bone aging. The BALB/c and C57Bl/6 strains lose mechanical functionality with age 
but in different ways. The CBA/J and DBA/2 strains maintain mechanical integrity with aging 
using different strategies. Different rates of remodeling, as well as mineralization, lead to the 
variation in mechanical function changes with age in the four strains. The second aim 
investigates the applicability of comparative mouse models of aging to humans. This aim 
applies modern theories of aging to the variable bone outcomes. The third aim demonstrates 
the potential influence age-related changes in mechanoresponse have on bone aging using a 
tibial axial loading model. The data in this thesis demonstrate the variability in bone aging in a 
mouse model, providing potential insight into human inter-individual aging variations. The work 
xiii 
 
presented also provides a platform for future aging experimentation investigating factors that 
influence how well bone ages. 
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CHAPTER I:  
INTRODUCTION 
 
As individuals age, bone becomes increasingly fragile and prone to fracture [1, 2, 3]. 
With medical advances and lifestyle changes, the average human lifespan has increased from 
the mid-40’s during the early 1900’s to over 80 years in some countries [4]. With this change in 
demography, healthcare must address new medical issues, including age-related bone fragility 
leading to increased fracture rates. As a response to this need, the ability to predict, diagnose, 
and treat bone fragility has become an area of major focus in medical research.  
The current standard for predicting fracture is dual-energy X-ray absorptiometry (DXA) 
measures of bone mineral density (BMD) [5]. Johnell et al estimate that every standard 
deviation away from the mean BMD increases the risk of fracture by 40% [6]. This provides a 
rapid method of predicting fracture risk. However, simplified guidelines such as BMD values are 
inherently flawed by not addressing the large range of variability in how people age. Cases in 
which BMD measures have proven ineffective include one study in which 1,012 elderly Chinese 
women were classified into three groups depending on DXA measures: osteoporotic, 
osteopenic, and normal. Within the normal group, 21.8% of the women suffered a fragility 
fracture [5]. This represents a large subgroup of the population that may pass screening and 
therefore receive no preventative measures, ultimately leading to preventable fractures. 
Another study demonstrating the complex nature of bone fragility was Aspray’s 1996 study of 
Gambian and European women. This study compared BMD values of age-, height-, and weight-
matched Gambian and European women. The Gambian women had BMD values 10-40% lower 
than values measured among the European group. However, incidents of fracture associated 
with aging were rare in the Gambian population compared to the European fracture rates [7].  
A major reason for the lack of predictive accuracy in fracture risk assessment is the 
multifaceted phenomenon of increasing bone fragility with age. Bone aging patterns are 
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interrelated with a number of variables. Kanis et al. have compiled a list of factors that 
influence risk of fragility-related fracture [8]: 
 
o Sex (females at higher risk) 
o Age 
o Low BMD 
o Low body weight/BMI  
o Ethnic origin (Asian or Caucasian) 
o Previous fragility fracture 
o Family history of fracture 
o Glucocorticoid treatment 
o High bone turnover 
o Smoking 
o High alcohol intake 
o Long-term immobility 
o Low calcium intake 
o Vitamin D deficiencies 
o Primary or secondary amenorrhea: surgery, 
chemotherapy, radiotherapy, anorexia nervosa, 
exercise, chronic illness, hyperprolactinemia 
o Primary or secondary hypogonadism in males 
Klinefelter’s syndrome, hypopituitarism, 
hyperprolactinemia, castration, prostate 
surgery 
o Other related conditions: chronic liver 
disease, irritable bowel disease, 
hyperparathyroidism, organ transplant, renal 
failure, Cushing’s syndrome, gastric surgery, 
neuromuscular disorders 
o Fall risk factors: hemiparesis, Parkinson’s 
dementia, vertigo, alcoholism, blindness/poor 
visual acuity, neuromuscular disorders 
 
With the high number of interrelated and interacting risk factors of fragility fractures, it 
is difficult to get a clear and comprehensive understanding of the etiology of fragility fractures. 
This results in disparities in understanding how the function of bone changes with age 
progression. The lack of consensus as to the causes and effects relevant to bone aging hinders 
accurate characterization and diagnosis of fracture risk. 
It is evident that guidelines for fracture risk cannot be universally applied to all 
populations and individuals. The insufficient understanding of the complex factors influencing 
bone fragility and fracture risk demonstrate the need for a method to investigate the sources of 
variability in bone aging. Human studies have inherent problems that hinder the ability to parse 
out individual factors in a controlled environment. Due to the limitations of human studies, it 
would be beneficial to develop a correlate for the bone aging variability evident in human 
populations.  
Murine models for biomedical studies are some of the best characterized and easily 
accessible. One of the primary benefits of utilizing small rodent models, such as mice and rats, 
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is the ability to control and manipulate environmental factors. This level of control allows for a 
reduction in the confounding variables inherent in human research. Currently, most age-related 
research conducted in murine models has approached aging through either surgical and/or 
genetic modification methods [9]. One of the most widely used models of aging is the SAMP6 
mouse strain [10, 11]. Unfortunately, this model—as well as the surgical models—does not 
demonstrate patterns of bone aging similar to that documented in humans [9].  
Some aging work in mice has utilized the C57Bl/6 mouse strain to investigate various 
changes and influences on aging [9, 12]. The benefit to using untreated mouse models is that it 
may provide a more accurate correlate of true physiological aging than accelerated aging 
mouse models. However, one of the biggest benefits of using inbred mice in research may also 
be a large drawback in their utility for bone aging work. Inbred mouse strains are used due to 
the minimal variability, yet, it has been demonstrated that there is a large range of variability in 
human bone aging.  
 The first aim of this project is to establish that there are differences in the trajectory of 
bone aging in different inbred mouse strains. Many studies have given evidence of phenotype 
differences between various inbred mouse strains upon reaching maturity [13, 14, 15, 16, 17]. 
Despite clear phenotypic differences between inbred mouse strains, little work has been done 
comparing how the various strains might differ in aging patterns. The primary goal of this 
chapter is to determine if the four aged inbred mouse strains that are available experience 
similar or variable patterns of bone aging. If such variation is present, investigating the factors 
involved in the different outcomes may be a useful tool for parsing out the cause and effect of 
aging-related changes in humans. 
 The second aim is concerned with developing the mouse model of aging variation and 
investigating the applicability to humans. In general, age bone strength is lost with age through 
a combination of alterations to the mineralization, morphology, and composition. Before 
drawing connections between human and murine patterns of aging, we must first provide a 
comprehensive picture of how and when both strains change. This involves an understanding of 
the onset and rate of change occurring in both the cortical and trabecular bone regions. 
Furthermore, it is important to determine if these patterns are systemic to the skeletal system 
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or isolated to single bone locations. Once elucidated, we can begin to relate patterns of aging in 
the murine models to those in humans. This approach could provide avenues for 
experimentation regarding bone aging not possible in humans. 
 The third and final aim demonstrates the potential influence age-related changes in 
mechanoresponse have on bone quality. Mechanical stimulation is critical for maintenance of 
healthy bone [18]. The mechanoresponse system allows bone to sense and adapt to its loading 
environment. Studies investigating the role of mechanical responsiveness in aging bone health 
have produced confounding results [12, 19, 20, 21, 22, 23, 24]. Using the models of successful 
and at-risk bone aging, this chapter will determine if the ability to respond to load is altered 
with age. This knowledge will provide direction for future research into diagnostic and 
therapeutic measures to alleviate fracture risk due to aging. 
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CHAPTER II:                                                                                                                                              
BONE FUNCTIONAL CHANGES VARY BETWEEN DIFFERENT INBRED MOUSE STRAINS 
 
Introduction 
 In this chapter, I will address the present lack of understanding regarding the variability 
in mouse bone aging models. Published data provide evidence of phenotype differences 
between various inbred mouse strains upon reaching maturity [1, 2, 3, 4, 5]. Despite clear 
phenotypic differences between inbred mouse strains, little work has been reported comparing 
how the various strains might differ in aging patterns. The National Institute of Aging (NIA), a 
department of the National Institutes of Health (NIH), maintains a colony of aged inbred mouse 
strains, of which the BALB/c, C57Bl/6, CBA/J, and DBA/2 strains are available for research 
purposes. The primary aim of this study is to determine if these four aged inbred mouse strains 
experience different patterns of bone aging. If such variation is present, investigating the 
factors involved in the different outcomes will be a useful tool for parsing out the factors 
related to aging changes of bone functionality in humans. 
 Bone functionality is a poorly defined term. For the context of bone aging, we are 
concerned with the increase in fracture risk. No single measure can explain all the changes in 
risk of fracture, but we will use ultimate load (or maximum stress) as a correlate for the ability 
to resist fracture. Stiffness and ultimate load are highly correlated in healthy adult humans with 
coefficients of determination (R2) around 0.92 for cortical bone in tension [6]. Whether this 
relationship holds up with aging will provide clues as to the underlying factors driving 
differences in mechanical properties. Mechanical changes with aging may be due to a number 
of morphological and/or material properties of the bone. By comparing changes in these 
properties to the mechanical outcomes we can begin to elucidate the size, shape, and 
mineralization factors that might be leading to the variation between the mouse strains in 
terms of how their bones are aging. 
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 The primary null hypothesis of this first aim is that there are no differences in ultimate 
load of the femora from 3-month and 18-month mice in any of the strains. This will be tested 
using 4-point mechanical loading. If our data do not support the primary null hypothesis, the 
secondary null hypothesis is that there are no differences in the percent change in ultimate 
load with age when comparing the four strains. We will test this second hypothesis using linear 
modeling. In the final part of this chapter, we will then attempt to correlate morphological 
measures to the changes in function. 
 
Materials and Methods 
Animals 
All animals used in this study are male mice procured through the NIA/NIH aged 
colonies. Inbred strains were chosen to provide a sample of phenotypically diverse mice but 
with less animals required than in a heterogeneous study design. Mice reach bone maturity 
around 3-months of age [7, 8, 9]. Age-related loss of bone stiffness and maximum load has 
been reported by 12-months in C57Bl/6 mice [7]. Therefore, we opted for a sample of young 
mice consisting of 3-month males. The old mouse sample was comprised of 18-month old 
males. The 18-month time point was chosen since it falls after the 12-month peak in mechanics 
but before the mean life expectancies of the four strains. While in the future, both sexes should 
be studied, resources limited this work to the males only. Males were chosen due to lower 
lifespans in the female of some strains [10]. Furthermore, within the four inbred strains, the 
survival curves for female mice had much higher ranges of variability [11].  
BALB/c mice are the second most widely utilized general-purpose inbred mouse strains, 
behind C57Bl/6. BALB/c has been recognized as an independent stock since 1913. This strain is 
notable for high cage activity and male aggression [12]. One study estimates average male 
lifespan at 620 days [13] and another at 662 days [11]. Ackert et al (2008), through the Nathan 
Shock Center for Aging Research, published data on 32 inbred strains of mice. At 6 months, 
BALB/c males have an average body weight of 30.3 grams, 19% of which is fat, and a DEXA 
estimated BMD of 0.0522 g/cm2. Average male body weight at 12 months is 31.9 grams, 20% of 
this is fat, and the average BMD is 0.0574 g/cm2 [14]. 
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C57Bl/6 mice are used in a large number of fields of study. This strain dates back to 
1921, developed by C.C. Little. Notably, C57Bl/6 may have 6.5% genome from Mus spretus. The 
C57Bl/6 mice are described as having high cage activity. Reports from Jackson puts average 
lifespan of males around 795 days [15] to 894 days [11]. These mice reportedly develop 
metabolic syndrome easily and are highly susceptible to diet-induced obesity and diabetes. 
Other relevant points of interest include the lower bone density and delayed hematopoietic 
stem cell senescence in this strain [16]. Ackert’s report for C57Bl/6 6-month old male mice 
estimates average body weight at 30.7 grams, 18% being fat, and mean BMD of 0.0524 g/cm2. 
The 12-month averages are 35.5 grams for body weight, 28% fat percentage, and 0.0547 g/cm2 
for BMD [14].  
The CBA/J mouse strain was first developed by Strong in 1920 through a cross of a 
female Bagg albino and a DBA male. Handlers report low cage activity and large proportion of 
time spent sleeping. Male lifespan is estimated at 527 days in one study [17] and 647 days in 
the Yuan report [11]. Researchers describe this strain as having high systolic blood pressure and 
high cell turnover [18]. Ackert’s 2008 estimates for 6-month male CBA/J means are 36.0 grams 
for body weight, 29% of that is fat, and 0.0570 g/cm2 for BMD. The 12-month body weight 
mean is 40.4 grams, 33% which is fat, and mean BMD is 0.0616 g/cm2 [14]. 
DBA/2 is the oldest inbred strain and was isolated by C.C. Little in 1909. Male lifespan is 
estimated around 700 days [19] in one study and 641 in another [11]. DBA/2, as reported by 
Ackert, have the smallest body weight of 29.5 grams at 6 months, 20% is fat, and 27.4 grams at 
12 months, 15% is fat. Mean BMD values are 0.0536 g/cm2 at 6 months and 0.0544 g/cm2 at 12 
months [14]. 
We analyzed each strain cross-sectionally at 3 and 18 months. The 3-month animals 
were euthanized upon arrival, and their femora excised and frozen in PBS. The oldest age at 
which all strains were available was 17 months. Therefore, animals were group-housed for four 
weeks. During this time, four of the BALB/c and four of the DBA/2 old mice died either of 
natural causes or were euthanized due to poor health. After the 4-week waiting period, all 18-
month animals were euthanized and their femora extracted and frozen. The premature death 
of four 18-month mice from each of the BALB/c and DBA/2 strains resulted in a sample size of 
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six, which was insufficient to produce adequate power, since a power analysis showed a 
recommended sample size of 7-8 animals per group. 
 
Micro-Computed Tomography (µCT) 
All bones were scanned with a GE Medical eXplore Locus SP scanner (GE Medical, 
Waukesha, WI) at 18 µm voxel size using a beam flattener. Specimens were scanned in a 
custom designed 8-bone holder to maximize throughput. The size of each region of interest 
(ROI) for cortical bone was defined as 10% of total bone length and was situated so that the 
most proximal point centered at the mid-diaphysis (50% of total bone length). Using GE 
MicroView 2.2 ABA software, an auto-thresholding algorithm was employed and morphological 
measures recorded. 
 
Mechanical Testing 
Bones were tested in 4-point bending with a custom designed system controlled using a 
Mini Bionix II servohydraulic system (MTS; Eden Prairie, MN). Femora were oriented such that 
load was applied in the anterior-posterior direction with the posterior surface in tension. Load 
was applied using a constant displacement rate of 0.05 mm/s. A custom MATLAB script was 
written to extract critical data from the load-displacement curves. Primary outcome measures 
of interest were ultimate load, fail load, and stiffness. Yield load, yield, ultimate, fail and post-
yield displacements, and total, elastic, and plastic energies were also recorded. Yield point was 
defined as the point when the slope of the linear region changes by 10% between two 
consecutive slope estimate iterations. Ultimate load was defined as the maximum load point of 
the entire test. Fail load was defined as the first point where the slope of the iteration is less 
than -100. Yield, ultimate, and fail points were visually verified before values were recorded.  
 
Statistical Analysis 
All statistics were run using commercially available software packages SPSS v22 (IBM 
corp., Armonk, NY) and GraphPad Prism 6 (GraphPad Software, San Diego, CA). All mechanical 
and morphological measures (including weight) were compared between 3- and 18-month 
animals within each strain using t-tests. Outcome measures were standardized by dividing by 
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body weight. Simple linear regressions were fitted to look at relationships between the primary 
outcome measures and weight. The coefficient of determination is presented as R2. 
Additionally, simple linear regressions were also run between stiffness and ultimate load for 
each strain and each age within strains. General linear models (GLMs) were designed to 
investigate strain differences in changes with age. The model was run including age and strain 
as factors and the interaction term: age+strain+age*strain. Bivariate correlations were run 
between measured parameters and Pearson’s correlation coefficient reported (R). All statistics 
were run with significance level defined at p<0.05. 
 
Results 
Experiment A: Mechanical Function 
Mechanical testing was employed to measure differences in bone strength and stiffness 
with age. Mean ultimate load values were lower in the BALB/c and C57Bl/6 18-month old mice 
compared to the 3-month mice, but there was no difference in age means in the CBA/J or 
DBA/2 mice. In 4-point bending of the femur (Table 2.1)1, the 18-month BALB/c mice exhibited 
a 24% lower mean ultimate load but no significant difference in stiffness compared to their 3-
month counterparts. The C57Bl/6 group showed dramatic age-related differences in mechanical 
function in the femur. Femoral ultimate load and stiffness were 34% and 26% lower, 
respectively, between the 3- and 18-month groups. Aging CBA/J mice appeared to be more 
successful in maintaining mechanical function compared to BALB/c and C57Bl/6. In the femur, 
there were no significant changes in ultimate load but a 39% greater stiffness. The femora of 
DBA mice showed no difference based on age in ultimate load but, similar to CBA/J mice, they 
exhibited a 41% greater stiffness (Figure 2.1 – A, B, C). These data demonstrate that not all 
strains change functionality with age similarly. 
In order to demonstrate changes in mechanical function, we tested for body size effects 
on the 4-point bending results. The ability for bone to adapt to mechanical loading has a large 
impact on bone health and remodeling [20, 21, 22, 23]. Therefore, it is important to consider 
the role weight change may have on the mechanical properties within the four mouse strains. 
                                                          
1 Complete table of data in Table 2.2 with unstandardized means. 
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BALB/c mice had an average 15% (p=0.003) greater body weight in the 18-month group 
compared to the 3-month animals. The 18-month C57Bl/6 animals, despite looking hunched 
and scruffy, also had body weights greater by 10% (p<0.001) than the 3-month mice. The most 
dramatic difference in weight was seen between the 3- and 18-month CBA/J mice, with a mean 
20% greater weight (p<0.001). The DBA/2 strain, however, showed no significant differences in 
body weight by age (Figure 2.1 – D). 
The consistent t-test outcomes before and after standardizing for weight suggested that 
weight was not significantly influencing the mechanical changes with age in each strain. To 
verify this, regressions between weight and mechanical parameters were run. In both BALB/c 
and C57Bl/6 mice, when age groups were pooled, weight did not change consistently with 
ultimate load or stiffness. In the CBA/J mice, ultimate load was not significantly related to 
weight. However, stiffness increased linearly with weight (R2=0.335, p<0.001). In the DBA/2 
strain, the regressions between weight and ultimate load and stiffness were not significant. Due 
to the fact that different strains seem to have different relationships with weight, standardizing 
values to body mass will remove bias from a weight interaction that might be different between 
strains.  
The two strains that had lower ultimate load means with age (BALB/c and C57Bl/6) may 
be losing strength at different rates. To test this, we ran general linear models as a full factorial 
model with age and strain as factors for ultimate load (Figure 2.2 – A) and stiffness (Figure 2.2 – 
B). By comparing the slopes of the age*strain interaction term, we were able to determine if 
age influences ultimate load and stiffness differently in the four mouse strains. For ultimate 
load, the age+strain+age*strain model was significant (p<0.001). The interaction of age and 
strain on ultimate load was not significantly different between the BALB/c and C57Bl/6 strains. 
However, values for BALB/c and C57Bl/6 mice differed in slope from values for CBA/J (p=0.004; 
p=0.002, respectively) and DBA/2 mice (p=0.016; p=0.022, respectively). This was expected 
based on the lack of change in ultimate load means with age in the CBA/J and DBA/2 strains. 
The model was also significant for estimating stiffness (p<0.001). As with ultimate load, 
the age-strain interaction was similar in the BALB/c and C57Bl/6 mice due to indistinguishable 
slopes. Again, BALB/c and C57Bl/6 mice showed different relationships between stiffness and 
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age compared to CBA/J (p=0.006; p<0.001) and DBA/2 mice (p=0.003; p<0.001). The change in 
stiffness was similar when CBA/J and DBA/2 were compared. 
Despite having different means at the 3-month time point in femoral ultimate load, the 
same age-related slope appeared for BALB/c and C57Bl/6 strains. This suggests that BALB/c and 
C57Bl/6 mice may engender similar patterns of bone aging relative to their starting values. 
CBA/J and DBA/2 mice also demonstrate similar aging patterns to each other, but display very 
different methods of aging when compared to the BALB/c and C57Bl/6 patterns.  
 
Experiment B: Causes of Functional Changes 
In Experiment A, we determined that the BALB/c and C57Bl/6 strains have less strength 
with age. Furthermore, the CBA/J and DBA/2 strains maintain strength with age. Our next goal 
was to determine the underlying causes behind the differential changes in ultimate load with 
age. To do this, we first investigated the contributions pre-yield and post-yield mechanics had 
on bone strength. The second part of this experiment compared the mechanical outcomes to 
morphological measures. The goal of this step was to consider the age-related changes in 
morphology and how they are influencing bone strength changes. 
  
BALB/c Mouse Parameter Relationships 
In BALB/c mouse aging, ultimate load was significantly lower in the 18-month mice 
compared to the 3-month mice with no difference in stiffness. In the 3-month mice, the 
regression between stiffness and ultimate load had an R2 = 0.64 (p=0.006). This relationship was 
not significant in the 18-month group (Figure 2.3 – A). An ANCOVA was run to test the similarity 
of intercepts and slopes between the two ages. The intercepts were significantly different 
(p=0.028) but the slopes followed similar trajectories. The offset of the intercept with invariant 
slopes indicated that at the same stiffness values, the older bones broke at lower loads. Since 
morphology would have influenced stiffness, the ANCOVA results suggest matrix alterations 
and post-yield changes leading to lower ultimate loads in the older animals. Average post-yield 
displacement (PYD) was 60% lower (p=0.002) in the older animals compared to younger 
animals. Furthermore, ultimate displacement was highly correlated with PYD (R=.924, p<0.001) 
but had no significant correlation with yield displacement. These data, in combination with the 
13 
 
lack of variant stiffness, all point to a dramatic change in post-yield properties leading to the 
weaker bone strength (Figure 2.4 – A).  
Comparing the 18-month mice to the 3-month mice, tissue mineral density (TMD) was 
11% lower (p=0.026) (Figure 2.6 – A), cortical thickness mean was 24% lower (p<0.001), and 
second moment of area (Iy) mean did not vary with age. There was no significant distinction 
between mean endosteal circumference between ages but there was a very small increase (2%) 
in marrow area (p=0.034). Average periosteal circumference was 9% greater in the aged 
animals (p=0.019), but there was an overall 17% reduction in average cortical area (p=0.001) 
(Figure 2.5 – A).2 
The marrow area did not increase greatly with aging in this strain. Therefore, periosteal 
expansion was not required to compensate for endosteal resorption. However, bone is able to 
adapt to changes in material properties by altering morphology [24]. The drop in TMD may be 
an explanation for small periosteal expansion that was measured as there tends to be a 
relationship between mineralization change and periosteal deposition [24]. The stiffness of the 
BALB/c femora does not seem to change statistically with age. Thus, the BALB/c femur is 
maintaining stiffness through minimizing endosteal resorption but still reducing ultimate load. 
The loss in strength is not likely due to major shape changes but rather differences in 
mineralization and alterations in collagen and/or porosity. Nyman (2007) asserts that non-
enzymatic collagen crosslinking and collagen content have a large effect on the age-related 
decrease in post-yield toughness [25]. Further study on the BALB/c mice should include 
assessment of the collagen and other matrix properties. 
 
C57Bl/6 Mouse Parameter Relationships 
Comparisons between femora of 18-month and 3-month C57Bl/6 mice demonstrated lower 
mean values of ultimate load and stiffness under 4-point bending in the 18-month mice 
compared to the 3-month group. The stiffness values were highly correlated with ultimate load 
(R2 = 0.609, p<0.001) in the 3-month mice, however, as in the BALB/c mice, this relationship 
was not present in the 18-month group (Figure 2.3 – B). ANCOVA results demonstrated a 
                                                          
2 Table of all microCT data with unstandardized means available in Table 2.3. 
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significant difference in both the intercepts (p<0.001) and slopes (p=0.008) of the ultimate load-
stiffness regressions. The average PYD was 25% less in the 18-month mice compared to 3-
month mice (p=0.004). Ultimate and post-yield displacements had a strong correlation 
(R2=0.737, p<0.001) whereas ultimate and yield displacements did not (Figure 2.4 – B). These 
results suggest large morphological and matrix changes occurring between the 3- and 18-
month periods leading to a disconnect between stiffness and ultimate load.  
 Compared to the 3-month mean, the 18-month average TMD was 8% lower (p<0.001) 
(Figure 2.6 – B). When mean values for the two ages were compared, the 18-month mice had 
23% thinner cortices (p<0.001), 3% larger second moment of area (p=0.045), and 5% greater 
endosteal circumference (p=0.025) leading to a 25% larger marrow area (p<0.001) compared to 
the 3-month mice. Mean periosteal circumference was not different between ages. The greater 
marrow area accompanied by the lack of periosteal expansion led to a 16% lower cortical area 
in the 18-month mice than the 3-month mean (p<0.001) (Figure 2.5 – B). 
 Reduced mineralization and an inadequate change in second moment of area led to less 
stiff bones in the 18-month C57Bl/6 mice than the 3-month mice. This was tested by estimating 
the increase in second moment of area required to compensate for the reduced TMD.  
First, we set up a simplified system assuming modulus was only dependent on TMD: 
 S = Iy  × TMD 
We calculated the stiffness of the 3-month C57Bl/6 group: 
S3mo = Iy 3mo  ×  TMD3mo 
S3mo = .0058 ×  34.63 
S3mo = .2009 
 
Now, we solved for the required second moment of area at 18 months to keep stiffness 
constant, accounting for the change in TMD: 
. 2009 = Iy 18mo  ×  TMD18mo 
. 2009 = Iy 18mo  ×  31.89 
 Iy 18mo =  .0063 
 
 Interestingly, the estimated necessary second moment of area value was almost exactly 
the same as the actual average second moment of area value at 18 months. Yet, stiffness was 
still smaller in the 18-month animals. This simplified model ignores the fact that bone is a 
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composite material. The true elastic modulus is dependent upon mechanical changes in mineral 
and matrix. Therefore, it is possible that mineral density is an insufficient correlate for the 
modulus of the mineral phase, or that the matrix modulus is changing enough to alter the total 
elastic modulus. This lends support for the need to further investigate differences in matrix 
properties in the aging mouse strains. 
The lower bending stiffness was likely contributing to the overall lower mechanical 
stability as evidenced by the correlation between stiffness and ultimate load. However, as 
C57Bl/6 mice aged, the strong relationship between stiffness and ultimate load disappeared, 
suggesting other factors were also causing the lower ultimate load. The loss in ultimate load 
was likely also caused by changes in the post-yield region, supported by the strong correlation 
between ultimate displacement and PYD. In addition to the hypothesized alteration to post-
yield properties, the C57Bl/6 mice also had mineralization and shape differences that led to less 
stiff bones in the 18-month mice than 3-month mice. An interesting aspect of C57Bl/6 
mechanical properties was the very long post-yield region in both age groups. This is suggestive 
of a strong reliance on matrix properties and organization to resist fracture. If aging alters 
collagen and other matrix properties, as has been proposed, the mouse strain most dependent 
on post-yield properties experiences the largest drop in ultimate strength without adequate 
shape adaptations. 
 Unlike the BALB/c mice, the second moment of area in the C57Bl/6 mice was greater in 
the 18-month mice compared to the 3-month mice. This difference was not sufficient to 
balance the lowered cortical thickness, cortical area, mineralization, and post-yield 
modifications. While aging in the BALB/c mice seemed to be dominated by post-yield changes 
with little morphological difference, C57Bl/6 mice experienced decreased stiffness and post-
yield properties in addition to marrow expansion.  
 
CBA/J Mouse Parameter Relationships 
 The CBA/J strain of mice experienced no significant difference in ultimate load when 
comparing the 3- and 18-month groups but stiffness was 16% greater in the 18-month animals 
(p=0.033). In the CBA/J strain, the femur had a significant regression between stiffness and 
ultimate load in both the 3-month group (R2 =0.682, p<0.001) and the 18-month group 
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(R2=0.488, p=0.002) (Figure 2.3 – C). The ANCOVA results showed no difference in either the 
intercepts (p=0.704) or the slopes (p=0.956) of the lines. However, PYD undergoes a dramatic 
65% drop in CBA/J with aging (p<0.001) and ultimate displacement had a strong relationship to 
PYD (R2=0.816, p<0.001) (Figure 2.4 – C). Interestingly, when the 18-month group was 
considered independently, the relationship between ultimate displacement and PYD was no 
longer significant. The 3-month mechanical properties seemed dependent upon both pre- and 
post-yield mechanics, however, the PYD approached zero in the 18-month animals. The loss of 
ductility could have led to the need to increase stiffness to maintain ultimate load. 
 The increase in stiffness was not likely due to mineralization increase, since TMD 
decreased 13% (p<0.001) with age (Figure 2.6 – C). We set up a simplified system to test if 
stiffness is maintained through morphology: 
 S = Iy  × TMD 
S3mo = Iy 3mo  ×  TMD3mo 
S3mo = .00316 ×  37.95 
S3mo = .1199 
 
Next, we solved for the required second moment of area at 18 months to keep stiffness 
constant, accounting for the change in TMD: 
. 1199 = Iy 18mo  ×  TMD18mo 
. 1199 = Iy 18mo  ×  32.83 
 Iy 18mo =  .0037 
 
 In order to maintain stiffness and compensate for the drop in mineral density, CBA/J 
mice would have required a new second moment of area value of .0037. The actual 18-month 
second moment of area value is .0049, suggesting that CBA/J aged animals were more than 
compensating for the drop in mineralization by adaptations to geometry.  
 In reality, second moment of area increased with age 53% (p<0.001). This was driven by 
changes on the endosteal and periosteal surfaces. The circumference of the endosteal surface 
increased by 12% (p<0.001) resulting in a 43% increase in marrow area (p<0.001). Periosteal 
circumference did not change significantly but total area increases 10% (p<0.001). This led to an 
overall 13% drop in cortical thickness (p<0.001) but no change in cortical area (Figure 2.5 – C). 
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The CBA/J mice are able to accommodate both the loss of TMD and endosteal resorption by 
adding bone on the periosteal surface.  
  
DBA/2 Parameter Relationships 
DBA/2 mice experienced no age-related loss in ultimate load but stiffness increased 23% 
(p=0.026). The femora of DBA/2 mice had a strong relationship between stiffness and ultimate 
load at 3-months of age (R2=0.535, p=0.016). This relationship is maintained in the 18-month 
group, as well (R2 = .983, p<0.001) (Figure 2.3 – D). The ANCOVA resulted in no difference in the 
intercepts (p=0.428) or slopes (p=0.332) of the regression lines.  In contrast with the other 
three strains, DBA/2 mice did not exhibit a drop in PYD as they aged. While CBA/J mice seem to 
have increased stiffness but lost ductility, the DBA/2 strain appeared to increase stiffness while 
maintaining ductility (Figure 2.4 – D). The increased stiffness of CBA/J mice may be at the 
expense of ductility. Furthermore, the increase in stiffness could be compensation for the loss 
of ductility. In the DBA/2 mice, stiffness increased but post-yield properties did not change. This 
trend demonstrates that the change in stiffness is accomplished without affecting ductility. The 
stiffness increase of DBA/2 old mice was, therefore, primarily geometric rather than 
compositional and/or organizational since most of these changes would result in modified post-
yield properties, as well. 
 This was supported by the lack of change in TMD value in the 18-month DBA/2 animals 
compared to 3-month mice (Figure 2.6 – D). Additionally, second moment of area increased a 
dramatic 96% (p<0.001) with age. In the previous strains, it was assumed that the loss of 
mineral density prompted the geometry changes leading to stiffness changes. However, in the 
DBA/2 strain, we saw no change in mineral density but still a large increase in both second 
moment of area and stiffness. If not a response to changing material properties, the increased 
second moment of area could have been a result of compensation for endosteal resorption.  
 To support this theory, we set up the second moment of area at 3 months and at 18 
months to be equal: 
Iy 18mo =  Iy 3mo 
Adding the equation for Iy: 
 (dperi18
4 − dendo18
4 ) = (dperi3
4 − dendo3
4 ) 
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Filling in our averages at 3 months and the change in endosteal surface: 
(dperi18
4 −. 03514) = (. 04394 −. 02764) 
(dperi18
4 ) = (. 04394 −. 02764 +. 03514) 
(dperi18
4 ) =  .0464 
 
Multiplying this by π we found the required periosteal circumference required to accommodate 
the endosteal resorption common in aging. The minimum required value to, at least, maintain 
second moment of area is 0.146. The actual average periosteal circumference in the DBA/2 18-
month animals is 0.157 (Figure 2.5 – D). The DBA/2 mice were capable of responding to age-
related endosteal resorption by adding bone to the periosteal surface, therefore providing 
support to maintain bone strength. 
 
Discussion 
The first hypothesis of this work asks if the four mouse inbred strains exhibit changes in 
bone strength with aging. We found that two of the strains, BALB/c and C57Bl/6, lose 
functionality with age and two, CBA/J and DBA/2 maintain functionality with age. The second 
hypothesis is proposed to determine if age-related changes in strength are parallel in the four 
strains. The linear models show that the two strains that lost strength have similar relative rates 
of loss. The last question investigated in this chapter asks if the changes in strength occur due 
to similar changes in morphology. The data demonstrate that the causes behind the loss of 
strength in the BALB/c and C57Bl/6 strains are different. Similarly, the CBA/J and DBA/2 strains, 
which maintained bone strength, also did so in two distinct ways. 
Those that lost strength either did not add or insufficiently added bone on the periosteal 
surface. The BALB/c mice maintained stiffness but had significant losses of post-yield 
displacement that led to the reduced strength. The combination of mechanical and 
morphological data indicates a loss of strength due to non-geometric changes. The reduced 
strength is due to the lower mineralization and matrix changes reducing post-yield properties. 
In the C57Bl/6 mice, the mechanical data demonstrate a reduction in strength, stiffness, and 
ductility. The loss of strength can be attributed to both the mineralization and matrix changes, 
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as in BALB/c, but also to geometric changes. The loss of strength and stiffness is partly due to 
the marrow expansion without adequate periosteal compensation.  
 In contrast to the first two strains, the CBA/J and DBA/2 mice maintained strength with 
age, in part, by increasing stiffness. In the CBA/J strain, the loss of mineralization, post-yield 
displacement, and endosteal bone are compensated for by periosteal expansion in CBA/J aging. 
The increase in periosteal bone led to the greater stiffness, however, the bones became much 
more brittle. Unique to the DBA/J mice, the older animals did not experience altered PYD or 
TMD. This indicates minimal changes to the composition of the bone throughout the aging 
process. However, the old mice do experience dramatic changes to their bone geometry. 
Similar to the CBA/J mice, the DBA/2 strain is able to compensate for the endosteal resorption 
by adding bone to the periosteal surface. 
 With respect to the first hypothesis, the results of this chapter differ slightly from 
previous work published on aging mouse strains. In one study, BALB/c males reportedly have a 
steady increase in stiffness throughout aging [27]. Our data found no change in stiffness in the 
male BALB/c mice with age. Reports of C57Bl/6 aging have shown no decline in stiffness or 
strength in the femur after 12 months [7]. Our data demonstrate a loss in both stiffness and 
ultimate load in this strain. One major difference in methodology is the use of standardized 
values to account for weight differences which would reduce variance in the samples. However, 
running the t-tests on unstandardized values produced the same significant trends. Another 
possible source of disagreement may be due to cohort and/or seasonality effects. Furthermore, 
variation in housing practices could lead to different results.  
The age-related changes reported in this paper, compared to previous work for BALB/c 
and C57Bl/6 strains, are more representative of changes documented in humans. In human 
bone aging, cortical bone strength declines with age [27, 28, 29, 30, 31]. The results of this work 
demonstrate that there are different ways to lose bone strength. Strength can be lost due to 
changes on the material level. This includes changes to collagen organization and cross-linkage 
and crystallinity, among others. Most current diagnostic approaches in assessing human 
fracture risk measure bone morphological changes. Unfortunately, as evidenced by the BALB/c 
aging patterns, loss of bone strength may be caused by matrix composition and organization 
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changes that are not commonly measured in clinical settings. Therefore, in order to better 
assess fracture risk, clinicians need methods of measuring both changes in morphology and 
material properties. One method that is currently being investigated is the use of RAMAN 
spectroscopy. RAMAN measures can provide information on material-level properties such as 
mineral and matrix profiles [32]. A combination of RAMAN and DXA diagnostics could provide 
more accurate predictions of fracture risk. 
There is a scarcity of research that reports on the maintenance of bone strength with 
age across mouse strains. The CBA/J and DBA/2 mouse strains could provide a useful model for 
humans that age without incurring an age-related fracture. Again, the maintenance of 
mechanical integrity can be attained in multiple ways. The CBA/J mice were able to compensate 
for aging changes by increasing periosteal diameter but potentially at the cost of ductility. The 
DBA/2 mice had large increases in second moment of area without compromising ductility. In 
human aging, there is a positive relationship between loss of mineralization and periosteal 
deposition [33]. This is supported when comparing CBA/J bone aging with BALB/c and C57Bl/6 
aging. The CBA/J mice had the greatest loss in TMD with age and experienced periosteal bone 
growth whereas BALB/c and C57Bl/6 did not expand periosteally. However, when comparing 
the CBA/J and DBA/2 aging patterns, this relationship is no longer valid. The DBA/2 mice did not 
lose mineralization with age as the CBA/J did, yet both strains had large amounts of periosteal 
bone growth. This suggests that the TMD loss may be related to periosteal growth but not 
necessary for the deposition to occur.  
In human bone aging, expansion occurs at both the endosteal and periosteal surfaces 
[34, 35, 36, 37, 38, 39]. Men tend to maintain bone strength better than women during aging 
[36, 37]. This is in part due to the geometry differences, where men have more robust bones, 
on average, than women. Therefore, periosteal deposition in men has a greater influence on 
second moment of area than in women [33]. Interestingly, the BALB/c and C57Bl/6 have more 
robust bones compared to the CBA/J and DBA/2 mice, yet the latter two strains are better at 
maintaining strength. This is contrary to what would be expected based on sex differences in 
humans.  
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Since there are no female mouse data in this study, direct conclusions cannot be drawn 
regarding sex differences in bone aging. It has been suggested that women are less able to 
maintain strength with age compared to men due to inherent geometric limitations. Periosteal 
deposition on a robust (male-like) individuals has a greater impact on second moment of area 
than it would have on a slender (more female-like) individual [33].  However, the finding that 
the more slender mouse strains maintain strength suggests that the inability for women to add 
sufficient bone periosteally is not due to the bone size and shape. Thus, the lack of periosteal 
expansion in some women may have other biological causes (e.g. hormonal differences). 
Following studies should investigate the aging patterns in the female mice of these strains. It is 
possible that we will see similar ability to maintain strength in the CBA/J and DBA/2 mice, 
compared to their male counterparts. If this is the case, we can begin to investigate what is 
unique in humans that leads to the loss of strength due to inadequate periosteal growth.  
The results of this chapter also provide a reason for using caution when studying mouse 
models as analogs for human aging. Most studies of mouse aging have been conducted on 
individual inbred strains or genetically modified strains [7, 9, 10, 27, 34]. The conclusions made 
concerning mouse bone aging will largely differ if one group using the C57Bl/6 strain only while 
another group studies the CBA/J strain. Therefore, it must be understood that results from 
single-strain studies are not representative of the range of variation possible in the mouse 
species.  
One drawback to the cross-sectional approach taken in this work is the assumption that 
differences in mean values between the two age groups are representative of changes within 
an individual as they age. Despite this limitation, many age-related studies are cross-sectional in 
design in order to expedite results. In one such study, researchers compared cross-sectional 
and longitudinal results from the same cohort. The authors conclude that cross-sectional study 
design may underestimate the age-related changes [26]. Therefore, the use of cross-sectional 
measures in this work provides a more conservative approach. 
 
Future Work 
Due to the limitations on the breadth of this thesis, these data do not illuminate the 
underlying biological causes of the variability in bone aging outcomes. However, having defined 
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the patterns of variation here will allow for future work to address the causative factors. In 
humans, individuals with greater resorption rates tend to have larger bone cross-sectional 
geometry. The ability to resorb bone may be allowing for increased periosteal expansion [38] in 
the CBA/J and DBA/J strains. The high amounts of resorption on the endosteal surface could 
permit associated periosteal deposition. Bone is a metabolically expensive tissue. With limited 
resources, the freeing of minerals bound to the endosteal surface of the bone may allow these 
to be recycled and added to the periosteal surface.  
Bone aging variation could also be due to age-related changes in the adaptive response 
to load. BALB/c, C57Bl/6, and CBA/J mice all increase body weight with age. The adaptive 
response to increased load should lead to changes in bone morphology and composition that 
increase resistance to failure. The fact that BALB/c and C57Bl/6 mice do not have the weight-
induced expected adaptive response, suggests that the mechanoresponse system is lost or 
modified with age in these strains.  
Variation in aging could also be due to metabolic and life history patterns that differ 
between the strains. The C57Bl/6 strain has the longest average lifespan of the four inbred 
strains used in this study, but the most significant loss in bone mechanical stability [14]. This 
strain could be reallocating resources towards organism survival at the cost of bone function. In 
support of this, the C57Bl/6 strain tends to have high body fat and low BMD compared to the 
other strains [14]. Tests were run using data from the Ackert-Bicknell and Yuan data reported 
on phenome.jax.org [11, 14]. Comparing the mean changes in BMD and body fat in the males of 
23 strains shows a strong negative correlation between these parameters (R=-0.587, p=0.003). 
The lower life expectancy of CBA/J mice could be due to the strain’s strategy of investing in 
body fat AND bone. This approach to aging could lead to over-expenditure of resources in bone 
and fat, at the expense of maintaining the integrity of other vital systems thus reducing life 
expectancy. This is supported by work not presented in this thesis. In a heterogeneous 
population of mice, those with larger bones at 4-months of age had a shorter lifespan [42].  
Future work should also include a better understanding of the variability in human 
aging. We have shown that within a single species, different genetic backgrounds and/or life 
histories can lead to variations in organism aging. We need to measure how variable human 
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bone aging is in order to provide adequate predictive, diagnostic, and treatment approaches 
that accounts for the heterogeneity inherent in humans. The biological causes of the difference 
in aging pattern are unknown. However, with evidence of variant aging patterns in the mouse 
strains, comparative studies between mice that lose mechanical integrity and those that do not 
may provide integral information as to the intrinsic and external influences leading to bone 
aging variation. Inferences from this future work could allow for a better understanding of the 
relationships between variables known to influence human bone aging and their effect on 
skeletal fragility and fracture risk. 
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A.       Ultimate Load     B.   Fail Load 
   
 
     C.               Stiffness     D.      Weight 
  
Figure 2. 1 - Changes in mechanical function parameters.   
T-tests were run within strains—BALB/c, C57Bl/6, CBA/J, and DBA/2—comparing 3- and 18-month 
groups. A) Ultimate load; B) Fail load; C) Stiffness; D) Body weight       *p<0.05 ±1 SD 
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Table 2. 1 - Femoral 4-point bending results. 
Numerical data reporting ultimate load, fail load, and stiffness changes in all 4 inbred strains. T-test are 
considered significant at p<0.05. Percent change = (18 month mean – 3 month mean)/(3 month mean) 
*100. 
   Ultimate Load (N) Fail Load (N) 
Strain Age n Mean Stdev p-value % Change Mean Stdev p-value % Change 
BALB 
3 10 39.82 6.19 
0.006 -23.98 
35.83 6.43 
0.054 -19.01 
18 6 30.28 4.83 29.03 5.93 
C57Bl/6 
3 18 29.09 4.23 
<0.001 -29.89 
25.39 7.14 
0.001 -29.38 
18 17 20.39 4.71 17.92 5.14 
CBA/J 
3 20 38.95 8.34 
0.195 10.19 
36.34 9.21 
0.12 13.57 
18 17 42.92 9.96 41.26 9.55 
DBA/2 
3 8 29.06 4.94 
0.515 -5.3 
26.78 4.43 
0.863 1.37 
18 6 27.52 3.28 27.15 3.05 
 
   Stiffness (N/mm) 
Strain Age n Mean Stdev p-value % Change 
BALB 
3 10 243.08 45.17 
0.486 -7.28 
18 6 225.39 52.39 
C57Bl/6 
3 18 153.1 45.84 
0.008 -27.19 
18 17 111.48 40.06 
CBA/J 
3 20 244.26 55.51 
<0.001 38.55 
18 17 338.43 55.63 
DBA/2 
3 8 185.49 25.29 
0.005 28.87 
18 6 239.03 37.02 
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A.  Ultimate Load         B.             Stiffness 
 
                       
Figure 2. 2 - Graphical representation of general linear models. 
General linear modeling was run with age and strain as factors and including the interaction term 
(age*strain). A) The linear model shows that the rate of change in BALB/c and C57Bl/6 are statistically 
similar to each other but both are different from CBA/J and DBA/2, as there is no difference in ultimate 
load in these strains. B) The model estimated slopes of stiffness change are not different between 
BALB/c and C57Bl/6. These two strains experience a similar relative loss of stiffness with age. The slopes 
are significantly divergent from the CBA/J and DBA/2 rates of change, regardless of starting values. 
CBA/J and DBA/2 stiffness increases with age. 
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A.       B.
 
C.       D.
 
 
Figure 2. 3 - Linear relationship between stiffness and ultimate load. 
Regressions were run for the 3 month and 18 month groups of all four strains. The blue lines represent 
the 3-month regressions and the green lines represent the 18-month regressions. A) At 3 months, the 
BALB/c femoral stiffness is linearly related with ultimate load (R2=0.636, p=0.006). In the 18-month 
sample, the relationship is no longer significant. B) The 3-month C57Bl/6 stiffness-ultimate load 
relationship is also significant (R2=0.609, p<0.001). The 18-month femora do not maintain this 
relationship. C) The linear relationship between stiffness and ultimate load is stronger in the CBA/J 
younger mice (R2=0.682, p<0.001) than the older mice (R2=0.488, p=0.002). The linear relationship is 
weaker in the DBA/2 younger mice (R2=0.535, p=0.016) when compared to the older animals (R2=0.983, 
p<0.001). 
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 A.         BALB/c     B.  C57Bl/6 
 
C.          CBA/J     D.  DBA/2 
 
 
Figure 2. 4 - Load-displacement curves for 4-point bending. 
Maize markers represent data points on the load-displacement curves of a representative 3-month 
animal for each strain. Blue markers are representative animals at 18 months. A) BALB/c have similar 
stiffness between ages but a lower ultimate load in the older animals. There is no difference in yield load 
or displacement. The older mice have a mean ultimate displacement that is 41% less (p<0.001) and a 
PYD that is 60% less (p=0.002) than the 3-month mean. B) C57Bl/6 femora have lower ultimate load and 
stiffness means in the older mice compared to younger. The 18-month yield load is 26% lower (p=0.002) 
than that of the 3-month mice. The old mice have a 13% lower ultimate displacement mean (p=0.053) 
and a 25% lower PYD mean (p=0.004) than the 3-month mice. Yield displacement is invariant between 
the age groups. C) The 18-month CBA/J mice have greater stiffness with similar ultimate and yield load 
averages compared to the 3-month mice. In the old mice, yield displacement is 25% less (p=0.025), 
ultimate displacement is 45% less (p<0.001) and PYD is 65% less (p<0.001) than the 3-month means. D) 
DBA/2 mice have greater stiffness in the older femora but there is no difference in ultimate, yield, or fail 
loads when compared to the 3-month means. Yield displacement if 42% lower in the older mice than the 
younger mice (p=0.002), ultimate displacement is 35% lower (p<0.001), but there is no difference in 
PYD.  
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Table 2. 2 - Summary of mechanical testing data. 
Data is presented in unstandardized form. Means are given ±1 SD. Values highlighted in BOLD represent 
18-month means that were significantly different from the 3-month means in t-test with significance 
determined p ≤ 0.05. 
 BALB/c C57Bl/6 CBA/J DBA/2 
 
3 
months 
18 
months 
3 
months 
18 
months 
3 
months 
18 
months 
3 
months 
18 
months 
N 10 6 18 19 20 17 10 6 
Ultimate Load 
39.82 
±6.19 
30.28 
±4.83 
29.09 
±4.23 
19.87 
±4.96 
38.95 
±8.34 
42.92 
±9.96 
29.05 
±4.66 
27.52 
±3.28 
Yield Load 
21.90 
±5.09 
21.80 
±6.70 
14.13 
±4.43 
11.45 
±5.28 
25.76 
±6.64 
31.44 
±9.58 
21.42 
±8.88 
20.96 
±5.22 
Fail Load 
35.83 
±6.43 
29.03 
±5.93 
25.39 
±7.14 
17.51 
±5.21 
36.34 
±9.21 
41.26 
±9.55 
26.75 
±4.18 
27.15 
±3.05 
Stiffness 
243.08 
±45.17 
225.39 
±52.39 
153.10 
±45.84 
103.87 
±45.62 
244.26 
±55.51 
338.43 
±55.63 
169.06 
±57.15 
239.03 
±37.02 
Ultimate 
Displacement 
.26 ±.03 .18 ±.04 .36 ±.05 .34 ±.08 .24 ±.04 .16 ±.03 .23 ±.03 .15 ±.02 
Yield 
Displacement 
.10 ±.02 .10 ±.03 .10 ±.04 .14 ±.12 .12 ±.04 .11 ±.04 .14 ±.04 .09 ±.02 
Fail 
Displacement 
.29 ±.06 .19 ±.05 .51 ±.17 
.37 
±.16 
.30 ±.15 .17 ±.04 .25 ±.05 .16 ±.02 
Total Energy 
8.00 
±2.75 
3.72 
±1.58 
10.77 
±3.34 
4.40 
±2.03 
7.33 
±2.98 
4.18 ±1.51 
4.56 
±1.64 
2.58 ±.91 
Elastic Energy 
1.20 
±.49 
1.26 ±.84 .80 ±.63 .61 ±.43 
1.77 
±.29 
1.85 ±.88 1.61 ±.92 .95 ±.53 
Plastic Energy 
6.80 
±2.71 
2.46 
±1.97 
9.97 
±3.39 
3.79 
±2.20 
5.56 
±2.83 
2.33 ±1.81 
2.95 
±1.81 
1.63 ±1.01 
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A - BALB/c           B - C57Bl/6 
                         
C - CBA/J           D - DBA/2 
                
 
Figure 2. 5 - Geometry comparisons between 3- and 18-month mice. 
Geometric outlines from µCT images demonstrate size and shape changes that occur with aging. Black 
outlines represent a typical 3 month animal and the red outlines are of a typical 18 month animal. 
Centroids of representative individuals from both time points are aligned. A) Compared to the 3-month 
means, BALB/c 18-month cortical thickness is 24% lower (p<0.001), cortical area is 17% lower (p=0.001), 
endosteal circumference is no different, marrow area is 2% larger (p=0.034), periosteal circumference is 
9% larger (p=0.019), resulting in no difference in second moment of area (Iy). B) Compared to the 3-
month means, C57Bl/6 18-month have a 23% smaller cortical thickness (p<0.001), 16% smaller cortical 
area (p=0.001), 5% greater endosteal circumference (p=0.025), 25% greater marrow area (p<0.001), and 
no difference in periosteal circumference, resulting in a 3% increase in Iy (p=0.045). C) Compared to the 
younger mice, CBA/J old mice have a 13% smaller cortical thickness (p<0.001), no difference in cortical 
area, 12% greater endosteal circumference (p<0.001), 43% greater marrow area (p<0.001), no 
difference in periosteal circumference, and a 10% greater total area (p<0.001), resulting in a 53% 
increase in Iy (p<0.001). D) Compared to the younger mice, DBA/2 old mice have a 10% smaller cortical 
thickness (p=0.014), 14% greater cortical area (p=0.002), 27% greater endosteal circumference 
(p<0.001), 82% greater marrow area (p<0.001), 14% greater periosteal circumference (p=0.003), and a 
38% greater total area (p<0.001), resulting in a 96% increase in Iy (p<0.001). 
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    BALB/c              C57Bl/6 
                  
          3 month       18 month        3 month  18 month 
 
                  CBA/J      DBA/2 
                  
           3 month      18 month          3 month  18 month 
 
 
Figure 2. 6 - Alpha-blend comparisons of mineralization patterns between ages. 
From µCT data, mineralization is visualized on a colorimetric scale with regions highlighted red having 
the most mineralized tissue. A) In the BALB/c old mice, TMD is 11% less than the younger mice 
(p=0.026). B) The old C57Bl/6 mice have an 8% lower TMD than the 3-month mean (p<0.001) C) The 
CBA/J old mice have a 13% lower mean TMD than the younger mice (p<0.001). D) DBA/2 young and old 
mice have TMD means that are not significantly different. 
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Table 2. 3 - Summary of microCT data results. 
Data is presented in unstandardized form. Means are given ±1 SD. Values highlighted in BOLD represent 
18-month means that were significantly different from the 3-month means in t-test with significance 
determined p ≤ 0.05. 
 BALB/c C57Bl/6 CBA/J DBA/2 
 
3 
months 
18 
months 
3 
months 
18 
months 
3 
months 
18 
months 
3 
months 
18 
months 
N 10 6 19 19 20 17 10 6 
TMC (mg) 
3.42 
±.34 
3.34 ±.43 2.55 ±.26 2.48 ±.22 3.11 ±.47 4.11 ±.38 2.18 ±.11 2.61 ±.20 
TMD (mg/cc) 
1218.87 
±24.22 
1251.85 
±14.34 
1064.26 
±44.38 
1084.76 
±60.24 
1273.13 
±74.22 
1318.68 
±36.64 
1242.95 
±25.92 
1251.66 
±21.89 
Cortical 
Thickness (mm) 
.28 ±.02 .24 ±.02 .22 ±.01 .19 ±.01 .34 ±.02 .34 ±.03 .25 ±.01 .24 ±.01 
Ix (mm4) .40 ±.09 .41 ±.09 .37 ±.05 .41 ±.05 .23 ±.04 .37 ±.04 .15 ±.01 .28 ±.04 
Iy (mm4) .15 ±.03 .19 ±.03 .18 ±.02 .21 ±.02 .11 ±.01 .19 ±.03 .06 ±.01 .13 ±.02 
Ixy (mm4) 
.009 
±.026 
.001 
±.018 
.02 ±.04 .02 ±.04 .01 ±.02 .01 ±.01 .01 ±.01 
.002 
±.005 
Endosteal 
Circumf. (mm) 
3.51 
±.29 
4.02 ±.27 4.17 ±.21 4.82 ±.17 2.38 ±.14 3.19 ±.29 2.60 ±.12 3.44 ±.23 
Periosteal 
Circumf. (mm) 
5.28 
±.32 
5.53 ±.32 5.56 ±.25 5.96 ±.19 4.57 ±.20 5.44 ±.27 4.12 ±.10 4.88 ±.22 
Marrow Area 
(mm2) 
.82 ±.12 1.11 ±.15 1.15 ±.10 1.58 ±.09 .38 ±.05 .65 ±.10 .43 ±.03 .82 ±.10 
Cortical Area 
(mm2) 
1.14 
±.13 
1.09 ±.11 .99 ±.06 .92 ±.06 1.10 ±.08 1.30 ±.09 .77 ±.03 .92 ±.07 
Total Area 
(mm2) 
1.97 
±.23 
2.20 ±.22 2.14 ±.15 2.50 ±.11 1.48 ±.10 1.94 ±.11 1.20 ±.05 1.73 ±.16 
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    3 month           18 month  
 
Figure 2. 7 - Summary of BALB/c results. 
Visualizations combined to summarized the findings for the BALB/c femora at 3 and 18 months. BALB/c-
18 month mice have lower mean ultimate load and fail load. Stiffness is not different and weight 
increases with age. There is little morphological differences between ages. TMD is 11% less in the older 
mice compared to 3-month mice. This, in addition to load-displacement curves, suggest loss in 
mechanical stability is primarily due to decreased mineralization and matrix changes leading to 
brittleness. 
* 
* * 
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        3 month      18 month 
 
Figure 2. 8 - Summary of C57Bl/6 results. 
Visualizations combined to summarized the findings for the C57Bl/6 femora at 3 and 18 months. 18-
month mice have lower mean ultimate load, fail load, and stiffness. Weight increases with age. TMD is 
less in the older mice and geometry is unable to adapt appropriately to maintain stiffness. The loss of 
mineralization, the lack of morphology adaptation, and a slight loss of ductility contribute to the 
reduced mechanical properties in the 18-month mice compared to the 3-month mice.  
 
* 
* * * 
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       3 month     18 month 
 
Figure 2. 9 - Summary of CBA/J results. 
Visualizations combined to summarized the findings for the CBA/J femora at 3 and 18 months. 18-month 
mice have no difference in ultimate or fail loads compared to the 3-month mice. Stiffness and weight 
are both greater in the older animals. There is large amount of marrow expansion, which is 
compensated for through periosteal apposition. The periosteal expansion leads to an increase in second 
moment of area that recovers the stiffness lost from a lower TMD in the older mice. This increase in 
stiffness maintains ultimate load but may occur at the expense of ductility. 
 
 
* 
* 
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                 3 month         18 month    
 
Figure 2. 10 - Summary of DBA/2 results. 
Visualizations combined to summarized the findings for the DBA/2 femora at 3 and 18 months. DBA/2 
18-month mice have no difference in ultimate load, fail load, or weight when compared to the 3-month 
mice but have a greater stiffness. There is no difference in TMD between the ages. Therefore, periosteal 
expansion is possibly in response to endosteal resorption. The increase in stiffness and maintenance of 
ultimate load suggest appropriate adaptive response to age-related marrow expansion. 
 
 
* 
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CHAPTER III:  
PATTERNS OF BONE AGING VARY BETWEEN MOUSE STRAINS 
 
Introduction 
 The previous chapter demonstrated that there are differing strategies to bone aging in 
the various inbred mouse strains. The two mouse strains with the most dissimilar aging 
outcomes are the C57Bl/6 and CBA/J mice. Due to limited availability of the aged mice, in this 
chapter, we will only investigate these two strains. Future work should expand to include the 
BALB/c and DBA/2 strains, as well as female mice. When comparing the age extremes – 3 and 
18 months –the C57Bl/6 mice do not maintain the same level of bone strength and stiffness. 
The CBA/J mice have mechanical properties that provide consistent ultimate load values at 3 
and 18 months.  
 The results from the first chapter suggest that the inbred mouse strains do, in fact, 
undergo different patterns of aging that lead to variable changes in mechanical functionality. 
However, in comparing 3- and 18-month mice, it is unclear as to the onset and continuity of 
age-related bone changes. That approach also prevents inference on which features of bone 
aging occur in response to changes in others. This chapter will include data from 10-month and 
14-month animals for more precise understanding of the onset and progression of the bone 
aging changes.  
 In this chapter, I will test two primary hypotheses. The first hypothesis is that age-
related changes in mouse bone will not occur at the same rate and timing in both strains. We 
predict that the C57Bl/6 mice will begin to lose mechanical properties and bone quantity earlier 
than the CBA/J mice. If this is not supported and both strains undergo bone changes 
simultaneously, we suggest that C57Bl/6 mice will lose bone properties at a faster rate.  
The second hypothesis that will be tested in this chapter is that changes in cortical bone 
with aging will be correlated with changes in trabecular bone with aging. Many fragility 
fractures occur in highly trabeculated regions such as the femoral neck. Therefore, it is critical 
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to compare the aging strategies in the two mouse strains with respect to the trabecular 
compartments. In human aging, cortical and trabecular bone changes do not always coincide. In 
order to utilize the comparative approach to variability in bone aging, the trabecular patterns of 
aging must be elucidated.  
The more complete examination of bone aging in the two mouse strains, will provide a 
stronger model for understanding the factors that impact bone aging. By enumerating a large 
array of age-related changes in the bones of the two mouse strains, we can determine if these 
strains are appropriate models for patterns of human bone aging. 
 
Materials and Methods 
Animals 
All animals used were male mice procured through the NIA/NIH aged colonies. The two 
inbred strains utilized are C57Bl/6 and CBA/J. Each strain was analyzed cross-sectionally at 3, 
10, 14, and 18 months. The 3, 10, and 14 month animals were euthanized upon arrival and 
femora and tibiae excised and frozen in PBS. The oldest age at which both strains were 
available was 17 months. Therefore, animals were group housed for 4 weeks. After the 4 week 
waiting period, all 18 month animals were euthanized and bones extracted and frozen. 
 
Micro-Computed Tomography (µCT) 
All bones were scanned with a GE Medical eXplore Locus SP scanner (GE Medical, 
Waukesha, WI) at 18 µm voxel size using a beam flattener. Specimens were scanned in a 
custom designed 8-bone holder to maximize throughput. The size of each region of interest 
(ROI) for cortical bone was defined as 10% of total bone length. The ROI was situation so the 
proximal-most point centered at 50% of length. Trabecular ROI was defined as 10% of total 
bone length. The most proximal point of the trabecular ROI coincided with the termination of 
the growth plate. Using GE MicroView 2.2 ABA software, an auto-thresholding algorithm was 
employed and morphological measures recorded. 
 
42 
 
Mechanical Testing 
Bones were tested in 4-point bending with a custom designed system controlled using a 
Mini Bionix II servohydraulic system (MTS; Eden Prairie, MN). Femora were oriented such that 
load was applied in the anterior-posterior direction with posterior in tension. Based on the 
curvature of the tibiae, they were loaded also in the anterior-posterior direction but with the 
anterior surface in tension. The fibula was separated prior to testing. Load was applied using a 
constant displacement rate of 0.05 mm/s. A custom MATLAB script was written to extract 
critical data from the load-displacement curves. Primary outcome measures of interest were 
ultimate load, fail load, and stiffness. 
 
Statistical Analysis 
All statistics were run using commercially available software packages SPSS (IBM corp., 
Armonk, NY) and GraphPad Prism (GraphPad Software, San Diego, CA). ANOVA analysis were 
used to compare parameters age groups within strains. A Games-Howell post-hoc analysis was 
used due to variation in sample size and variance. Simple linear regression was employed to 
quantify relatedness of various measures. General linear modeling was also used in order to 
identify differences between the strains in timing and scale of bone aging changes. All results 
are considered significant when p<0.05.  
 
Results 
Mechanical Testing 
In 4-point bending of the C57Bl/6 femur, ultimate load averages were significantly 
different between age groups (p<0.001) (Figure 3.1—A). More specifically, the 18-month 
ultimate load mean was 32% lower than the 3-month mean (p<0.001) and 29% lower than the 
10-month means (p<0.001). The average stiffness values for C57Bl/6 femora differed between 
ages (p<0.001). The 10-month mean was 42% greater than the 3-month mean (p<0.001). The 
18-month mean stiffness was 32% lower than the 3-month mean (p=0.012), 52% lower than the 
10-month mean (p<0.001), and 43% lower than the 14-month mean (p=0.008). Mean ultimate 
load values in C57Bl/6 tibiae were not statistically different between age groups (p=0.234). For 
the mean stiffness, the ANOVA was significant when comparing the C57Bl/6 ages (p=0.039). The 
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only pair-wise comparison that was significant is the 10-month and 14-month difference 
(p=0.047). 
Results of 4-point bending in the CBA/J mice demonstrated similar average ultimate 
load values when comparing age groups (p=0.099) (Figure 3.1—A). The mean stiffness values of 
the CBA/J mice were significantly different (p<0.001) (Figure 3.1—C). Comparing the age-groups 
individually, the 3-month mean was 46% less than the 10-month mean (p=0.046), 36% less than 
the 14-month mean (p=0.002), and 29% less than the 18-month mean (p<0.001). The average 
ultimate load of the CBA/J tibiae demonstrated no difference in means between the age groups 
(p=0.258) (Figure 3.2—A). The mean stiffness of the CBA/J tibiae were significantly different 
(p=0.034) with a 10-month mean that is 27% greater than the 3-month mean stiffness (p=0.012) 
(Figure 3.2—C). 
 
Body Weight Relationship 
Running an ANOVA test for weight differences in the C57Bl/6 age groups demonstrated 
an average 12% greater body weight in the C57Bl/6 18-month mice than the 3-month group 
(p<0.001). The CBA/J average body weights were also different between the age groups 
(p<0.001), with the 18-month mice being 23% heavier than the 3-month mice (p<0.001) (Figure 
3.3). When femoral ultimate load and stiffness values were normalized by body weight, ANOVA 
results for C57Bl/6 remained the same (Figure 3.1—B, D). The tibial ultimate load values 
became significantly different when standardized to weight (p=0.002). Following normalization, 
the 18-month mean ultimate load is 20% lower than the 3-month mean (p=0.003) (Figure 3.2—
B). The total ANOVA remained significant when stiffness was normalized by body weight 
(p=0.030), however, no pairwise comparisons reached significance (Figure 3.2—D).  
The ANOVA results for ultimate load and stiffness remained the same after normalizing 
the CBA/J data to body weight (Figure 3.1—B, D). However, the 3-month comparison to the 14- 
and 18-month means was no longer significant (Figure 3.1—D). The comparison in tibial 
ultimate load in the CBA/J was not significant prior to standardizing to weight, but showed 
statistically significant differences after (p=0.029). Following standardization, the 18-month 
tibial ultimate load was 16% less than that recorded in the 3-month mice (p=0.026) (Figure 
3.2—B). Where ultimate load comparisons gained significance following standardization in 
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CBA/J, the comparisons of mean tibial stiffness lost significance following standardization 
(p=0.801) (Figure 3.2—D).3  
  
General Linear Models: Mechanical Properties 
 General linear modeling is a useful tool to determine if the manner in which age 
influences bone properties is different between the C57Bl/6 and CBA/J mouse strains. We ran 
the model using the weight-normalized values to eliminate the different impact weight had on 
the outcome variables. We used a model looking at the effects of age, strain, and the 
interaction of age and strain on both ultimate load and stiffness. In the femur, this model for 
ultimate load was significant with R2=0.594 (p<0.001). Strain, alone, significantly influenced 
ultimate load (R2=0.435, p<0.001) with CBA/J mice having greater mean ultimate load at all 
ages compared to C57Bl/6 means. Independent of strain, age also had an individual influence 
on the ultimate load values (R2=0.254, p<0.001). The interaction term between strain and age 
was not significant (p=0.287). This suggested that the age-related changes in ultimate load are 
similar in the C57Bl/6 and CBA/J strains within each time interval. However, cumulatively, there 
was a loss of ultimate load in the C57Bl/6 strain by 18-months but not in the CBA/J mice (Figure 
3.4 – A). 
Similar to the GLM results for ultimate load, the model for femoral stiffness was 
significant R2=0.733 (p<0.001). Strain and age, alone, had an effect on stiffness (R2=0.576, 
p<0.001 and R2=0.291, p<0.001, respectively). Unlike the ultimate load model, the interaction 
term was significant (R2=0.117, p=0.012). This suggests that the strains differed in how age 
influences stiffness of the femur. Post-hoc tests were run in order to determine when, during 
the aging process, the two strains differ. The slopes for C57Bl/6 and CBA/J mice were not 
distinct between 3 and 10 months (p=0.854), 10 and 14 months (p=0.103), or 14 and 18 months 
(p=0.445). However, slopes between 3 and 18 months were significantly divergent (p=0.004), as 
were the slopes between 10 and 18 months (p=0.022). This suggests a cumulative difference in 
aging effects that occur between 10 and 18 months of age (Figure 3.4 – B). 
                                                          
3 Note: The remaining statistics are run using the normalized values unless otherwise stated. 
45 
 
 These models were also run on the ultimate load and stiffness in the tibiae. The model 
was significant for tibial ultimate load with R2=0.247 (p<0.001). However, in this model, age was 
the only factor that significantly influenced ultimate load (R2=0.216, p<0.001). The strains did 
not differ in either the values for ultimate load or how these values changed with age (Figure 
3.4 – C). The model for tibial stiffness was also significant with R2=0.260 (p<0.001). Strain was 
the only factor significantly influencing the model (R2=0.151, p<0.001). The stiffness of the tibia 
does not appear to change in either strain as age increases (Figure 3.4 – D). 
 
Mechanical Parameter Relationships 
C57 Femur:4 The ultimate load did not significantly drop until the 18-month. Femoral 
stiffness in the C57BL/6 mice was greatest in the 10-month group. Ultimate load, when all ages 
were pooled, was linearly correlated with stiffness (R=0.649, p<0.001). When the 3-month 
animals were isolated, ultimate load was still correlated with stiffness (R=0.779, p<0.001). In 
the 10-month-only group, ultimate load and stiffness had a relationship approaching 
significance (R=0.813, p=0.094), as well as in the 14-month mice (R=0.844, p=0.072). Ultimate 
load was not significantly related to stiffness (p=0.523) in the 18-month age group. Running 
pairwise ANCOVA, we determined that the 18-month intercept was significantly different from 
all other time points. None of the slopes were significantly different, however. (Figure 3.5 – A). 
This suggests a change in the ultimate load and stiffness relationship occurring between the 14- 
and 18-month times, likely due to matrix-level changes. Post-yield displacement differed 
between 3 months and the other age groups (p=0.004). The 3-month mean was 46% greater 
than the 14-month mean (p=0.001) and 30% greater than the 18-month mean (p=0.030) (Figure 
3.7 – A).  
C57 Tibia:5 The ultimate load did not significantly drop until the 18-month group where 
it was 20% lower than at 3 months. Tibial stiffness in the C57BL/6 mice was invariant, 
statistically, when the ages are compared. Ultimate load, when all ages were pooled, was 
linearly correlated with stiffness (R=0.544, p<0.001). When the 3-month and 14-month animals 
were isolated, ultimate load was no longer correlated with stiffness. In the 10-month and 18-
                                                          
4 Load-displacement curve visualized in Figure 3.6 – A. 
5 Load-displacement curve visualized in Figure 3.6 – C. 
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month groups, ultimate load and stiffness had a significant relationship (R=0.889, p=0.044 and 
R=0.616 p=0.007). As in the C57Bl/6 femur, the ANCOVA revealed no difference in slopes of the 
ultimate load – stiffness relationship. However, the 18-month intercept was significantly 
different from all other time points (Figure 3.5 – B).  Post-yield displacement was different 
between the age groups (p=0.054) (Figure 3.7 – B). The 10-month mean was 53% greater than 
the 18-month mean (p=0.035). The mechanical trends, again, suggest matrix-level changes 
affecting the ultimate load – stiffness relationship.  
CBA Femur:6 The ultimate load did not differ between the age groups. Femoral stiffness 
was statistically different when comparing age groups, however, most of the post-hoc pair-wise 
comparisons disappeared when normalizing for weight. Ultimate load, when all ages are 
pooled, was linearly correlated with stiffness (R=0.616, p<0.001). When the 3-month animals 
were isolated, ultimate load was still correlated with stiffness (R=0.701, p=0.001). The 10-
month and 14-month relationships were not significant. However, ultimate load was 
significantly related to stiffness in the 18-month age group (R=0.711, p=0.001). The ANCOVA 
resulted in no significant differences in intercept or slope of the regression lines at the different 
ages (Figure 3. 5 – C). Post-yield displacement differed between 3 months and the other age 
groups (p<0.001) (Figure 3.7 – A). The 3-month mean was 41% greater than the 10-month 
mean, 74% greater than the 14-month mean (p=0.012) and 69% greater than the 18-month 
mean (p<0.001). The mechanical data suggest that the loss of PYD did not influence the 
relationships between ultimate load and stiffness.  
CBA Tibia:7 The ultimate load did not significantly drop until the 18-month group and 
tibial stiffness in the mice was invariant when normalized to weight. Ultimate load, when all 
ages were pooled, was linearly correlated with stiffness (R=0.491, p<0.001). When the 3-month 
animals were isolated, ultimate load was still correlated with stiffness (R=0.708, p<0.001). The 
10-month-only group had a relationship approaching significance (R=0.866, p=0.058). The 14-
month and 18-month mice did not have a significant relationship between ultimate load and 
stiffness (Figure 3.5 – D). Unlike the femoral ANCOVA, the 18-month intercept of the regression 
                                                          
6 Load-displacement curve visualized in Figure 3.6 – B. 
7 Load-displacement curve visualized in Figure 3.6 – D. 
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line was significantly different from those at all other ages, though the slopes were invariant. 
Post-yield displacement also was invariant across the age groups (Figure 3.7 – B).  
 
Mechanics and Morphology 
 C57Bl/6 Femur: In the C57Bl/6 femora, the means for TMD differed between the age 
groups (p<0.001) with the 18-month mean being 9% lower than the 3-month mean (p<0.001) 
and 10% lower than the 10-month mean (p=0.018) (Figure 3.8 – A).  C57BL/6 cortical thickness 
was different when age groups were compared (p<0.001), with the 3-month mean being 15% 
greater than the 14-month mean (p<0.001) and 26% greater than the 18-month mean 
(p<0.001). The 10-month mean was 11% greater than the mean at 14 months (p=0.035) and 
22% greater than the mean at 18 months (p<0.001). The 14-month mean was 13% greater than 
the 18-month mean (p=0.002) (Figure 3.8 – C). C57Bl/6 age groups had different means for 
second moment of area (Iy) in the bending direction (p=0.003). The 14-month mean was 21% 
greater than the 3-month mean (p=0.003), 23% greater than the 10-month mean (p=0.017), 
and 14% greater than the 18-month mean (p=0.052) (Figure 3.8 – E). The age-related changes in 
mechanical function (loss of ultimate load and stiffness) were largely related to the reduction in 
both amount and mineralization of bone. The slight increase in Iy that occurred in the older age 
groups was not sufficient to mechanically accommodate the loss of function from cortical 
thinning and decreased TMD.  
The ANOVA demonstrated differences in endosteal perimeter means (p=0.032), 
however, none of the post-hoc comparisons reached significance (Figure 3.9 – A). The 
periosteal perimeter means were invariant between age groups (p=0.066) (Figure 3.9 – C). 
Despite the lack of statistical evidence of periosteal or endosteal surface change, both marrow 
area and cortical area differed between the age groups (p<0.001). The 3-month marrow area 
mean was 24% less than the 14-month mean (p<0.001) and 23% less than the 18-month mean 
(p<0.001). The 10-month mean was 30% lower than the 14-month mean (p<0.001) and 28% 
lower than the 18-month mean (p<0.001) (Figure 3.9 – E). The mean cortical area in the 18-
month group was 18% lower than the 3-month mean (p<0.001), 12% lower than the 10-month 
mean (p=0.001), and 11% lower than the 14-month mean (p=0.005) (Figure 3.9 – G).  
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 C57Bl/6 Tibia: The mean TMD values in the C57Bl/6 tibiae were different when 
comparing the age groups (p=0.016) with the 3-month mean being 8% greater than the 18-
month mean (p=0.006) (Figure 3.8 – B). This pattern was similar to the pattern of change 
measured in the tibial ultimate load. The C57Bl/6 tibiae undergo little functional change until 
after the 14-month time point, at which time TMD decrease may account for much of the loss 
of ultimate load. However, with a decrease in TMD, we would expect an associated decrease in 
stiffness, yet this did not occur in the samples compared here. Therefore, the lower ultimate 
load was possibly due to changes influencing the post-yield mechanics without influencing the 
pre-yield measures. Cortical thickness also varied between age groups (p<0.001). The 3-month 
mean was 20% greater than the 14-month mean (p<0.001) and 27% greater than the 18-month 
mean (p<0.001). Additionally, the 14-month mean was 9% greater than the 18-month mean 
(p=0.026) (Figure 3.8 – D). However, this should also have influenced stiffness values which did 
not change. This is further evident by the lack of variation in the Iy values between age groups 
(Figure 3.8 – F). The mineralization and shape changes that were measured did not influence 
stiffness. The lack of change in stiffness might be due to interactions with the fibula that were 
not investigated.  
 The lower cortical thickness was due to greater endosteal perimeter (p<0.001) with the 
3-month mean being 14% less than the 14-month mean (p=0.016) and 10% less than the 18-
month mean (p<0.001) (Figure 3.8 – B). This led to an expansion of marrow area (p<0.001). The 
3-month mean was 12% lower than the 10-month mean (p=0.039), 36% lower than the 14-
month mean (p=0.001), and 29% lower than the 18-month mean (p<0.001). The 10-month 
mean was 21% less than the 14-month mean (p=0.007) and 15% less than the 18-month mean 
(p=0.012) (Figure 3. 9 – F). This loss of bone on the endosteal surface was not compensated 
through periosteal apposition. The periosteal circumference means varied between ages 
(p<0.001), however the difference in means was due to a 4% drop, rather than increase, 
between the 3- and 18-month age groups (p=0.010) (Figure 3.9 – D). This resulted in a 
significant difference in cortical area between ages (p<0.001). The 3-month mean was 12% 
greater than the 14-month mean (p=0.004) and 19% greater than the 18-month mean 
(p<0.001) (Figure 3.9 – H).  
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CBA/J Femur: In the femora of the CBA/J mice, the age groups demonstrated different 
mean TMD, cortical thickness and Iy values (p<0.001). The 3-month mean TMD was 16% greater 
compared to the 18-month mice (Figure 3.8 – A). The 3-month mean cortical thickness was 19% 
greater than the 18-month mean (p<0.001) (Figure 3.8 – C). Despite the lower TMD and cortical 
thickness, the ultimate load and stiffness means remained fairly constant. This was likely due to 
the increasing Iy values with age. The 3-month Iy mean was 11% less than the 10-month mean 
(p=0.045), 19% less than the 14-month mean (p=0.045), and 50% less than the 18-month mean 
(p<0.001). The 10-month mean was 36% less (p<0.001) and the 14-month mean was 26% less 
(p=0.005) than the 18-month mean (Figure 3. 8 – E). 
 Using the mean values for TMD and Iy, we assessed how well the CBA/J femur was able 
to accommodate age-related loss of mineralization with size/shape changes. The normalized 
TMD values for 3, 10, 14, and 18 months were 38.86, 35.27, 36.95, and 32.76, respectively.8 The 
normalized values for Iy are 0.0032, 0.0036, 0.0039, and 0.0048, respectively. Assuming a 
simplified tissue modulus where E is only based on mineralization, we used the equation for 
stiffness: 
K = TMD x Iy 
The calculated arbitrary stiffness value at 3 months was equal to 0.1256. We added in the TMD 
and Iy values to see if changes in shape accounted for the maintenance of stiffness despite a 
decrease in TMD. 
K3 = (38.86) x (. 0032) =  .1243 
K10 = (35.27) x (. 0036) =  .1270 
K14 = (36.95) x (. 0039) =  .1441 
K18 = (32.76) x (. 0048) =  .1572 
 
Thus, it seems that using a simplified model for stiffness, the age-related increase in Iy was able 
to compensate for the loss of mineralization also evident with age increase. The CBA/J mean 
endosteal and periosteal perimeters did not differ between age groups (Figure 3.9 – A, C). 
Differences in marrow area were significant between ages (p<0.001), where the 3-month mean 
                                                          
8 Note: due to the values being standardized by weight, the true unit is mg/mm^3/g. However, we will treat it as 
dimensionless for ease of calculation. 
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was 39% lower than the 18-month mean (p<0.001) (Figure 3. 9 – E). Although, there was no 
significant differences in cortical area means in the CBA/J femora (Figure 3.9 – G).  
 CBA/J Tibia: TMD means in the CBA/J tibiae differed between ages (p<0.001), with the 3-
month mean being 12% greater than the 18-month mean (p<0.001) (Figure 3.8 – B). The lower 
TMD value paralleled the changes measured in CBA/J tibial ultimate load. Additionally, the 
differences in cortical thickness between age groups (p<0.001) occurred in a pattern similar to 
the ultimate load differences. The 3-month cortical thickness mean was 15% greater than the 
mean at 14-months (p=0.010) and 21% greater than the mean at 18 months (p<0.001) (Figure 
3.8 – D). The loss of TMD and cortical thickness are driving the reduction in mean ultimate load 
in the CBA/J tibia. The TMD and cortical thickness patterns did not seem to greatly influence 
stiffness. The lack of change to stiffness might have been due to the 12% greater Iy mean at 3 
months compared to 18 months (p=0.047) (Figure 3.8 – F). Using the same formula for stiffness 
as above, we tested if stiffness was being maintained due to appropriate compensation in 
shape to offset the loss of TMD. Since the only significant difference in TMD occurred between 
the 3- and 18-month groups, we limited our calculations to those: 
K3 = (36.52) x (. 002213) =  .0808 
K18 = (32.21) x (. 002477) =  .0800 
 
It seems that the increase in Iy was able to accommodate the loss of mineralization to maintain 
stiffness. This fact suggests that the decrease in ultimate load is occurring due to changes 
influencing the post-yield properties.  
 The age groups had different endosteal perimeter means in the CBA/J mice (p=0.010) 
with the 3-month mean being 7% smaller than the 18-month mean (p=0.010). The CBA/J 
periosteal perimeter means were not statistically distinguishable (Figure 3.9 – D). 
Marrow area means were also significantly different (p<0.001). The 3-month mean was 38% 
lower than the 14-month mean (p=0.012) and 41% lower than the 18-month mean (p<0.001) 
(Figure 3.9 – F). Cortical area in the CBA/J age groups had different means, as well (p=0.007). 
The 3-month mean was 9% larger than both the 14-month mean (p=0.045) and the 18-month 
mean (p=0.003) (Figure 3.9 – H). 
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Trabecular Bone 
 C57Bl/6 Distal Femur: Mean trabecular BMD (tBMD) was different when C57Bl/6 ages 
were compared (p<0.001). The 3-month mean was 43% greater than the 14-month mean 
(p<0.001) and 40% greater than the 18-month mean (p<0.001). The 10-month mean was 35% 
greater than the 14-month mean (p=0.010) and 32% greater than the 18-month mean 
(p=0.003) (Figure 3.10 – A). Mean trabecular TMD (tTMD) values also differed when the C56Bl/6 
age groups were compared (p=0.001). The 3-month mean was 19% greater than at 18 months 
(p=0.003). The 10-month mean was 24% greater than at 18 months (p=0.012) (Figure 3.10 – B). 
The 3-month bone volume fraction (BVF) mean was 41% greater than the 10-month mean 
(p<0.001), 52% greater than the 14-month mean (p<0.001), and 58% greater than the 18-month 
mean (p<0.001) (Figure 3.10 – C). The age group means for anisotropy were overall significantly 
different (p<0.001), with a 14-month mean that was 19% greater than the 3-month mean 
(p=0.012), 26% greater than the 10-month mean (p=0.004), and 24% greater than the 18-month 
mean (p<0.001) (Figure 3.10 – D).9 The ratio of bone surface to bone volume (BS/BV) was not 
statistically different between the age groups in the C57BL/6 mice (Figure 3.10 – A). However, 
trabecular thickness means were different (p<0.001). The 3-month mean was 10% greater than 
the 18-month mean (p<0.001) and the 14-month mean was 23% greater than the 18-month 
mean (p=0.030) (Figure 3.11 – B). The average number of trabeculae was also statistically 
different between age groups (p<0.001). The 3-month mean was 44% greater than the 10-
month mean (p<0.001), 57% greater than the 14-month mean (p<0.001), and 60% greater than 
the 18-month mean (p<0.001) (Figure 3.11 – C).  
C57Bl/6 Proximal Tibia: Mean tBMD values differed between age groups in the C57BL/6 
tibiae (p<0.001). The 3-month mean was 19% greater than the 10-month mean (p=0.002), 34% 
greater than the 14-month mean (p<0.001), and 33% greater than the 18-month mean 
(p<0.001). The 10-month mean was 18% greater than the 18-month mean (p=0.034) (Figure 
3.12 – A). Mean tTMD values were also different (p=0.019) due to a 9% greater mean in the 3-
month mice compared to the 18-month mice (p=0.042) (Figure 3.12 – B). The BVF means for 
the age groups differed with age (p<0.001). The 3-month mean was 46% greater than the 10-
                                                          
9 Note: BVF and anisotropy are the only trabecular measures not normalized by weight due to the fact that they 
are already ratios with the same units, making normalization unnecessary. 
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month mean (p<0.001), 63% greater than the 14-month mean (p<0.001), and 55% greater than 
the 18-month mean (p<0.001) (Figure 3.12 – C). Anisotropy measures were not taken for the 
proximal tibiae. The BS/BV ratio in the tibia did not vary between ages in the C57Bl/6 mice 
(Figure 3.13 – A). Trabecular thickness of the trabeculae did, however, differ between ages 
(p<0.001). The 3-month mean was 14% greater than the 10-month mean (p=0.011) and 16% 
greater than the 18-month mean (p<0.001) (Figure 3.13 – B). In addition to trabecular 
thickness, the mean trabecular number varied between age groups (p<0.001). The 3-month 
mean was 46% greater than the 10-month mean (p<0.001), 65% greater than the 14-month 
mean (p<0.001), and 58% greater than the 18-month mean (p<0.001) (Figure 3.13 – C). 
CBA/J Distal Femur: The age group mean tBMD values in the CBA/J mice were different 
(p=0.003) with the 3-month mean being 28% greater than the 18-month mean (p=0.003) 
(Figure 3.10 – A). The mean tTMD values were not different in the CBA/J mice when comparing 
age groups (Figure 3.10 – B). The BVF means, however, were different (p<0.001) with the 3-
month mean being 65% greater than the 10-month mean (p<0.001), 74% greater than the 14-
month mean (p<0.001), and 67% greater than the 18-month mean (p<0.001) (Figure 3.10 – C). 
Anisotropy was not different between the CBA/J age groups (Figure 3.10 – D). The ratio of 
BS/BV was not statistically different between the age groups (Figure 3.11 – A). However, 
trabecular thickness was different between ages (p=0.038). The only pairwise comparison that 
was significant was the 16% greater mean thickness at 3 months than at 18 months (p=0.054) 
(Figure 3.11 – B). The CBA/J trabecular number means were also different (p<0.001). The mean 
at 3 months was 68% greater than that at 10 months (p<0.001), 73% greater than at 14 months 
(p<0.001), and 75% greater than at 18 months (p<0.001) (Figure 3.11 – C). 
CBA/J Proximal Tibia: Means differed for tBMD in the CBA/J tibiae (p<0.001). The 3-
month tBMD mean was 18% greater than the 10-month mean (p=0.018) and 25% greater than 
both the 14- and 18-month means (p<0.001) (Figure 3.12 – A). However, CBA/J tibiae were 
invariant in mean tTMD (Figure 3.12 – B). The BVF means for the age groups differed by age 
(p<0.001).  The 3-month mean was 46% greater than the 10-month mean (p<0.001), 72% 
greater than the 14-month mean (p<0.001), and 52% greater than the 18-month mean 
(p<0.001) (Figure 3.12 – C). BS/BV varied between the age groups (p<0.001). The 3-month mean 
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was 27% greater than the 10-month mean (p=0.010) and 31% greater than the 18-month mean 
(p<0.001). The 10-month mean was 40% lower than the 14-month mean (p=0.040), which was 
in turn 43% greater than the 18-month mean (p=0.001) (Figure 3.13 – A). While trabecular 
thickness was indistinguishable between age groups (Figure 3.13 – B), trabecular number 
differed (p<0.001). The 3-month mean was 60% greater than the 10-month mean (p<0.001), 
68% greater than the 14-month mean (p<0.001), and 67% greater than the 18-month mean 
(p<0.001) (Figure 3.13 – C). 
 
General Linear Models: Femur 
 The GLM that we applied was strain+age+strain*age where strain*age is the interaction 
term. Using this model on tBMD values was significant (R2=0.671, p<0.001). Strain and age were 
significant factors (R2=0.278, p<0.001 and R2=0.582, p<0.001, respectively). The interaction 
between strain and age was also significantly influencing the outcomes (R2=0.247, p=0.002). 
The change in means from the 3-month group to 18-month group was significant (p=0.035). The 
slopes from 3 months to 10 months and 14 to 18 months were not statistically different. The 
slopes between 10 months and 14 months were different between the two strains (p=0.008). 
The C57Bl/6 mice lost relatively more tBMD than the CBA/J mice. The interval most responsible 
for this difference was from 10 to 14 months, where the C57Bl/6 mice continued to lose tBMD 
while the CBA/J did not. The change in tBMD in the C57Bl/6 femora began after 3 months and 
continued to 14 months. The loss of tBMD in the CBA/J femora occurred during the 3 to 10 
month interval and then was stable (Figure 3.14 – A). 
 The model run for tTMD in the femur was also significant (R2=0.442, p<0.001). Strain did 
not influence outcomes in the model, but age had an effect (R2=0.246, p=0.002), as did the 
interaction of age and strain (R2=0.213, p=0.005). The ANOVA demonstrated a lower mean in 
the C57BL/6 mice between 3 and 18 months but not in the CBA/J mice. The slopes from 3 to 10 
months differed between the strains (p=0.007). The 10-to-14 and 14-18 month slopes did not 
differ. However, the rate of change from 10 to 18 months did differ by strain (p=0.004). The 
C57Bl/6 tTMD was still increasing from 3 to 10 months and then began to decline consistently 
from 10 to 18 months. The CBA/J mice lost tTMD from 3 to 10 months but rebounded with an 
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increase in mineral density from 10 to 18 months. This resulted in cumulatively no change in 
CBA/J means from 3 to 18 months (Figure 3.14 – B). 
The overall model was significant for BVF (R2=0.782, p<0.001). Strain (R2=0.619, 
p<0.001), age (R2=0.659, p<0.001), and the interaction term (R2=0.160, p=0.025) were all 
significant. The slopes of the two strains differed from 3 to 18 months (p=0.001), however, 
none of the smaller intervals were divergent enough to reach significance. Both strains 
experienced a dramatic loss of trabecular volume from 3 to 10 months. From 10 months on, 
C57BL/6 mice seemed to steadily lose more volume than the CBA/J mice by the final 18 month 
time point. CBA/J mice at 3 months had much lower BVF than C57Bl/6 mice, so the CBA/J mice 
may have hit a lower limit in BVF earlier than C57Bl/6 mice due to the lower starting point. 
(Figure 3.17 – C). 
The model for anisotropy was significant (R2=0.344, p<0.001). Strain was the only factor 
that influences the outcome values (R2=0.220, p<0.001). The interaction term did not 
significantly contribute to the model. The ANOVA for anisotropy showed no difference between 
3 and 18 months in either strain. Therefore, differences in anisotropy between C57Bl/6 and 
CBA/J mice were due to CBA/J mice initially having greater levels of anisotropy at 3 months 
(Figure 3.17 – D).  
 The model was significant when applied to BS/BV ratios (R2=0.306, p=0.005). Strain and 
the interaction term were significant factors of the model (R2=0.082, p=0.034 and R2=0.221, 
p=0.004, respectively), but age was not a significant factor. The overall rate of change was 
different in the strains from 3 to 18 months (p=0.001). The only sub-interval that had diverging 
slopes was from 14 to 18 months (p=0.002). During this interval, C57Bl/6 increased BS/BV, 
which could have occurred due to thinning of the trabeculae. A second explanation that could 
not be addressed with these data is that there was a greater preponderance of trabecular 
plates than rods (Figure 3.15 – A). 
The model for trabecular thickness was significant (R2=0.495, p<0.001) with strain 
(R2=0.188, p=0.001) and age (R2=0.380, p<0.001) as influencing factors. The interaction term 
was not significant. The lack of significance in the interaction term was likely due to the 
consistent means in both strains from 3 to 14 months. The lack of variation in these intervals 
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masked the difference in the 14 to 18 month interval. During this time span, C57Bl/6 mice had a 
marked drop in trabecular thickness but there was little change in the CBA/J mean. This was 
supported by running the model on a subset of data including only the 14- and 18-month data. 
In this analysis, the interaction was highly significant (p=0.001) (Figure 3.18 – B). 
The model for trabecular number was significant (R2=0.800, p<0.001). Strain (R2=0.657, 
p<0.001) and age (R2=0.675, p<0.001) were significant factors in the model, but the interaction 
did not reach significance. Not surprisingly, the changes in trabecular number paralleled those 
measured in the BVF. There was a significant drop from 3 to 10 months in both strains with the 
C57Bl/6 starting much higher (Figure 3.15 – C).  
 
General Linear Models: Tibia 
The linear model was significant for tibial tBMD (R2=0.792, p<0.001). Strain (R2=0.510, 
p<0.001) and age (R2=0.661, p<0.001) were significant factors, as was the interaction between 
strain and age (R2=0.157, p<0.001). The C57Bl/6 and CBA/J slopes from 3 to 18 months differed 
(p<0.001) with much of the divergence occurring in the interval between 3 and 14 months 
(p=0.043). Both strains experienced a drop in tibial tBMD from 3 to 10 months but only the 
C57Bl/6 strain lost further tBMD from 10 to 14 months, leading to a relatively greater loss in 
tBMD by 18 months for the C57Bl/6 mice than the CBA/J mice. This was consistent with the 
changes occurring in the femoral trabecular compartment (Figure 3.16 – A). 
The model applied to tTMD was not significant (p=0.128). This is due to the lack of 
variability between strains as well as between ages within both strains (Figure 3.16 – B). The 
model run for BVF was significant (R2=0.855, p<0.001). Strain (R2=0.594, p<0.001), age 
(R2=0.724, p<0.001), and the interaction term (R2=0.322, p<0.001) were all significant factors. 
The slopes of the two strains differed from 3 to 18 months (p<0.001), with the most divergence 
occurring between 3 and 10 months (p=0.001). This pattern of change coincides with that 
measured in the femur (Figure 3.16 – C). 
The overall model for BS/BV was significant (R2=0.568, p<0.001). All three factors were 
significant – strain (R2=0.298, p<0.001), age (R2=0.254, p<0.001), and the interaction (R2=0.220, 
p<0.001). The overall rate of change from 3 to 18 months differed between the two strains 
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(p<0.001). Significant divergence of the slopes occurred in the 3 to 10 month interval (p=0.001) 
and the 14 to 18 month interval (p=0.001) (Figure 3.17 – A).  
 The model was significant when run for trabecular thickness (R2=0.215, p=0.002). Strain 
was not a significant factor, but both age (R2=0.109, p=0.014) and the interaction were 
(R2=0.113, p=0.011). The amount of change differed from 3 to 18 months when comparing the 
two strains (p=0.002). The most divergence of slope occurred in the 3 to 10 month interval 
(p=0.032) and the 14 to 18 month interval (p=0.054). The C57Bl/6 trabecular thickness 
decreased from 3 to 10 months, increased from 10 to 14 months, and decreased from 14 to 18 
months. The CBA/J pattern is reverse where the mean increased from 3 to 10 months, 
decreased from 10 to 14 months, and increased from 14 to 18 months. This resulted in an 
overall loss of thickness in the C57Bl/6 mice and no change in the CBA/J mice (Figure 3.17 – B). 
The model for trabecular number was significant with R2=0.903 (p<0.001). Strain 
(R2=0.714, p<0.001), age (R2=0.795, p<0.001), and the interaction between strain and age 
(R2=0.392, p<0.001) were all significant factors. The rate of change differed between the 
C57Bl/6 and CBA/J mice from 3 to 18 months (p<0.001). The slopes diverged in the 3 to 10 
month interval (p=0.005) and 10 to 14 month interval (p=0.039). Like BVF patterns, the C57Bl/6 
mice lost a significant number of trabeculae during the 3 to 10 month interval and again from 
10 to 14 months. The rate at which CBA/J mice lost trabeculae was much slower from 3 to 10 
months and then stayed constant from 10 months on (Figure 3.17 – C). 
One interesting aspect of the trabecular regions of the C57Bl/6 and CBA/J mice 
concerned BMD and TMD when regressed against weight. The tBMD-weight regression in the 
femur was significant for the C57Bl/6 mice (R=-0.296, R2=0.09, p=0.043) but not for the CBA/J 
mice (Figure 3.18 – A). The tTMD-weight regression was not significant in the C57Bl/6 mice, but 
was in the CBA/J mice (R=0.369, R2=0.142, p=0.012) (Figure 3.18 – B). The same pattern was 
recorded in the tibiae where tBMD-to-weight regression was significant in the C57Bl/6 mice 
(R=-0.309, R2=0.095, p=0.033), but not in the CBA/J mice (Figure 3.18 – C). The regression 
between tTMD and weight in the tibia was not significant for the C57Bl/6 mice but was 
significant for CBA/J mice (R=0.671, R2=0.443, p<0.001) (Figure 3.19 – D).  
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In both the femur and tibia, there was a pattern in which weight and tBMD were 
inversely related in the C57Bl/6 mice and unrelated in the CBA/J mice. Conversely, weight and 
tTMD were positively related in the CBA/J mice but unrelated in the C57Bl/6 mice. This suggests 
that as weight increased in the C57Bl/6 mice, there was a negative effect on the amount of 
bone in the trabecular region but not on the mineralization of bone present. This was 
supported by the negative relationship between weight and BVF in the C57Bl/6 femora (R=-
0.486, p=0.001) and tibiae (R=-0.430, p=0.002). In the CBA/J mice, as weight increased, there 
was no change in tBMD, despite the negative relationship between weight and BVF in both the 
femora (R=-0.575, p<0.001) and tibiae (R=-0.422, p=0.001). There was, however, a positive 
relationship in CBA/J mice between weight and tTMD.  
 
Trabecular and Cortical Relationships 
In the C57Bl/6 femora, stiffness was linearly related to tTMD (R2=0.299, p<0.001), BVF 
(R2=0. 101, p=0.032), and trabecular thickness (R2=0.255, p<0.001), but not to anisotropy or 
trabecular number. Trabecular TMD was not linearly related to cortical geometry, therefore, 
the stiffness-tTMD relationship was likely due to mineralization of the cortical region. Further 
supporting this relationship, regression between tTMD and cortical TMD was significant 
(R2=0.319, p<0.001). These relationships suggest that as TMD decreased with age in the cortical 
compartment, it also decreased in the trabecular region of the femur.  
 The stiffness of the CBA/J femora did not change with tTMD, anisotropy, trabecular 
thickness, or trabecular number. However, there was a negative relationship between cortical 
stiffness and BVF (R2=0.108, p=0.026). As stiffness increased, the volume of trabecular bone 
was decreasing. Differing from C57Bl/6 mice, the BVF of CBA/J mice was inversely related to the 
Iy (R2=0.253, p<0.001) and positively related to cortical TMD (R2=0.212, p<0.001). It is possible 
that aging induced the reduction in trabecular volume and bone mineralization in order to 
allocate resources to the periosteal bone apposition to maintain ultimate load. 
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Discussion 
 The C57Bl/6 and CBA/J mouse strains demonstrate that variation is present in murine 
aging. C57Bl/6 mice experience a steady decline in ultimate load and stiffness after 10 months. 
Which is in line with other findings [1]. The drop in ultimate load in the C57Bl/6 femora is 
primarily due to cortical thinning through marrow expansion without adequate periosteal 
deposition, as well as reduced tissue mineralization. These changes, in combination, reduce the 
stiffness. In addition to the mineral and shape changes, there are matrix composition 
alterations that negatively affect the post-yield properties. Unlike the C57Bl/6 femoral patterns, 
the tibial decrease in ultimate load is independent of changes to stiffness. The lack of change in 
stiffness is suggestive of matrix compositional and organizational changes reducing bone 
strength in the tibia.   
 The CBA/J strain does not elicit changes in ultimate load or stiffness in 18 months. The 
femora of CBA/J mice do not undergo dramatic functional change with age. The consistent 
mechanical properties are due to a rearrangement of tissue to increase Iy, compensating for 
loss of mineralization and marrow expansion. In the normalized values, there does not appear 
to be a dramatic increase in the periosteal surface to account for the increase in Iy.  However, 
when the raw values are compared, the 18-month periosteal length is almost double the 3-
month mean. The CBA/J mice are able to respond to increasing body size through periosteal 
expansion. The loss of significance when normalized to weight suggests that periosteal 
deposition is occurring in order to adapt to increased load from the mouse body. Instead of 
shape change in order to compensate for a loss of TMD, it is possible that the weight-induced 
periosteal deposition allows the body to redirect mineral resources without compromising 
bone mechanical function. 
 Both strains experience a drop in tissue mineralization. Unique to the CBA/J is the 
increase in the moment of inertia. The shape changes in the CBA/J mice prevent the loss of 
stiffness and ultimate load that is evident in the C57Bl/6 mice. The initial cross-section of the 
C57Bl/6 femur is wide and thin, some might say robust. The cross-sectional geometry of the 
CBA/J femur is thick and more concentrated near the centroid. Due to differences in geometry, 
there is greater surface area for endosteal resorption in the C57Bl/6 mice than in the CBA/J 
mice. Additionally, bone resorption on the endosteal surface of C57Bl/6 will have a greater 
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influence on moment of inertia due to the greater distance from the centroid. More slender 
bones in the CBA/J mice may be suppressing remodeling while the more robust C57Bl/6 bones 
are not [2]. Differences in aging outcomes between the two strains could be a product of bone 
phenotype upon reaching maturity. This is true in human aging, as well. Peak bone mass is a 
strong determinant of fracture risk later in life [3]. Due to this similarity between human and 
mouse aging, comparative studies using the two mouse strains may be helpful in optimizing 
prevention strategies for a wide range of people with varying bone morphology. 
 There is a high amount of phenotypic integration in patterns of bone aging [1] including 
a relationship between age-induced morphology changes and age-induced composition 
changes in bone. Jepsen and Andarawis-Puri describe the relatedness between changes in 
tissue modulus and those in geometry in human tibiae. Individuals with greater loss of tissue 
modulus with age elicit greater periosteal bone apposition [5]. In the mouse strains described in 
this chapter, tissue modulus was not directly measured. However, bone mineralization greatly 
influences modulus. In the C57Bl/6 femora, the 18-month mean cortical TMD was 9% lower 
than the mean at 3 months. This is in contrast to reports showing an increase in TMD in C57Bl/6 
males [6]. The discrepancy may be in the inaccuracy of TMD estimates using microCT.  The 
difference in CBA/J represents a 16% lower mean. Cortical area is reduced with aging in the 
C57Bl/6 strain but not in the CBA/J strain. It is possible that the phenomenon described in 
human bone is also present in mouse bone aging. The strain with greater loss of TMD maintains 
cortical area through periosteal deposition while the strains with less severe TMD loss 
experiences cortical area reduction.  
How direct the relationship between TMD and cortical area change is not clear. A 
possible explanation is that periosteal expansion is modulated to balance the loss of mechanical 
integrity that results from the lower mineralization. This suggests differential mechanical 
response in bones that lose more mineral with aging compared with those that have a less 
dramatic loss of mineral. Conversely, it is possible that the maintenance of cortical area and 
increase of moment of inertia in the CBA/J mice allows for redirection of expensive resources. 
Due to the greater mechanical stability these shape changes provide, mineral may not be as 
necessary to maintain function. Better resolution in the timing of mineral decrease and shape 
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change may provide insight as to which parameter change precedes the other. The CBA/J femur 
increases Iy by 10 months. The difference in TMD is not significant until the 18-month time 
point. The relationship between the timing of these changes suggests that shape change may 
be a permissive change allowing for reallocation of mineral in the aging animal.  
Some of the most frequent sites of fragility fracture occur in trabeculated regions of 
bones. Therefore, it is important to include the changes that occur to the trabecular bone in the 
two strains. Compressive tests on the trabecular bone was not possible, therefore, we cannot 
make direct relationships between the trabecular changes and how these influence whole-bone 
functionality. Further work including mechanical testing of the trabecular region is necessary to 
fully understand how age is altering function and the interplay between mechanics of the 
cortical region and those of the trabecular region. 
Age-related changes in mineralization are not uniform throughout the bone. In the 
sample studied, C57Bl/6 trabecular bone loses TMD with age while the CBA/J bone does not. In 
the cortical compartments, both strains lose mineral density in the older ages. The loss of 
mineralization may be an artifact of porosity in the bone. Ashing the bones will help determine 
if the changes in TMD are real or due to increase in porosity. Assuming ashing reveals the 
mineralizing decline is real, the C57Bl/6 strategy may be to distribute the demand for limited 
resources between the cortical and trabecular compartments. The geometry of the C57Bl/6 
cortical bone limits the ability to lose large amounts of mineral and still maintain functionality. 
The CBA/J mechanical integrity is less prone to the loss of mineralization in the cortical region 
due to shape and size. However, the amount of bone in the trabecular region of CBA/J mice is 
much lower than that in C57Bl/6 mice. Thus, TMD is only lost from CBA/J cortical bone since 
extraction from the trabeculae would reduce stability of the trabecular region even more. 
 The interaction between cortical and trabecular bone is supported by the fact that loss 
of BVF in the trabecular bone is associated with periosteal expansion in humans [2]. However, 
of the two mouse strains, both of which lose BVF, only the CBA/J has an associated increase of 
moment of area. Periosteal expansion, after normalizing for weight, did not demonstrate 
significant differences. However, using the raw values, there is a 19% increase in the CBA/J 
femora and a 6% increase in C57Bl/6. Since BVF loss is greater in CBA/J bones, the greater 
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periosteal expansion demonstrates that variation in mouse bone aging may be regulated in a 
similar manner as human bone. This pattern integrates changes in the cortical and trabecular 
bone to satisfy mechanical and resource demands. 
 Aging changes in the cortical bone mechanical properties are similar in the femur and 
tibia for both strains. The cortical morphology of the femur and tibia also change in a similar 
pattern and degree. Age-related loss in trabecular bone is analogous in the C57Bl/6 mice except 
for a greater degree of TMD loss in the femur than tibia (19% vs. 9%). In the CBA/J mice, the 
only deviation from the femur patterns of change occurs in the trabecular thickness. There is a 
16% decrease in trabecular thickness in the femur and an insignificant difference in the tibia. 
Overall, both strains seem to share patterns of bone aging between the femur and tibia.  
  
Models for Human Aging 
The general trend of bone aging in humans can be described as increased fragility and 
greater risk of fracture. However, not all individuals undergo these changes [8]. The C57BL/6, 
vis-à-vis cortical strength and stiffness, is more analogous to the aging patterns in the at-risk 
aging population (more common in women). CBA/J mice do not appear to lose mechanical 
integrity by 18 months, potentially making a good model for successful bone aging without 
increase in risk of failure (more common in men).  
 Persons considered at greater risks of sustaining a fragility fracture reach this state 
through a combination of material and morphological changes. The combination of marrow 
expansion, periosteal expansion, increase in tissue mineralization, and cortical thinning are 
determine how well the bone maintains strength. Most individuals experience some degree of 
marrow expansion and increased tissue mineralization [8, 9]. However, variation in functional 
outcomes is derived from variation in accompanying periosteal expansion. Men are more able 
to maintain bone strength because of periosteal deposition leading to increased second 
moment of inertia [5, 8, 9]. The CBA/J male mice demonstrate similar periosteal bone growth, 
while C57Bl/6 male mice do not. This further supports the use of CBA/J as a correlate for the 
successful aging often seen in men and of C57Bl/6 as a correlate for potentially problematic 
bone aging. 
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 Men and women both lose trabecular bone volume during aging progression [9, 10], 
though it is more extreme is some women. Furthermore, women tend to lose trabecular 
number and men lose trabecular thickness [11]. The relative trabecular BVF lost with age is 
similar in the tibia of the two strains. However, there is greater relative loss of BVF in the CBA/J 
femur compared to the C57Bl/6 mice. The decrease in trabecular number is much greater in the 
CBA/J femur and tibia (75% and 67%) than the C57Bl/6 femur and tibia (60% and 58%). 
Trabeculae are thinner in the femora of both strains, but only C57Bl/6 lost trabecular thickness 
in the tibia. This is consistent with previous findings that C57Bl/6 males are more prone to loss 
in number of trabeculae rather than thickness of those present [9, 10]. These findings suggest 
that C57Bl/6 trabecular aging occurs in a more male-like fashion. The CBA/J patterns of 
trabecular loss is more aligned with those observed in women.  
 The patterns of bone aging in humans and those described here demonstrate that 
C57Bl/6 male mice are a good model for poor cortical aging but more successful trabecular 
aging. Conversely, CBA/J male mice are a good analog for successful cortical aging and poor 
trabecular aging. We may be able to more accurately predict sites of fracture based on early 
bone morphology. If the two mouse strains presented are indicative of variation in humans, it is 
reasonable to suggest that individuals with thicker cortices and undergo periosteal expansion, 
are at greater risk of fractures located in the trabecular regions. Meanwhile, individuals with 
thinner, cortices with no periosteal expansion with age are at greater risk for diaphyseal 
fractures. 
 The patterns of bone aging described here, while illuminating, are phenomenological. 
Despite the evident difference in bone aging strategies, these data cannot conclusively inform 
us as to the physiological mechanisms underlying the variable patterns. Having established the 
utility of comparing the inbred strains, we can begin to investigate the ultimate causes that 
yield aging variation.  
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A       B 
      
 
C       D 
         
           
Figure 3. 1 - Femoral mechanical properties. 
Results from 4-point testing of the femur in C57Bl/6 and CBA/J mice. A) Mean ultimate load (N) values at 
3, 10, 14, and 18 months. Mean C57Bl/6 values are 29.09 (±4.23) N at 3 months, 27.9 (±1.74) N at 10 
months, 23.93 (±3.69) N at 14 months, and 19.87 (±4.96) N at 18 months. The overall ANOVA is 
significant (p<0.001). The 18-month mean is 32% lower than 3-month (p<0.001) and 29% lower than the 
10-month means (p<0.001). The means for CBA/J are 40.19 (±7.22) N at 3 months, 50.98 (±8.317) N at 
10 months, 43.11 (±6.71) N at 14 months, and 42.92 (±9.96) N at 18 months. ANOVA shows no 
difference between the CBA/J means (p=0.099). B) Mean ultimate load normalized by weight. 
Significance of ANOVA results are no different for either C57Bl/6 or CBA/J when using normalized 
instead of raw ultimate load values. C) Mean stiffness values for C57Bl/6 femora are 153.10 (±45.84) 
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N/mm at 3 months, 217.93 (±15.76) N/mm at 10 months, 181.45 (±32.02) N/mm at 14 months, and 
103.87 (±45.62) N/mm at 18 months. The overall ANOVA is significant (p<0.001) and the 10-month 
mean is 42% greater than the 3-month mean (p<0.001). The 18-month mean stiffness is 32% lower than 
the 3-month mean (p=0.012), 52% lower than the 10-month mean (p<0.001), and 43% lower than the 
14-month mean (p=0.008). The mean stiffness of the CBA/J mice is 262.48 (±50.66) N/mm at 3 months, 
382.38 (±66.80) N/mm at 10 months, 356.44 (±29.73) N/mm at 14 months, and 338.43 (±55.63) N/mm 
at 18 months. The general ANOVA is significant in the CBA/J femoral stiffness values (p<0.001). The 3-
month mean is 46% less than the 10-month mean (p=0.046), 36% less than the 14-month mean 
(p=0.002), and 29% less than the 18-month mean (p<0.001). D) Mean stiffness values normalized by 
weight. ANOVA results do not change for the C57Bl/6 femora. The overall ANOVA remains significant for 
CBA/J normalized stiffness (p=0.006). However, significant differences between 3- and 14-month means 
as well as the 3- and 18-month means are lost.  
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C.       D. 
      
 
Figure 3. 2 - Tibial mechanical properties. 
Results from 4-point testing of the tibia in C57Bl/6 and CBA/J mice for the 3-, 10-, 14-, and 18-month 
groups. A) Mean ultimate load (N) values in C57Bl/6 tibiae are 29.13 (±4.26) N at 3 months, 29.17 
(±3.97) N at 10 months, 30.32 (±4.77) N at 14 months, and 26.22 (±5.87) N at 18 months. These values 
are not statistically different between age groups (p=0.234). The average ultimate load of the CBA/J 
tibiae is 34.15 (±6.81) N at 3 months, 38.99 (±5.35) N at 10 months, 32.98 (±9.34) N at 14 months, and 
34.02 (±6.84) N at 18 months. ANOVA shows no difference between CBA/J means (p=0.258). B) Mean 
ultimate load normalized by weight. ANOVA results for C57Bl/6 tibia are now significant (p=0.002) with 
the 18-month mean being 20% less than the 3-month mean (p=0.003). Similarly, the ANOVA for CBA/J 
becomes significant (p=0.029) with the 18-month mean ultimate load being 16% less than the 3-month 
mean (p=0.026). C) Mean stiffness values (N/mm) for C57Bl/6 tibiae are 179.84 (±37.66) N/mm at 3 
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months, 154.23 (±24.64) N/mm at 10 months, 229.17 (± 42.12) N/mm at 14 months, and 189.41 
(±46.00) N/mm at 18 months. ANOVA is significant when comparing mean for C57Bl/6 (p=0.039). 
However, the only pair-wise comparison that is significant is the 10 month and 14 month difference 
(p=0.047). The mean stiffness of the CBA/J mice is 240.58 (±70.20) N/mm at 3 months, 304.70 (±32.26) 
N/mm at 10 months, 267.77 (±86.57) N/mm at 14 months, and 296.20 (±67.52) N/mm at 18 months. 
The overall ANOVA is significant (p=0.034) with a 10-month mean that is 27% greater than the 3-month 
mean stiffness (p=0.012). D) Mean stiffness values normalized by weight in C57Bl/6 remain significant 
(p=0.030), however, no pair-wise comparison between age groups is significant. The ANOVA loses 
statistical significance for CBA/J tibial stiffness differences when normalized to weight (p=0.801). 
 
 
 
 
 
Figure 3. 3 - Average body weights in age groups. 
Average body weights for C57Bl/6 are 30.16 (±1.74) grams at 3 months, 32.00 (±3.94) grams at 10 
months, 32.00 (±1.23) grams at 14 months, and 33.79 (±1.78) grams at 18 months. The 18-month body 
weight is 12% greater than the 3-month group (p<0.001) in the C57Bl/6 mice. Average body weights for 
CBA/J are 32.88 (±2.41) grams at 3 months, 39.60 (±6.11) grams at 10 months, 35.20 (±3.63) grams at 14 
months, and 40.41 (±2.51) grams at 18 months. The 18-month mice are 23% heavier than the 3-month 
mice (p<0.001). * Denotes significant difference to the 3-month mean. 
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Table 3. 1 - Mean values of mechanical measures in femur and tibia. 
Mean values (± 1 standard deviation) are presented with the p-values for ANOVA tests.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
C57Bl/6 Means 
  3-month 10-month 14-month 18-month p-value 
 Body Weight (g) 30.16 (±1.74)  32.00 (±3.94)  32.00 (±1.78)  33.79 (±1.78)  <0.001 
Femur 
Ultimate Load (N) 29.09 (±4.23)  27.9 (±1.74)  23.93 (±3.69)  19.87 (±4.96) <0.001 
Stiffness (N/mm) 153.10 (±45.84)  217.93 (±15.76)  181.45 (±32.02)  103.87 (±45.62)  <0.001 
Tibia 
Ultimate Load (N) 29.13 (±4.26)  29.17 (±3.97) 30.32 (±4.77)  26.22 (±5.87)  0.234 
Stiffness (N/mm) 179.84 (±37.66)  154.23 (±24.64)  229.17 (± 42.12)  189.41 (±46.0)  0.039 
       
CBA/J Means 
  3-month 10-month 14-month 18-month p-value 
 Body Weight (g) 32.88 (±2.41)  39.60 (±6.11)  35.20 (±3.63)  40.41 (±2.51)  <0.001 
Femur 
Ultimate Load (N) 40.19 (±7.22)  50.98 (±8.317)  43.11 (±6.71)  42.92 (±9.96)  0.099 
Stiffness (N/mm) 262.48 (±50.66)  382.38 (±66.80)  356.44 (±29.73)  338.43 (±55.63)  <0.001 
Tibia 
Ultimate Load (N) 34.15 (±6.81)  38.99 (±5.35) 32.98 (±9.34)  34.02 (±6.84)  0.258 
Stiffness (N/mm) 240.58 (±70.20)  304.70 (±32.26)  267.77 (±86.57)  296.20 (±67.52)  0.034 
69 
 
 
A.       B.   
 
C.       D. 
   
 
Figure 3. 4 - Graphical representations of general linear models of mechanical properties. 
Estimated means of normalized ultimate load and stiffness values are plotted for both strains at 3, 10, 
14, and 18 months for a general linear model age+strain+age*strain. A) Model for normalized femoral 
ultimate load is significant (p<0.001) with R2=0.594. Strain affects outcome values with R2=0.435 
(p<0.001). Age affects outcome values with R2=0.254 (p<0.001). The interaction term is not significant 
(p=0.287). B) Model for normalized femoral stiffness is significant with R2=0.733 (p<0.001). Strain affects 
outcome values with R2=0.576 (p<0.001). Age affects outcome values with R2=0.291 (p<0.001). The 
interaction term is significant with R2=0.117 (p=0.012). The slopes for C57Bl/6 and CBA/J mice are not 
distinct between 3 and 10 months (p=0.854), 10 and 14 months (p=0.103), or 14 and 18 months 
(p=0.445). However, slopes between 3 and 18 months are significantly divergent (p=0.004), as are the 
slopes between 10 and 18 months (p=0.022). C)  Model for ultimate load in the tibia is overall significant 
(p<0.001) with R2=0.247. Age is the only factor significantly influencing the outcome (p<0.001, 
R2=0.216). The slopes are invariant between the strains at all age iterations. D) Model for tibial stiffness 
is overall significant (p<0.001) with R2=0.260. Strain is the only factor significantly influencing the model 
(p<0.001, R2=0.151). Slopes are invariant between C57Bl/6 and CBA/J. 
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Figure 3. 5 - Linear relationships between stiffness and ultimate load in four age groups. 
A) C57Bl/6 femoral ultimate load is regressed with stiffness. Regressions are significant in the 3-month 
mice (p<0.001, R=0.779, R2=0.606). Regressions near significance but may lack power in the 10-month 
(p=0.094, R=0.813, R2=0.661) and 14-month mice (p=0.072, R=0.844, R2=0.713). The relationship is not 
significant in the 18-month mice. B) Ultimate load of the C57Bl/6 tibiae versus stiffness. The linear 
relationship is significant in the 3-month mice (p=0.035, R=0.530, R2=0.281) and the 10-month mice 
(p=0.044, R=0.889, R2=0.790). The 14-month relationship nears significance (p=0.059, R=0.865, 
R2=0.747). The relationship is once again significant in the 18-month mice (p=0.007, R=0.616, R2=0.379). 
C) Ultimate load versus stiffness in the CBA/J femora at the four different ages. Relationships are 
significant in the 3-month mice (p=0.001, R=0.701, R2=0.492) and 18-month mice (p=0.001, R=0.711, 
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R2=0.506). Due to lack of numbers, the 10-month and 14-month regressions are not significant. D) 
Regressions of tibial ultimate load versus stiffness. The relationship is significant in the 3-month 
(p<0.001, R=0.708, R2=0.501) and 10-month (p=0.003, R=0.864, R2=0.746) mice, but not in the 14- or 18-
month groups.  
 
 
 
 
A.                  B. 
 
 
C.                    D. 
 
    
Figure 3. 6 - Representative load-displacement curves for 4-point bending in four age groups. 
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A.      Femur                   B.           Tibia   
    
 
 
Figure 3. 7 - Post-yield displacement means from 4-point bending. 
Bar graphs demonstrate the differences in mean values of each strain in each age group. A) Femoral 
post-yield deflection – PYD is significantly different in C57Bl/6 age groups (p=0.004). Compared to the 3-
month mean, the 14-month mean is 46% lower (p=0.001) and the 18-month mean is 30% lower 
(p=0.030). Femoral PYD in the CBA/J age groups are different (p<0.001). Compared to the 3-month 
mean, the 10-month mice have 41% lower PYD (p=0.024), the 14-month mice have 74% lower PYD 
(p=0.012) and the 18-month mice have 69% lower PYD (p<0.001). B) Tibial PYD – PYD in the C57Bl/6 
mice is different when comparing age groups (p=0.009). The 18-month mean is 49% lower than the 3-
month mean (p=0.022) and 53% lower than the 10-month mean (p=0.035). The PYD means are not 
different when the CBA/J age groups are compared (p=0.164). 
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A.      Femur                   B.           Tibia 
    
C.      Femur                   D.           Tibia 
    
E.      Femur                   F.           Tibia 
    
 
Figure 3. 8 - MicroCT parameters influencing mechanics. 
Mineralization and shape parameters are reported in bar graphs. A) Femoral TMD – C57Bl/6 TMD means 
are significantly different between ages (p<0.001) with the 18-month mean being 9% lower than the 3-
month mean (p<0.001) and 10% lower than the 10-month mean (p=0.018). CBA/J TMD means are also 
significantly different between the age groups (p<0.001), however the only significant pairwise 
comparison is the 16% greater mean in the 3-month mice compared to the 18-month mice. B) Tibial 
TMD – C57Bl/6 Tibial TMD is different when ages are compared (p=0.016) with the 3-month mean being 
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8% greater than the 18-month mean (p=0.006). The CBA/J means are also different between ages 
(p<0.001), with the 3-month mean being 12% greater than the 18-month mean (p<0.001). C) Femoral 
cortical thickness – C57BL/6 cortical thickness is different when age groups are compared (p<0.001), 
with the 3-month mean being 15% greater than the 14-month mean (p<0.001) and 26% greater than the 
18-month mean (p<0.001). The 10-month mean is 11% greater than the mean at 14 months (p=0.035) 
and 22% greater than the mean at 18 months (p<0.001). The 14-month mean is 13% greater than the 
18-month mean (p=0.002). The CBA/J femoral cortical thickness means are different when the ages are 
compared (p<0.001) with the 3-month mean being 19% greater than the 18-month mean (p<0.001). D) 
Tibial cortical thickness – C57Bl/6 age groups have differing mean cortical thickness (p<0.001). The 3-
month mean is 20% greater than the 14-month mean (p<0.001) and 27% greater than the 18-month 
mean (p<0.001). Additionally, the 14-month mean is 9% greater than the 18-month mean (p=0.026). The 
CBA/J means are also different when the age groups are compared (p<0.001), with the 3-month mean 
being 15% greater than the mean at 14-months (p=0.010) and 21% greater than the mean at 18-months 
(p<0.001). E) Femoral Iy – C57Bl/6 age groups have different means for second moment of inertia in the 
bending direction (p=0.003). The only significant differences are when the ages are compared to the 
spike in the 14-month mean which is 21% greater than the 3-month mean (p=0.003), 23% greater than 
the 10-month mean (p=0.017), and 14% greater than the 18-month mean (p=0.052). CBA/J means are 
also significantly different (p<0.001), with the 3-month mean being 11% less than the 10-month mean 
(p=0.045), 19% less than the 14-month mean (p=0.045), and 50% less than the 18-month mean 
(p<0.001). The 10-month mean is 36% less (p<0.001) and the 14-month mean is 26% less (p=0.005) than 
the 18-month mean. F) Tibia Iy – C57BL/6 mean values are invariant across age groups (p=0.446). 
However, the CBA/J means are different between the age groups (p=0.045), with the 3-month mean 
being 12% less than the 18-month mean (p=0.047). 
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C.      Femur                   D.           Tibia 
    
E.      Femur                   F.           Tibia 
    
G.      Femur                   H.           Tibia 
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Figure 3. 9 - Cortical bone morphological measures in femur (left) and tibia (right). 
Shape parameters are reported in bar graphs from microCT analysis. A) Femoral endosteal perimeter – 
C57Bl/6 means are different according to the overall ANOVA (p=0.032), however, none of the pairwise 
comparisons reached significance. CBA/J mean endosteal perimeter does not quite reach significance 
when comparing the age groups (p=0.075). B) Tibial endosteal perimeter – C57Bl/6 means are variant 
when ages are compared (p<0.001). The 3-month mean is 14% less than the 14-month mean (p=0.016) 
and 10% less than the 18-month mean (p<0.001). The age groups have different means in the CBA/J 
mice (p=0.010) with the 3-month mean being 7% smaller than the 18-month mean (p=0.010). C) 
Femoral periosteal perimeter – C57Bl/6 age groups do not have significantly different means (p=0.066). 
This is also the case in the CBA/J mice (p=0.705). D) Tibial periosteal perimeter – C57Bl/6 mean 
perimeter values differ between the age groups (p<0.001), with the 3-month mean being 4% greater 
than the 18-month mean (p=0.010). The CBA/J means are not statistically distinguishable (p=0.141). E) 
Femoral marrow area – C57Bl/6 means are different between age groups (p<0001). The 3-month mean 
is 24% less than the 14-month mean (p<0.001) and 23% less than the 18-month mean (p<0.001). The 10-
month mean is 30% lower than the 14-month mean (p<0.001) and 28% lower than the 18-month mean 
(p<0.001).The means in the CBA/J mice are also significantly different when comparing the age groups 
(p<0.001), where the 3-month mean is 39% lower than the 18-month mean (p<0.001). F) Tibial marrow 
area – C57Bl/6 means are different when age groups are compared (p<0.001). The 3-month mean is 12% 
lower than the 10-month mean (p=0.039), 36% lower than the 14-month mean (p=0.001), and 29% 
lower than the 18-month mean (p<0.001). The 10-month mean is 21% less than the 14-month mean 
(p=0.007) and 15% less than the 18-month mean (p=0.012). The CBA/J means are also significantly 
different (p<0.001). The 3-month mean is 38% lower than the 14-month mean (p=0.012) and 41% lower 
than the 18-month mean (p<0.001). G) Femoral cortical area – C57Bl/6 mean cortical area is different 
when comparing the age groups (p<0.001). The 18-month mean is 18% lower than the 3-month mean 
(p<0.001), 12% lower than the 10-month mean (p=0.001), and 11% lower than the 14-month mean 
(p=0.005). The femoral cortical area is invariant between the age groups of the CBA/J mice (p=0.634). H) 
Tibial cortical area – C57Bl/6 means are significantly different between the ages (p<0.001). The 3-month 
mean is 12% greater than the 14-month mean (p=0.004) and 19% greater than the 18-month mean 
(p<0.001). The CBA/J age groups have different means, as well (p=0.007). The 3-month mean is 9% 
larger than both the 14-month mean (p=0.045) and the 18-month mean (p=0.003).  
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Figure 3. 10 - Trabecular properties of the distal femur. 
MicroCT-based measures of the trabecular region in both C57Bl/6 and CBA/J mice in the four age 
groups. A) Trabecular BMD – Mean BMD is different when C57Bl/6 ages are compared (p<0.001). The 3-
month mean is 43% greater than the 14-month mean (p<0.001) and 40% greater than the 18-month 
mean (p<0.001). The 10-month mean is 35% greater than the 14-month mean (p=0.010) and 32% 
greater than the 18-month mean (p=0.003). The mean BMD values in the CBA/J mice are also different 
(p=0.003) with the 3-month mean being 28% greater than the 18-month mean (p=0.003). B) Trabecular 
TMD – Mean TMD values differ when the C56Bl/6 age groups are compared (p=0.001). The 3-month 
mean is 19% greater than that at 18 months (p=0.003). The 10-month mean is 24% greater than that at 
18 months (p=0.012). The means are not different in the CBA/J mice when comparing age groups 
* 
* * 
* 
* 
* 
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(p=0.207). C) Trabecular Bone Volume Fraction (BVF) – Mean values of BVF are different in the C57Bl/6 
mouse strain age groups (p<0.001). The 3-month mean is 41% greater than the 10-month mean 
(p<0.001), 52% greater than the 14-month mean (p<0.001), and 58% greater than the 18-month mean 
(p<0.001). The CBA/J age groups also differ in mean BVF (p<0.001) with the 3-month mean being 65% 
greater than the 10-month mean (p<0.001), 74% greater than the 14-month mean (p<0.001), and 67% 
greater than the 18-month mean (p<0.001). D) Trabecular Anisotropy – The age group means for 
anisotropy are overall significantly different (p<0.001), however, the only age that differs is the 14-
month mean which is 19% greater than the 3-month mean (p=0.012), 26% greater than the 14-month 
mean (p=0.004), and 24% greater than the 18-month mean (p<0.001). Anisotropy is not different 
between the CBA/J age groups (p=0.193). 
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A.       B.  
     
 
C.        
Figure 3. 11 - Trabecular stereology of the distal 
femur. 
A) Bone Surface/Bone Volume – The ratio of bone 
surface to bone volume is not statistically different 
between the age groups in either the C57BL/6 mice 
(p=0.786) or the CBA/J mice (p=0.172). B) 
Trabecular Thickness – The trabecular thickness 
means are different in the C57Bl/6 age groups 
(p<0.001). The 3-month mean is 10% greater than 
the 18-month mean (p<0.001) and the 14-month 
mean is 23% greater than the 18-month mean 
(p=0.030). The means are also different in the CBA/J 
mice (p=0.038). The only pairwise comparison that 
is significant is the 16% greater mean thickness at 3 
months than at 18 months (p=0.054). C) Trabecular 
Number – The average number of trabeculae differs in the C57Bl/6 age groups (p<0.001). The 3-month 
mean is 44% greater than the 10-month mean (p<0.001), 57% greater than the 14-month mean 
(p<0.001), and 60% greater than the 18-month mean (p<0.001). Similarly, the CBA/J means are also 
different (p<0.001). The mean at 3 months is 68% greater than that at 10 months (p<0.001), 73% greater 
than at 14 months (p<0.001), and 75% greater than at 18 months (p<0.001).  
 
 
 
 
* 
* 
* 
* 
* 
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A.       B. 
 
C.  
 
Figure 3. 12 - Trabecular properties of the proximal 
tibia. 
MicroCT-based measures of the trabecular region of 
the proximal tibia. A) Trabecular BMD – Mean 
trabecular BMD values differ between age groups in 
both the C57BL/6 and CBA/J mice (p<0.001). In the 
C57Bl/6 strain, the 3-month mean is 19% greater 
than the 10-month mean (p=0.002), 34% greater 
than the 14-month mean (p<0.001), and 33% 
greater than the 18-month mean (p<0.001). The 10-
month mean is 18% greater than the 18-month 
mean (p=0.034). In the CBA/J mice, the 3 month 
mean is 18% greater than the 10-month mean 
(p=0.018) and 25% greater than both the 14- and 
18-month means (p<0.001). B) Trabecular TMD – Mean trabecular TMD values are different in the 
C57Bl/6 mice (p=0.019) but only a 9% greater mean in the 3-month mice compared to the 18-month 
mice (p=0.042). CBA/J mice are invariant in mean TMD (p=0.252).  C) Trabecular Bone Volume Fraction 
(BVF) – The means for the age groups differ in both the C57Bl/6 and CBA/J mice (p<0.001). In the 
C57Bl/6 mice, the 3-month mean is 46% greater than the 10-month mean (p<0.001), 63% greater than 
the 14-month mean (p<0.001), and 55% greater than the 18-month mean (p<0.001). The CBA/J means 
follow a similar pattern with the 3-month mean being 46% greater than the 10-month mean (p<0.001), 
72% greater than the 14-month mean (p<0.001), and 52% greater than the 18-month mean (p<0.001).  
 
* 
* 
* 
* 
* 
* 
* 
81 
 
 
 
A.       B. 
 
  
C.    
 
Figure 3. 13 - Trabecular stereology of the proximal 
tibia. 
A) Bone Surface/Bone Volume – The BS/BV ratio 
does not vary between ages in the C57Bl/6 mice 
(p=0.349). It does vary between the age groups of 
the CBA/J mice (p<0.001). The 3-month mean is 
27% greater than the 10-month mean (p=0.010) and 
31% greater than the 18-month mean (p<0.001). 
The 10-month mean is 40% lower than the 14-
month mean (p=0.040), which is in turn 43% greater 
than the 18-month mean (p=0.001). B) Trabecular 
Thickness – Mean thickness of the trabeculae differ 
between ages in the C57Bl/6 mice (p<0.001). The 3-
month mean is 14% greater than the 10-month 
mean (p=0.011) and 16% greater than the 18-month mean (p<0.001). Trabecular thickness does not 
differ between the age groups in CBA/J mice (p=0.413). C) Trabecular Number – Both strains have 
difference in trabecular number when age groups are compared (p<0.001). The C57Bl/6 3-month mean 
is 46% greater than the 10-month mean (p<0.001), 65% greater than the 14-month mean (p<0.001), and 
58% greater than the 18-month mean (p<0.001). The CBA/J 3-month mean is 60% greater than the 10-
month mean (p<0.001), 68% greater than the 14-month mean (p<0.001), and 67% greater than the 18-
month mean (p<0.001).  
 
* * 
* 
* 
* 
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A.       B. 
         
 
C.       D.  
         
 
Figure 3. 14 - General linear models of femoral trabecular parameters. 
The model run for the trabecular parameters was strain+age+strain*age. Graphs show model-estimated 
means. A) Trabecular BMD – Model is significant with R2=0.671 (p<0.001). Strain is a significant factor 
with R2=0.278 (p<0.001). Age, as a factor, is significant with R2=0.582 (p<0.001). The interaction between 
strain and age is also significantly influencing the outcomes (R2=0.247, p=0.002). The C57Bl/6 and CBA/J 
slopes from 3 months to 10 months are not statistically different, but approach significance (p=0.071). 
The slopes between 10 months and 14 months are different between the two strains (p=0.008). The 
change from 14 months to 18 months is not different in the two strains (p=0.459). B) Trabecular TMD – 
Model is significant with R2=0.442 (p<0.001). Strain does not influence outcomes in the model (p=0.211). 
However, age does influence outcomes (R2=0.246, p=0.002), as does the interaction of age and strain 
(R2=0.213, p=0.005). The slopes from 3 to 10 months differ between the strains (p=0.007). The 10-to-14 
and 14-18 month slopes do not differ. However, the accumulation of change from 10 to 18 months does 
differ between the strains (p=0.004). C) Trabecular Bone Volume Fraction (BVF) – The overall model is 
83 
 
significant for BVF with R2=0.782 (p<0.001). Strain (R2=0.619, p<0.001), age (R2=0.659, p<0.001), and the 
interaction term (R2=0.160, p=0.025) are all significant. The slopes of the two strains differ from 3 to 18 
months (p=0.001), however, none of the smaller intervals are divergent enough to reach significance. D) 
Trabecular Anisotropy – The model for anisotropy is significant with R2=0.344 (p<0.001). Strain is the 
only factor that influences the outcome values (R2=0.220, p<0.001). The interaction term does not 
significantly contribute to the model, however, the slopes from 3 to 18 months differ between C57Bl/6 
and CBA/J mice (p=0.022). None of the sub-intervals have differing slopes. 
 
 
 
A.       B. 
         
 
C.        
Figure 3. 15 - General linear models of femoral 
stereology. 
The general linear model of strain+age+strain*age 
was run on the normalized trabecular stereology 
values of the distal femur. A) Bone Surface/Bone 
Volume (BS/BV) – The model run on BS/BV is 
significant with R2=0.306 (p=0.005). Strain and the 
interaction term are significant factors of the model 
(R2=0.082, p=0.034 and R2=0.221, p=0.004, 
respectively). Age is not a significant factor. The 
overall rate of change is different in the strains from 
3 to 18 months (p=0.001). The only sub-interval that 
has diverging slopes is from 14 to 18 months 
(p=0.002). B) Trabecular Thickness – The model for 
trabecular thickness is significant (R2=0.495, p<0.001) with strain (R2=0.188, p=0.001) and age (R2=0.380, 
p<0.001) as influencing factors. The interaction term is not significant. C) Trabecular Number – The 
model for trabecular number is significant with R2=0.800 (p<0.001). Strain (R2=0.657, p<0.001) and age 
(R2=0.675, p<0.001) are significant factors in the model. The interaction does not reach significance.  
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C.      
Figure 3. 16 - General linear models of tibial 
trabecular parameters. 
The model run for the trabecular parameters was 
strain+age+strain*age. Graphs show model-
estimated means. A) Trabecular BMD – Model is 
significant with R2=0.792 (p<0.001). Strain is a 
significant factor with R2=0.510 (p<0.001). Age, as a 
factor, is significant with R2=0.661 (p<0.001). The 
interaction between strain and age is also 
significantly influencing the outcomes (R2=0.157, 
p<0.001). The C57Bl/6 and CBA/J slopes from 3 to 18 
months differ (p<0.001) with much of the divergence 
occurring in the interval between 3 and 14 months 
(p=0.043). B) Trabecular TMD – The model for TMD 
is not significant. C) Trabecular Bone Volume Fraction (BVF) – The overall model is significant for BVF 
with R2=0.855 (p<0.001). Strain (R2=0.594, p<0.001), age (R2=0.724, p<0.001), and the interaction term 
(R2=0.322, p<0.001) are all significant. The slopes of the two strains overall differ from 3 to 18 months 
(p<0.001), with the most divergence occurring between 3 and 10 months (p=0.001).  
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C. 
Figure 3. 17 - General linear models of tibial 
trabecular stereology. 
The model strain+age+strain*age was run on 
stereological measures of the proximal tibia. A) 
BS/BV – The overall model for BS/BV is significant 
with R2=0.568 (p<0.001). All three factors are 
significant – strain (R2=0.298, p<0.001), age 
(R2=0.254, p<0.001), and the interaction (R2=0.220, 
p<0.001). The overall rate of change from 3 to 18 
months differs between the two strains (p<0.001). 
Significant divergence of the slopes occurs in the 3 to 
10 month interval (p=0.001) and the 14 to 18 month 
interval (p=0.001). B) Trabecular Thickness – The 
model is significant when run for trabecular thickness 
(R2=0.215, p=0.002). Strain is not a significant factor, but both age (R2=0.109, p=0.014) and the 
interaction are (R2=0.113, p=0.011). The amount of change differs from 3 to 18 months when comparing 
the two strains (p=0.002). The most divergence of slope occurs in the 3 to 10 month interval (p=0.032) 
and the 14 to 18 month interval (p=0.054). C) Trabecular Number – The model for trabecular number is 
significant with R2=0.903 (p<0.001). Strain (R2=0.714, p<0.001), age (R2=0.795, p<0.001), and the 
interaction between strain and age (R2=0.392, p<0.001) are all significant factors. The rate of change 
differs between the C57Bl/6 and CBA/J mice from 3 to 18 months (p<0.001). The slopes diverge in the 3 
to 10 month interval (p=0.005) and 10 to 14 month interval (p=0.039).  
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Figure 3. 18 - Trabecular BMD and TMD regressed against weight. 
Linear regressions were run comparing trabecular BMD and TMD to weight (values not normalized). A) 
Femoral Trabecular BMD – Regression is significant for the C57Bl/6 mice with a correlation coefficient 
of R=-0.296. (R2=0.09, p=0.043). Regression is not significant for the CBA/J mice (p=0.755). B) Femoral 
Trabecular TMD – Regression is not significant for TMD vs. weight in the C57Bl/6 mice (p=0.776). The 
linear relationship is significant in the CBA/J mice with a correlation coefficient of R=0.369 (R2=0.142, 
p=0.012). C) Tibial Trabecular BMD – Regression is significant in the C57Bl/6 mice with a correlation 
coefficient of R=-0.309 (R2=0.095, p=0.033). Regression is not significant in the CBA/J mice (p=0.920). D) 
Tibial Trabecular TMD – Regression is not significant for the C57Bl/6 mice (p=0.176). The regression is 
significant for CBA/J mice with a correlation coefficient of R=0.671 (R2=0.443, p<0.001).  
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CHAPTER IV: 
DIFFERENTIAL AGE-RELATED CHANGES IN MECHANORESPONSE 
 
Introduction   
 In the previous two chapters, we have demonstrated the variability in aging strategies 
that can be found in mice. We have also demonstrated how these differences in bone aging 
may be applicable to trends in human aging. The variable bone-related aging patterns in a 
mouse model provide a useful research tool for investigating the underlying factors of the bone 
outcomes. While there are numerous sources that influence bone health with age, we cannot 
study all of them in one dissertation. One factor stands out from the analyses presented in the 
previous chapters. Both mouse strains, C57Bl/6 and CBA/J, increase body mass as they age. The 
positive correlation between body weight and bone mineral density in men [1] and women [2, 
3] has been well documented by researchers. The relationship between bone phenotype and 
weight is partly due to the adaptive response of bones to increase load. Published data have 
also demonstrated the relationship between body mass and bone mass in C57Bl/6 male mice, 
specifically [4]. What is not known is whether this relationship is maintained throughout aging. 
 In the 3-month C57Bl/6 mice, there are strong positive relationships between body 
weight and ultimate load (R2=0.360, p=0.009) as well as weight and cortical area (R2=0.350, 
p=0.008). In the 14- and 18-month C57Bl/6 mice combined, the relationships between weight 
and ultimate load (p=0.364) and weight and cortical area (p=0.697) are lost. In the CBA/J 3-
month mice, there is a linear relationship between body weight and ultimate load (R2=0.361, 
p=0.008), as well as between body weight and cortical area (R2=0.244, p=0.037). Like the 
C57Bl/6 mice, the weight-ultimate load relationship is lost in the older CBA/J mice (p=0.861). 
However, this strain does maintain a relationship between weight and cortical area (R2=0.238, 
p=0.025). These data lead to the hypothesis that the C57Bl/6 mice lose the ability to respond to 
88 
 
the increase in body weight. The CBA/J mice, however, maintain the mechanoresponsiveness 
throughout aging and can adapt to the load increase. 
 Research in the field of skeletal biology supports the notion that mechanical stimulation 
is necessary for healthy skeletal maintenance and function [5]. Bone is able to respond to 
mechanical stimuli through a complex, multi-tiered process of mechanotransduction. It is still 
unclear how aging influences the mechanoresponsiveness of bone. With advanced age, people 
have reduced bone response to exercise [6, 7]. This suggests that some level of the 
mechanoresponse system is impaired by senescence.  
 Studies focused on how aging affects mechanoresponse in rodents have yielded mixed 
results. A number of findings suggest that mechanoresponse is diminished in older mice [8, 9, 
10, 11, 12, 13]. However, the strains and sexes used in these studies are not universal, 
preventing confidence in drawing conclusions. Rats have also been used to study aging effects 
on mechanoresponse. Turner et al. demonstrate that strain thresholds are increased to elicit a 
response in the older animals. Furthermore, when eliciting a response, older animals had 16-
fold less bone growth than the young adults [14]. Contrary to these findings, other groups have 
presented data refuting the change in mechanoresponse with age. Therefore, more work needs 
to be done in order to come to a consensus regarding the relationship between aging and 
response to mechanical stimuli. 
 In this chapter, we will compare the in vivo response to load in the C57Bl/6 and CBA/J 
mouse strains using tibial axial compression. Previous studies have demonstrated the ability to 
elicit an anabolic response using this method in adult mice [10, 13, 15, 16]. In the last chapter, 
findings were presented suggesting that CBA/J mice maintain mechanical integrity of the 
cortical bone with aging, whereas C57Bl/6 mice do not. Therefore, we propose that the 
mechanoresponse in the CBA/J diaphysis will not diminish with age and the C57Bl/6 diaphyseal 
response will be reduced in the older animals.  
In the CBA/J older mice, much of the mechanical stability is derived from the continued 
periosteal bone apposition. In the C57Bl/6 mice, the periosteal surface fails to expand to 
maintain mechanical function. Due to these findings, the periosteal tissue will specifically be 
tested for changes in mechanoresponse. Periosteum has been shown to be integral in bone 
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formation, growth, repair, and even mechanical response [17, 18, 19, 20]. Periosteal cells are 
responsive to dynamic fluid pressure by increasing proliferation [21]. Periostin, a critical 
extracellular protein in periosteal tissue, is upregulated in response to mechanical loading [22]. 
Periostin and is responsive to increases in both Runx2 [23] and c-Fos [24], both of which are 
upregulated with mechanical stimulation. 
Older humans and rats both have decreased periosteal thickness, micro-vessel density, 
fibroblasts, osteoblasts, and collagen compared to younger individuals [25, 26, 27, 28]. The 
periosteal cells’ interaction with the underlying bone largely influences its ability to transduce 
mechanical signals [29, 30, 31]. Due to the age-related changes in both the periosteal tissue and 
cortical bone, we expect the response to mechanical loading will also be altered with age. This 
leads to the prediction that the C57Bl/6 mice, which do not have periosteal bone apposition 
with aging, will lose mechanoresponsiveness in the periosteum. Furthermore, we predict the 
CBA/J periosteal response will remain constant throughout aging.  
 The cortical bone from the tibial diaphysis will be measured, as well. It is thought that 
the osteocyte is one of the primary mechanosensory cells and found in high abundance in the 
cortical bone [12]. Differences in bone apposition on the periosteal surface may be regulated by 
the osteocytes of the peripheral cortical bone instead of, or in addition to, the periosteal cells. 
Therefore, we expect to see maintenance of cortical responsiveness in the CBA/J mice with age, 
but a decrease in the C57Bl/6 mice. 
In addition to the diaphyseal tissue, the epiphyseal region of the proximal tibia will be 
isolated to look at changes in mechanical response in the trabecular bone. In the trabecular 
compartment, C57Bl/6 appears to lose trabecular bone volume more slowly than CBA/J mice. 
Therefore, we hypothesize that both strains will reduce the epiphyseal response to load with 
age, but the reduction will be more severe in the CBA/J mice.  
  
Materials & Methods 
Tibial Loading  
 Male C57Bl/6 and CBA/J mice were used at 3-, 10-, and 18-months of age. Each group 
had 10 animals. The right tibia was loaded in a similar manner to experiments done by other 
investigators [10, 15, 32] (Figure 4.1). Custom platens were designed and manufactured at the 
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Orthopaedic Research Laboratories at University of Michigan. Loading was conducted on a Bose 
ElectroForce® 3300 mechanical testing system (Bose Corp., Eden Prairie, MN). Limbs were 
loaded axially while mice were under anesthesia (isofluorene) as approved by University of 
Michigan Animal Care.  
 Strain-matched loads were applied based on pilot strain gaging data. All animals were 
loaded using a 2 Hz sine wave with a 2 N preload. The 3-month and 10-month old mice of both 
strains were loaded at 10 N compressive force, approximating 2500 µƐ. The 18-month mice, in 
order to match the strain levels, were loaded at 12 N maximum compressive force. Each animal 
was loaded for 600 cycles with a 100 cycle tow-in period under indirect load-based cyclic 
feedback control. Animals were euthanized 30 minutes following loading. Both left and right 
tibiae were extracted immediately following sacrifice and placed in RNAlater (AMBION, Inc., 
Austin, TX). Samples were stored at -80°C for at least two days to ensure no cellular response 
during RNA extraction.  
 Pilot experiments were run in order to ensure mechanical response was elicited that 
could be measured with rtPCR. For this pilot test, marrow was flushed and the whole tibia 
homogenized for RNA extraction. Quantitative rtPCR was run using primers for c-Fos, runx2, 
and Gja1 using β2m as a housekeeping gene. Six 3-month old C57Bl/6 mice were loaded and 
sacrificed 15 minutes following load, six 3-month old CBA/J mice were sacrificed 20 minutes 
post-load, and another six 3-month C57Bl/6 mice were sacrificed 30 minutes post-load. This 
was done to test for the optimal timing of sacrifice for measuring gene response. Previous work 
done in the lab demonstrated a drop in response in c-Fos and COX-2 from 30 minutes to 60 
minutes post-loading [33]. 
 Results for whole bone gene expression changes demonstrate a 4.5-fold increase of c-
Fos, 0.99-fold change in Runx2, and a 0.67-fold change in Gja1 at 15 minutes post-load. At 20 
minutes post-load, there was a 6.21-fold increase in c-Fos expression, 1.07-fold increase in 
Runx2, and a 1.09-fold increase in Gja1 expression. After 30 minutes post-load, c-Fos expression 
was increased 10.35-fold, Runx2 expression was increased 1.03-fold, and Gja1 expression was 
increased 2.98-fold (Table 4.1). These data validate the use of this loading method for eliciting a 
mechanical response in both C57Bl/6 and CBA/J tibiae. Furthermore, 30 minutes post-loading is 
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the ideal time for sacrifice for c-Fos expression. Runx2 expression does not increase during this 
period, likely due to insufficient time for up-regulation. 
 
Quantitative Real-Time PCR 
 Bones were removed from the -80°C storage and thawed on ice. All extractions were 
done using appropriate RNA techniques. Marrow was flushed and collected using 1 mL TRIzol® 
(AMBION Inc., Austin, TX).10 Proximal epiphyses were removed just below the proximal tibia-
fibula junction and placed in 1 mL Trizol. Periosteum was scraped under a dissection 
microscope in 0.5 mL DNase/RNase-free water, collected, and added to 0.5 mL Trizol. 
Remaining cortical bone was rinsed and placed in 1 mL Trizol. All tissue types were 
homogenized for 30 seconds.  
 Homogenates were immediately treated with 200 uL of chloroform and shaken for 15 
seconds. They were then centrifuged for 20 minutes at 4° C at 12,000 g. The top (clear) layer 
was extracted. The RNeasy® Mini-kit was then utilized according to manufacturer protocols to 
further purify the RNA. This included the optional DNase treatment. RNA was eluded from 
columns using 30 uL RNase-free water warmed to 65° C. Elution was run through twice for 
cortical and periosteal RNA columns to maximize yield. Two separate elutions of 30 uL were run 
for the epiphyseal and marrow columns in order to dilute RNA to usable ranges. Extracted RNA 
was immediately stored at -80° C.  
 Little work has been done using isolated periosteum for rtPCR. Therefore, pilot work 
was done to ensure RNA yields were sufficient for downstream quantification. The first trial 
provided yields of 61.3 ng/ul of cortical RNA, 19.3 ng/ul of periosteal RNA, 333.3 ng/ul of 
epiphyseal RNA, and 377.8 ng/ul of marrow RNA. Due to the low yield of the periosteal RNA, 
the extraction method was modified to reduce time between thawing and homogenization in 
TRIzol. Additionally, trials were run that demonstrated higher yields when combining TRIzol-
only and RNeasy-kit® (Qiagen, Valencia, CA) extraction and RNA isolation techniques. Following 
these changes, a second trial was run and periosteal RNA yield averaged 65.9 ng/ul.  
                                                          
10 Marrow was run though none of the genes showed expression in any strain or age or treatment, therefore 
results are omitted.  
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 Following RNA extraction, samples were thawed on ice and yield measured using a 
NanoDrop system. Reverse transcription was done using qScript cDNA SuperMix (Quanta 
Biosciences, Inc., Gaithersburg, MD) according to manufacturer’s protocol for 30 uL-reaction 
volume. For cortical, epiphyseal, and marrow RNA, 1 ug of total RNA was used for the RT 
reaction. Due to lower yields, 500 ng of periosteal RNA was used for the reactions. Pilot work 
demonstrated that the downstream quantification would still work with this lower 
concentration of RNA. Real-time PCR was performed in triplicate and quantified using SYBR 
Green fluorescent markers (Invitrogen, Carlsbad, CA). Beta-2-microglobulin (β2m) was used as 
an internal control due to pilot work comparing other commonly used housekeeping genes. 
PrimeTime® qPCR primers were obtained (Applied Biosystems, Foster City, CA) for C-Fos (Fos), 
COX-2 (Ptgs2), eNOS (Nos3), Cx43 (Gja1), and β2m (Table 4.2). Expression changes are 
measured using the ΔΔC(t) method with the left limb as control.  
 The ΔΔC(t) method is an equation to calculate fold-change in gene expression. For each 
rtPCR experiment run, a threshold for LOG of the fluorescence is set just the onset of the 
exponential phase of the fluorescent curve.11 The C(t)-value is the cycle number (point on the x-
axis) that intersects with the fluorescent threshold. Following export of the data, we compared 
the triplicate values to point out possible errors in technique leading to highly variable C(t) 
values within the three wells. C(t)-values for wells were averaged and the equations used were 
the following: 
∆𝐶(𝑡)𝑙𝑖𝑚𝑏 =  𝐶(𝑡)̅̅ ̅̅ ̅̅ 𝑔𝑒𝑛𝑒 − 𝐶(𝑡)̅̅ ̅̅ ̅̅ 𝛽2𝑚 
  Where each gene of each limb is normalized to the housekeeping gene (β2m). 
∆∆𝐶(𝑡) = ∆𝐶(𝑡)𝑟𝑖𝑔ℎ𝑡 − ∆𝐶(𝑡)𝑙𝑒𝑓𝑡 
  Such that the ∆∆𝐶(𝑡) of each gene is the difference between the ΔC(t) of the 
experimental (loaded/right) limb and the control (unloaded/left). 
𝐹𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 =  2−∆∆𝐶(𝑡)  
  This equation results in a fold-change value, which is only considered if greater 
than 1-cycle, or 2-fold up/down-regulation. Values greater than 1 indicate an increase in gene 
                                                          
11 Note: In a LOG graph, linear change is actually exponential, so threshold is set where the LOG graph becomes a 
straight line. 
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expression in the loaded limb. Values less than 1 indicate a down-regulation in expression in the 
loaded limb. 
C-Fos (Fos) is a commonly reported early mechanoresponse gene [34]. In response to 
mechanical stimuli, the JNK and ERK pathways are activate, which lead to up-regulation of the 
Fos-gene family, of which c-Fos is a member. The c-Fos is a major component of the 
transcription factor activator protein-1 (AP-1) which mediates gene expression in early 
osteoblastic differentiation [5, 35, 36]. 
Cyclooxygenase-2 (COX-2/Ptgs2) is another early-response transcription factor often 
reported in bone mechanoresponse studies. COX-2 activity leads to the conversion of 
arachidonic acid into prostaglandin-E2 (PGE2). COX-2 transcription is upregulated through the 
ERK and PKA pathways when mechanically stimulated [5, 37]. There is evidence that aged mice 
have a reduction in the expression of COX-2 compared to young adult mice [38].  
Endothelial nitric oxide synthase (eNOS/Nos3) and is one of three enzymes that produce 
active nitric oxide (NO). Nitric oxide suppresses osteoclasts and promotes osteogenesis [5, 39, 
40]. Under mechanical stimulation, NO has been shown to be released by both osteoblasts [37, 
41, 42, 43, 44] and in bone marrow stromal cells [45, 46, 47]. The inhibition of eNOS 
significantly impairs load-induced bone osteogenesis [40, 48, 49]. 
The final gene of interest is connexin-43 (Cx43/Gja1). Connexin proteins are involved in 
the formation of hemi-channels and gap-junctions [50]. Cx43 is a marker of mechanical 
response that is involved in the mobilization and movement of calcium within and outside the 
cell [51, 52]. Expression of Cx43 is upregulated in response to mechanical stimulation [53, 54] 
and promotes osteogenesis along the PGE2-signaling axis [5]. The responsiveness of Cx43 
channels to mechanical stimuli is lost with advancing age [55, 56]. 
 
Adaptive Loading 
In order to assess the downstream adaptive responsiveness in the two strains, an initial 
long-term loading pilot experiment was run on 3-month-old male C57Bl/6 and CBA/J mice. This 
experiment used the same tibial loading parameters as described above. However, animals 
were loaded three days a week for four weeks. Alizarin I-P injections were administered on day 
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28 of loading. Calcein injections were administered on day 33 and animals were euthanized on 
day 35. 
Bones were excised following sacrifice and prepared for embedding in PMMA. Cortical 
sections were taken just distal to the tibia-fibula junction. Trabecular regions were taken from 
just below the proximal tibia-fibula junction. Images were taken using a Zeiss fluorescent 
microscope and measured using BioQuant® software. Mineralizing surface, mineral apposition 
rate (MAR), and bone formation rate (BFR) were recorded for both loaded and unloaded limbs. 
 
Statistics 
Statistical analyses were run using commercially available SPSS software. Statistics were 
done on the ddC(t) values due to the lack of linearity and Gaussian distribution inherent in fold-
change values. For graphical purposes, the 3-month C57Bl/6 mean fold-change value was set at 
1 and all other values offset accordingly. Outliers for the PCR data were only removed if the 
fold-change exceeded 100 in order to avoid biasing the data. ANOVA was used to compare the 
3-, 10-, and 18-month age groups within each strain. T-tests were used to compare C57Bl/6 and 
CBA/J means at each age. Significance is defined as p ≤ 0.05. Paired t-tests were used to 
compare the loaded and unloaded limbs for dynamic histomorphometry. Due to high levels of 
variability, near-significance was defined as a p-value between 0.055 and 0.01. 
 
Results 
Periosteal Gene Expression 
 In the periosteum of the C57Bl/6 mice, c-Fos was differentially expressed when 
comparing age groups following loading (p=0.045). Though significant, the difference in 
expression between the 10-month and 18-month means only represented a 1.6-fold increase at 
18 months (p=0.047) (Figure 4.2 – A). Expression of COX-2 was also variant in the periosteum of 
C57Bl/6 mice when ages were compared (p=0.025). The expression at 18 months was 2.0-fold 
greater than the expression at 10 months (Figure 4.2 – B). Due to primer issues, data for 3-
month COX-2 expression were unavailable. Periosteal expression of eNos and Cx43 (Gja1) were 
not different between age groups (Figure 4.2 – C and D). 
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 The age groups in the CBA/J strain expressed differing levels of c-Fos following loading 
(p=0.032). The difference in expression between 3 and 18 months neared significance and 
represented a 5.6-fold greater c-Fos expression at 18 months compared to 3 months (p=0.081). 
The difference between the 10-month and 18-month means represented a 5.8-fold greater 
expression of c-Fos in the 18-month group (p=0.046) (Figure 4.2 – A). Difference in COX-2 
expression between CBA/J age groups did not reach significance (p=0.118). However, 
qualitatively, the expression at 18 months is much greater than that at 3 and 10 months (Figure 
4.2 – B). Statistics returned as not significant due to high levels of variability. Greater sample 
size and removal of outliers might yield significant results. Expression of eNos is invariant when 
CBA/J age groups are compared (Figure 4.2 – C). The expression of Cx43 (Gja1) was also similar 
at all ages in the CBA/J periosteum (Figure 4.2 – D). 
 The expression of c-Fos was similar in the C57Bl/6 and CBA/J strains at 3 and 10 months. 
However, the 18-month CBA/J mean was significantly greater than the C57Bl/6 18-month mean 
(p=0.006). Similar to c-Fos, expression of COX-2 did not differ between strains at 3 and 10 
months. The 18-month CBA/J mean expression was much greater than the C57Bl/6 expression 
at 18 months (p=0.003). Expression of Cx43 (Gja1) was greater in the CBA/J 18-month mice 
compared to the expression of the C57Bl/6 18-month mice (p=0.016).  
 
Cortical Gene Expression 
 In the C57Bl/6 mice, expression differences between age groups were not significant for 
any of the genes measured (Figure 4.3 – A, B, C, D). Similarly, expression in the CBA/J mice did 
not differ when ages were compared for the genes of interest (Figure 4.3 – A, B, C, D). 
 
Epiphyseal Gene Expression 
 Expression of c-Fos was different when C57Bl/6 age groups were compared (p=0.036) 
with the 18-month response showing a 3.2-fold greater expression than the 10-month mice 
(p=0.033) (Figure 4.4 – A). There were also differences in expression of COX-2 when C57Bl/6 
age groups were compared (p=0.008). The 18-month mean expression is 10.5-fold greater than 
the 3-month mean (p=0.026) and 12.2-fold greater than the 10-month mean (p=0.012) (Figure 
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4.4 – B). Expression of eNos (Figure 4.4 – C) and Gja1 (Figure 4.4 – D) did not differ when 
C57Bl/6 ages were compared.  
 Expression profiles of c-Fos, COX-2, and eNos, in the epiphysis of CBA/J mice, were 
invariant between age groups (Figure 4.4 – A, B, C). Comparisons between the age groups for 
Gja1 expression in CBA/J mice neared significance (p=0.072) with the 3- and 18-month 
difference in expression falling just outside the range of significance (p=0.081) (Figure 4.4 – D).  
 
Periosteal Dynamic Histomorphometry 
 There was no difference in periosteal mineralizing surface (MS) or mineralizing 
surface/bone surface (MS/BS) when comparing the C57Bl/6 loaded and unloaded limbs. There 
was a significant increase in MS in the CBA/J tibiae when loaded (p=0.048). The ratio of MS/BS 
was not significantly different in the CBA/J loaded and unloaded groups (Figure 4.5). Neither 
strain produced double labeling on the periosteal surface. For this reason, mineral apposition 
and bone formation rates were not measurable.  
Endosteal Dynamic Histomorphometry 
 The averages for MS and MS/BS in the C57Bl/6 left (control) limbs were significantly 
greater than the average in the loaded limbs (p=0.042, p=0.053) (Figure 4.6 – A, B). The average 
mineral apposition rate (MAR) for the C57Bl/6 was not statistically different when comparing 
the loaded and unloaded limbs (Figure 4.6 – C). Additionally, the bone formation rate (BFR) was 
not different when the sides were compared (Figure 4.6 – D). 
The CBA/J control limbs had a significantly lower mean MS and MS/BS than the loaded 
side (p=0.021 and p=0.028, respectively) (Figure 4.6 – A, B). The mean MAR values was greater 
in the loaded limb than the contralateral controls (p=0.031) (Figure 4.6 – C). However, the mean 
BFR was not different in the loaded and unloaded limbs (Figure 4.6 – D). 
 
Metaphyseal Dynamic Histomorphometry 
 In the trabecular region of the tibial metaphysis, the MS/BS and MAR averages were not 
different in the C57Bl/6 loaded and unloaded limbs (Figure 4.7 – A, B). However, the BFR in the 
loaded C57Bl/6 limb was significantly greater than the BFR of the unloaded limb (p=0.019) 
(Figure 4.7 – C). 
97 
 
 The mean MS/BS of the CBA/J control limbs was invariant from the mean of the loaded 
limb. (Figure 4.7 – A). The mean MAR in the CBA/J tibiae was significantly greater in the loaded 
limb compared to the unloaded limb (p=0.015) (Figure 4.7 – B). The mean BFR was, however, 
not different in the loaded and unloaded CBA/J limbs (Figure 4.7 – C). 
 
Discussion 
 A number of researchers in the field have proposed that age-related bone loss and 
fragility is due to inappropriate adaptation to mechanical loading [12, 57]. In the first 
hypothesis of this chapter, we estimated that the C57Bl/6 periosteum was expected to lose 
response to load with aging. The data do not support these projections. The expression in the 
C57Bl/6 periosteal tissue is not greatly affected by age. Despite significance between the 10-
month and 18-month mean fold change in c-Fos and COX-2 expression, the actual fold change is 
not above 2x. The 3-month periosteal tissue did not demonstrate an upregulation in the genes 
tested for. Therefore, a loss of expression could not be measured.  
Due to the continued periosteal expansion, we predicted that CBA/J mice would 
experience a consistent response to loading regardless of age. Instead of maintaining 
expression levels, the CBA/J response markedly increased with age in c-Fos and COX-2. It is 
possible that as the periosteal tissue is displaced further from the neutral bending axis, the 
strain each cell experiences is greater due to increased moment. This would suggest that the 
cells are not altering the responsiveness, but rather the response is scaled to the level of strain 
the mechanosensory cells experience. Another explanation is that the extracellular matrix of 
the periosteum is losing ductility due to collagen cross-linkage. This would lead to increased 
strain experienced by the cells. Since the C57Bl/6 periosteal cells do not seem to increase 
response, it is more likely that the location away from the neutral axis is having a greater effect 
on the increase in change measured in CBA/J mice. 
 The cortical bone response in the C57Bl/6 mice was expected to be decreased in the 
older aged animals. Statistically, there are no differences in the gene expression profiles. 
However, the expression for c-Fos (2.18-fold increase) and COX-2 (2.67-fold increase) fall below 
the 2-fold threshold for relevance in the 10-month and 18-month animals. It is possible that 
98 
 
these data do, in fact, represent a loss in response, but is masked by the high degree of 
variation.  
 The CBA/J cortical bone also does not appear to have any statistically different 
expression values. The 3-month mean c-Fos and COX-2 expression is upregulated due to loading 
over the 2-fold criterion. The lack of significant change in expression at 10- and 18-months 
suggests that the response is maintained with age. However, the c-Fos 18-month mean does 
dip slightly below the 2-fold threshold.  
 We hypothesized that the C57Bl/6 epiphyseal expression would decrease slightly but 
less so than the CBA/J mice.  The data disprove this hypothesis but still provide interesting 
results. The epiphyseal upregulation of c-Fos, COX-2, and eNOS due to loading are all increased 
in the 18-month C57Bl/6 mice. The CBA/J mice do not appear to have any change in the gene 
expression profiles with age, with all ages having low amounts of upregulation due to loading. 
 While these data do not match exactly the proposed outcomes, they do support the 
idea that the two strains of mice undergo varying changes to loading response with age. The 
C57Bl/6 mice either maintain or reduce the ability to response to load in the diaphyseal region, 
possibly leading to the lack of periosteal deposition that is evident in this strain’s older mice. 
This aligns with the proposition that C57Bl/6 mice do not increase bone mass and second 
moment due to weight increase because they lack the ability to respond to load in the 
diaphyseal bone. Conversely, the CBA/J mice have a large increase in response in the 
periosteum and maintain load-induced upregulation in the cortex. These results are indicative 
of the continued or increased deposition of bone in response to greater loads from body mass. 
 The reason for the increase in trabecular response in the C57Bl/6 older mice could be 
due to the decreased cortical bone at the diaphysis. The increase in trabecular response could 
be a compensatory mechanism to prevent further loss of bone. Since there is an overall 
reduction in the amount of trabecular bone in the old C57Bl/6 mice, it is possible that the 
remaining trabecular bone is taking on greater responsibility for load bearing leading to per cell 
response increasing.  
 These results are not consistent with previous reports of decreasing mechanoresponse 
with age in mice [8, 9, 10, 11, 12, 13, 58]. However, most of the previous work has been 
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conducted on C57Bl/6 or BALB/c mice and focused on the cortical bone. Based on the data 
presented here, it is not surprising that a loss in mechanoresponse has been reported. By 
adding the CBA/J mice to the analysis, we demonstrate that aging does not influence 
mechanoresponse universally in all strains of mice. Furthermore, a loss of mechanoresponse in 
the cortical bone does not necessitate a loss in response in the trabecular region.  
 The high amounts of variability in the expression profiles within each strain is 
concerning. Prior to the experiment, a power analysis was run using similar PCR data from a 
tibial loading model from our lab. The levels of variability from those data led to our calculation 
of 7-8 mice per group. However, the variability in the data we present in this chapter is well 
above that from the previous work. One potential explanation for this discrepancy is due to the 
use of old mice in our study. Age inherently increases variability, likely leading to a greater 
range of outcomes regarding gene expression. Another possible reason for the large variability 
in the PCR outcomes arises from the separation of periosteal, cortical, and epiphyseal tissue. 
This method reduces the RNA yield, making the outcomes more sensitive to minor variations. In 
order to account for the heightened variation in measures, larger sample sizes are necessary. 
Additionally, quality control using RIN values could provide insight into influence of handling 
and processing on RNA quality. 
 One interesting observation relates to the curvature of the tibiae in the two strains. The 
CBA/J tibiae are clearly much more curved than those of the C57Bl/6 mice. The differing 
curvature suggests different concentrations of stressors in the whole bone. The C57Bl/6 tibia is 
almost straight, with little bowing. With the greater curvature of the tibiae in the CBA/J mice, 
strain experienced is different than the C57Bl/6 diaphysis due to altered 3-D stress state. These 
geometry patterns would help explain the greater mechanical response in the C57Bl/6 
epiphysis and the CBA/J periosteum and cortex.  
 One drawback to this study is the lack of information on the fibula. The fibulae were all 
removed and discarded prior to RNA extraction. The tibiae in the C57Bl/6 mice may be much 
straighter but the fibulae much more bowed. This would put a greater demand on the fibula 
and alleviate the amount of strain required in the tibia. Future work should include analysis of 
the gene profiles in the tibiae, as well. Another complication could be in the pilot strain-gaging 
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data that provided load estimates for the strain-matched model. Whole-bone mechanics might 
be altered by the absence of periosteal tissue [59]. In order to adhere the gages to the surface 
of the bones, periosteum is stripped. This could lead to altered in vivo strain in the tibiae. 
Unfortunately, there are currently no methods for direct gage application without removal of 
the periosteal tissue. However, future strain measures might be taken using visual/infrared 
tracking of stable points to get more accurate measures.  
 Another critical limitation of this work is the inability to assess the functional 
implications of the gene expression changes. The mechanoresponse system is comprised of 
four mechanisms. Age could influence any or all levels, leading to an ultimate reduced adaptive 
response to load. The first step in the mechanoresponse system is the transmission of load 
through the tissue [60, 61]. The previous chapters demonstrated age-related changes in 
mineralization, shape, and post-yield properties in both strains. Increased collagen crosslinks 
have been reported to influence aging bone stiffness and post-yield properties in both human 
and rodents [9, 62]. These changes will alter the transmission and propagation of through the 
bones. Furthermore, substrate stiffness has been shown to alter cell fate [59, 63, 64, 65, 66]. 
Alterations in the end results of mechanical load could be due to material level properties 
altering direction and concentration of loads and how the cells receive the mechanical signals.  
 The next steps in the mechanical response process is the sensation of load by sensory 
cells and the transduction of the physical signal into bioelectric or biochemical signals [61, 67]. 
Experimentally, these two processes are difficult to distinguish as cell response is the only in 
vivo method to assess cell sensation. Using in vitro methods, there is evidence that older bone 
cells have decreased response to mechanical challenges compared to younger cells [47, 58, 68]. 
Aging cells may lose the ability to sense and/or respond to load due to general senescence. 
Telomere shortening could prevent appropriate production of upregulated genes necessary to 
elicit an adequate remodeling response. DNA error rates increase in each successive replication 
cycle. Therefore, older cells may have difficulty in transcription factor binding and/or correct 
translation.  
 One intriguing finding of this work was the tendency for some individual mice to elicit a 
down-regulation in response to loading. This would not be surprising in a long-term loading 
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study. However, 30 minutes is a short timespan for reducing presence of mRNA. One 
explanation that bear future study is that potential role of epigenetic effects on 
mechanoresponse. miRNA’s have the ability to inhibit protein production from transcribed 
RNA. These can be fast-acting molecules and have been suggested as influencing dysfunction 
leading to osteoporosis [69]. Therefore, miRNA and other post-transcriptional and post-
translational modifications should be investigated and may be important regulatory 
mechanisms for bone loading response.  
 This study is able to assess the mechanical response through the early parts of the third 
step. However, the immediate response profiles are not necessarily indicative of down-stream 
changes to bone adaptation. The final step in the ability for bone to respond to load is the 
effector cells’ response to transmitted signals. A large percentage of mechanotransduction 
work related to aging has focused on the long-term effects of loading. Many of these studies 
suggest an overall drop in mechanoresponse based on reduced bone formation in the older 
animals in response to load [10, 14, 16]. These findings combined with the results presented in 
this paper suggest that the loss of mechanotransduction may be primarily caused by 
senescence of the responding cells or their ability to receive the signal.  
 Klein Nulend et al. discovered aging cells had no change or increased response to load in 
vitro but a reduction in cell growth and proliferation [70]. Other studies have demonstrated 
that older age has no effect on the load-induced osteocyte response but reduces the 
osteoblastic proliferation in vitro [12, 71]. These studies suggest that the impaired osteo-
adaptive response to load is a product of effector cell senescence rather than 
mechanosensation. In order to compare these findings to those presented here, long-term 
loading experiments should be run looking at both gene regulation and bone deposition 
through dynamic histomorphometry.  
 Initial work was started on investigating the long-term effects of loading in both strains, 
however, only 3-month animals have been tested thus far. In the preliminary work, the CBA/J 
mice demonstrated an increase in mineralizing surface on the periosteal side due to loading. 
The C57Bl/6 mice showed no significant difference. The lack of response in the C57Bl/6 mice is 
conducive to results presented previously [15]. On the endosteal surface, the C57Bl/6 mice 
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decreased MS and MS/BS values but had no change in MAR or BFR. The CBA/J mice had a 
significant load-induced increase in MS, MS/BS, MAR, and BFR. 
These data suggest that even at the young adult stage, the CBA/J mice are more 
responsive in the mid-diaphysis. The lack of significance to the increase in MS/BS, MAR, and 
BFR in the C57Bl/6 metaphysis is likely due to the low number of animals used for the pilot 
work. This is supported by Holguin et al’s findings that trabecular bone increased in C57Bl/6 
young adults [13]. More work needs to be done to verify the difference in initial response to 
long-term loading in the strains as well as how the ability to respond may change with age. 
The PCR and initial long-term adaptive response data, together, suggest that there is a 
large range of variation in the mechanoresponse patterns of bone even at 3-months of age. The 
aging process likely does not affect all individuals in the same manner. If the C57Bl/6 mice, as 
proposed previously, are a good model for mid-shaft fracture risk in humans, the lack of 
responsiveness may indicate that load-bearing exercises in this population of the elderly may 
not be an effective preventative measure. The CBA/J mice, as a model for successful cortical 
bone aging, could demonstrate that loading exercises may not ease risk of fracture in trabecular 
regions.  
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Figures: Chapter IV 
 
Figure 4. 1 - Axial compressive loading system. 
From DeSouza et al 2005 [15]. 
 
Table 4. 1 - Preliminary results for mechanoresponse in tibial loading. 
Values represent fold-changes in gene expression compared to unloaded control limb. 
 
 
 
 
 
 
Table 4. 2 – PrimeTime® qPCR primers and sequences. 
Target 
Gene 
Name 
RefSeq 
Number 
IDT Assay Name Sequence 
c-Fos Fos NM_010234 Mm.Pt.56a.29988214 
5’-GGCACTAGAGACGGACAGAT-3’  
5’-ACAGCCTTTCCTACTACCATTC-3’ 
COX-2 Ptgs2 NM_011198 Mm.PT.58.14196835 
5’-ACATTGTAAGTAGGTGGACTGTC-3’ 
5’-GCACTACATCCTGACCCACT-3’ 
eNOS Nos3 NM_008713 Mm.PT.58.12579546 
5’-TGGTCCACTATGGTCACTTTG-3’ 
5’-CTTGAGGATGTGGCTGTGT-3’ 
Cx43 Gja1 NM_010288 Mm.PT.56a.5955325 
5’-GACCTTGTCCAGCAGCTTC-3’ 
5’-CCTTTGACTTCAGCCTCCAA-3’ 
β2m Β2m NM_009735 Mm.PT.39a.22214835 
5’-GGGTGGAACTGTGTTACGTAG-3’ 
5’-TGGTCTTTCTGGTGCTTGTC-3’ 
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A.       B. 
 
C.       D.
 
Figure 4. 2 - Periosteal gene expression. 
Graphs represent fold change in gene expression with β2m as housekeeping gene and the left 
(unloaded) limb as control. Fold changes are normalized to the C57Bl/6, 3 month mean for reference. 
One-way ANOVA are run within strains on the ddC(t) values. T-tests are run between strains at the same 
age. * signifies p-value ≤ 0.05 in pairwise comparisons within strains. ⱡ signifies p-value ≤ 0.05 in t-tests 
between strains at the same age. A) Periosteal c-fos – Differences in expression are significant in 
C57Bl/6 (p=0.045). The difference in expression between 10 and 18 months is a 1.62-fold increase 
(p=0.047). Difference in expression in CBA/J is significant (p=0.032). The expression at 18 months is 5.6-
fold greater than expression at 3 months (p=0.081) and 5.8-fold greater than expression at 10 months 
(p=0.046). Periosteal expression of c-fos is significantly greater in the CBA/J 18-month group than the 
* 
* 
* 
ⱡ ⱡ 
ⱡ 
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C57Bl/6 18-month group (p=0.006). B) Periosteal cox-2 – Differences in expression between the 10-
month and 18-month means are significant in C57Bl/6 mice, representing a 2.03-fold increase (p=0.025). 
Since there is no 3-month group, C57Bl/6 10-month mean is used as reference. In the CBA/J mice, 
difference in expression does not quite reach significance (p=0.118). Periosteal cox-2 expression is 
significantly greater in the CBA/J 18-month mice than the C57Bl/6 18-month mice (p=0.003). C) 
Periosteal eNos – Differences between C57Bl/6 age groups is not significant (p=0.406). The CBA/J mean 
differences are also not significant (p=0.368). D) Periosteal Cx43 (gja1) – Age groups are not significantly 
different in C57BL/6 mice (p=0.183) or in CBA/J mice (p=0.202). However, t-test comparison of 18-
month means demonstrate a significantly greater level of expression in the CBA/J mice compared to the 
C57Bl/6 mice (p=0.016).  
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C.       D.
 
 
Figure 4. 3 - Cortical gene expression. 
Graphs represent fold change in expression with β2m as housekeeping gene and unloaded limb as 
control. Fold changes normalized to C57Bl/6, 3-month mean for reference. One-way ANOVA are run 
within strains on the ddC(t) values. T-tests are run between strains at the same age. * signifies p-value ≤ 
0.05 for ANOVA pair-wise comparisons. ⱡ signifies p-value ≤ 0.05 in t-tests between strains at the same 
age. A) Cortical c-fos – Differences in expression in C57Bl/6 mice are not significant (p=0.171). The 
differences in CBA/J mice are also not significant (p=0.345). B) Cortical cox-2 – Differences in expression 
in C57Bl/6 mouse age groups are not significant (p=0.163). The differences are also not significant in the 
CBA/J mice (p=0.861). C) Cortical eNos – Differences between the age groups are not significant in either 
the C57BL/6 mice (p=0.926) or the CBA/J mice (p=0.848). D) Cortical Cx43 (gja1) – Expression is not 
significantly different between age groups in C57BL/6 mice (p=0.431) or CBA/J mice (p=0.992). 
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Figure 4. 4 - Epiphyseal gene expression. 
Graphs represent fold change in gene expression with β2m as housekeeping gene and the left 
(unloaded) limb as control. Fold changes are normalized to the C57Bl/6, 3 month mean for reference. 
One-way ANOVA are run within strains on the ddC(t) values. T-tests are run between strains at the same 
age. * signifies p-value ≤ 0.05 in pairwise comparisons within strains. ⱡ signifies p-value ≤ 0.05 in t-tests 
between strains at the same age. A) Epiphyseal c-fos – Differences in expression are significant in 
C57Bl/6 (p=0.036). With the 10-month and 18-month difference in means representing a 3.23-fold 
difference in expression (p=0.033). Expression in the CBA/J age groups is invariant (p=0.562). B) 
Epiphyseal cox-2 – The difference in expression between ages in the C57Bl/6 strain is significant 
(p=0.008). The 18-month expression is 10.54-fold greater than the 3-month expression (p=0.026) and 
12.19 -fold greater than the 10-month expression (p=0.012). There is no difference in expression in the 
* * 
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CBA/J age groups (p=0.885). C) Epiphyseal eNos – Differences between C57Bl/6 age groups is not 
significant (p=0.153), nor are the differences in the CBA/J age groups (p=0.229). D) Epiphyseal Cx43 
(gja1) – Age groups are not significantly different in C57BL/6 mice (p=0.148). The differences in the 
CBA/J mice near significance (p=0.072) with the difference between 3- and 18-month means not quite 
reaching the level of significance (p=0.081). 
 
 
 
 
 
A.       B. 
 
 
Figure 4. 5 - Periosteal dynamic histomorphometry. 
Graphs demonstrate the comparisons between loaded (right) and unloaded control (left) tibiae in 3-
month C57Bl/6 and CBA/J mice. Paired t-tests are run to test for differences in means within strains. * 
signifies significant difference between loaded and unloaded means. A) Periosteal Mineralizing Surface 
– In the C57Bl/6 mice, means for mineralizing surface of the periosteum are 918.93 (±437.68) µm in the 
left limb and 1006.6 (±620.94) µm in the right limb. This is not a significant difference (p=0.702). There is 
a significant increase in mineralizing surface in the CBA/J tibiae when loaded (p=0.048). The mean for 
the left tibiae is 539.93 (±293.67) µm. The right tibia mean is 740.27 (±251.83) µm. B) Periosteal 
Mineralizing Surface/Bone Surface (MS/BS) – The mean MS/BS for C57Bl/6 control limb is 0.209 
(±0.103). The mean of the loaded limb is 0.202 (±0.114). This is not a significant difference between 
loaded and unloaded limbs (p=0.849). The CBA/J MS/BS means are also not significantly different 
(p=0.295) with a control mean of 0.141 (±0.080) and a loaded mean of 0.175 (±0.058).  
 
  
* 
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A.       B.
 
 
C.       D. 
 
 
Figure 4. 6 - Endosteal dynamic histomorphometry. 
Graphs demonstrate comparisons between loaded (right) and unloaded control (left) tibiae in 3-month 
C57Bl/6 and CBA/J mice. Paired t-tests are run to test for differences in means within strains. * signifies 
significant difference between loaded and unloaded means. A) Endosteal Mineralizing Surface (MS) – 
Average MS in the C57Bl/6 left (control) limb is 1204.92 (±273.55) µm. The average MS of the right 
(loaded) limb is 980.76 (±218.03) µm. This is a significant drop in MS on the endosteal surface of C57Bl/6 
mice following the experimental loading (p=0.042). There is also a significant difference in loaded and 
unloaded means in the CBA/J mice (p=0.021). However, in this strain, the unloaded mean of 306.93 
(±156.49) µm is less than the loaded mean of 573.88 (±207.51) µm. B) Endosteal MS/BS – There is a 
significantly lower MS/BS ratio in the C57Bl/6 loaded limbs—with a mean of 0.434 (±0.085)—compared 
* 
* * 
* 
* 
* 
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to the unloaded, control limbs that had a mean of 0.534 (±0.107) (p=0.053). Conversely, in the CBA/J 
strain, the mean MS/BS of the loaded limbs is 0.345 (±0.140) greater than that of the unloaded limbs 
(0.185 ±0.090) (p=0.028). C) Endosteal Mineral Apposition Rate (MAR) – The average MAR for the 
C57Bl/6 unloaded limbs is 0.902 (±0.337) µm/day and for the loaded limbs is 1.124 (±0.138) µm/day. 
There is not a significant difference between the MAR of loaded and unloaded limbs in the C57Bl/6 mice 
(p=0.264). MAR in the CBA/J tibiae is significantly greater in the loaded limb (1.393 ±0.548 µm/day) 
compared to the unloaded limb (0.322 ±0.304 µm/day) (p=0.031). D) Endosteal Bone Formation Rate 
(BFR) – Bone formation rate is not different in the C57Bl/6 loaded (1123.39 ±373.43 µm/day) and 
unloaded (1060.10 ±449.17 µm/day) limbs (p=0.693). The average BFR of the CBA/J loaded (724.97 
±183.91 µm/day) and unloaded (131.73 ±130.25 µm/day) limbs are significantly different (p=0.001).  
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A.      B. 
 
C. 
Figure 4. 7 - Metaphyseal trabecular dynamic 
histomorphometry. 
Graphs compare loaded (right) and unloaded (left) 
tibiae in 3-month C57Bl/6 and CBA/J mice. Paired t-
tests are run to test for differences in means within 
strains. * signifies significant difference between 
loaded and unloaded means. A) Trabecular MS/BS – 
There is no significant difference in mean MS/BS 
ratio in the C57Bl/6 loaded limbs (0.226 ±0.071)—
compared to the unloaded, control limbs (0.185 
±0.093) (p=0.071). The means of the CBA/J strain are 
also similar with the loaded limbs averaging 0.331 
(±0.029) and the unloaded limbs averaging 0.338 
±0.095) (p=0.897). B) Trabecular (MAR) – The 
average MAR for the C57Bl/6 unloaded limbs is 
0.851 (±0.157) µm/day and for the loaded limbs is 
1.100 (±0.220) µm/day. There is not a significant difference between the MAR of loaded and unloaded 
limbs in the C57Bl/6 mice (p=0.092). MAR in the CBA/J tibiae is significantly greater in the loaded limb 
(0.952 ±0.099 µm/day) compared to the unloaded limb (0.739 ±0.092 µm/day) (p=0.015). C) Trabecular 
(BFR) – Bone formation rate is greater in the C57Bl/6 loaded limbs (0.257 ±0.114 µm/day) and unloaded 
(0.165 ±0.100 µm/day) limbs (p=0.019). The average BFR of the CBA/J loaded (0.316 ±0.061 µm/day) 
and unloaded (0.254 ±0.101 µm/day) limbs are not significantly different (p=0.275).  
 
 
* 
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Control (Left)      Loaded (Right) 
 
Figure 4. 8 - Representative images of CBA/J diaphysis in control (left) and loaded (right) limbs. 
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CHAPTER V: 
CONCLUSIONS AND FUTURE WORK 
 
Mouse Model for Human Bone Aging 
Humans are unique amongst other most organisms in their ability to live beyond 
reproductively viable years. This has only been witnessed in a handful of other species, and 
many of these only in captivity [1]. Only recently have humans achieved this ability which is 
largely due to increased cultural advancements preventing earlier death [1]. The term “aging” is 
used here to describe the process of decline in biological function that occur after reaching 
maturity. How and why the aging process occurs has been debated in the field. One argument 
states that age-related loss of function is a stochastic process due to an accumulation of errors 
in cells over time [2, 3, 4, 5]. The molecular views of aging include the somatic mutation, 
telomere loss, mitochondrial, altered protein, waste accumulation, and ROS theories [3]. Many 
of these concepts are based on the biophysicist notion that the processes involved in aging are 
products of imperfect repair and replication leading to an increase in entropy [6].  
Weismann’s theory of “programed death” is another highly debated view of aging. This 
theory states that natural selection has resulted in aging in order to remove competing 
members of a population to make way for the next generations [3]. Another approach was 
presented by Medawar and attributes aging to the declining effectiveness of natural selection 
to act on the post-reproductive population [2, 5]. Natural selection acts on the breeding 
population leading to the more successful biological variants reproducing more effectively. 
Therefore, natural selection is unable to influence adaptations that promote living after an 
individual’s reproductive years [5,7].  
 The theory of aging ascribed to here argues that senescence is a byproduct of earlier 
developmental and life history patterns [3, 8, 9] that have evolved through selection. These 
early life adaptation, with little selective force acting late in life, ultimately lead to maladaptive 
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traits in old age. Humans have evolved to survive highly heterogeneous environments and as a 
k-selective species. In order to accommodate these demands, humans have evolved a high level 
of plasticity in order to acclimate to changing environments [10]. This, in combination with 
parental investment requiring long lifespans, has led to a biological system capable of change 
and repair.  
 In order to acclimate to changing environments, humans have adapted a high level of 
plasticity. One example of this capacity can be found in bone biology. Bone has evolved as a 
repository for resources such as calcium and phosphate that can be accessed for use and 
deposited for storage [11, 12]. During times of scarcity or when demands on resources are high 
(e.g. pregnancy and lactation) the body can access these stored nutrients for use. Once the 
demand on resources has alleviated, new bone can be added in anticipation for the next period 
of need. Bone is also responsible for biomechanical functions in support and movement. As 
mechanical demands change, bone is able to acclimate in order to most efficiently prevent 
fracture [13, 14]. Vast amounts of research have focused on bone adaptive response to 
increased loading and mechanical demand [15, 16, 17, 18]. Additionally, when bone is not as 
critical in locomotion (e.g. prolonged bed rest or microgravity environments) it is resorbed so 
resources are not tied up in superfluous bone mass [16, 19, 20].  
As an organism ages, this adaptive mechanism loses efficacy due to cellular and 
molecular senescence [2]. The remodeling ability of bone, previously critical to survival, loses 
regulation leading to unbalanced resorption and deposition [21, 22, 23]. These changes result in 
excess resorption relative to deposition and an overall loss in bone leading to increased risk of 
fragility fractures. However, not all humans experience the same patterns of bone aging. 
Cummings and Melton estimate that 40-50% of women [24, 25] and 13% of men [26] over the 
age of 50 will have a fragility fracture in their remaining lifetime. 
 Aging is highly dependent upon an individual’s life history, as well. Organisms with 
shorter life expectancy due to predation, disease, or environmental stresses are more likely to 
have an early investment in reproduction. Humans, evolving with lower predation and highly 
variable environments, developed a reproductive strategy that includes long-term parental 
investment, leading to increased life expectancy [1]. Hayflick asserts that organisms that 
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expend energy and resources quickly and early retain lower excess resources to put towards 
longevity [1]. Therefore, early biological demands determine the ability and patterns of aging 
later in life. 
 There is evidence for this pattern of early-life determinism of aging in the relationship 
between peak bone mass and aging-induced skeletal fragility [27, 28]. An interesting avenue for 
research includes investigating the correlation between peak bone mass and longevity. Men 
have shortened life expectancy than women but have also been reported to maintain skeletal 
function better [29]. Women have higher reproductive investment than men and may therefore 
have less resources available for bone maintenance upon reaching old age.12 Men also are 2.9 
times more likely to sustain a fracture between the ages of 15-59 [30]. The greater need to 
repair bone during reproductively active ages in men may have protective consequences later 
in life. The maintenance of the remodeling system is might be more efficient in older aged men 
than women, but at the energetic cost of lifespan. These trends may be indicative of a trade-off 
between energetic demands on bone homeostasis and resources allocated to prolong life 
expectancy.  
 While interesting theories, there is a severe lack of research into the life history and 
evolutionary trade-offs involved in human age progression. The study of human aging is 
exceedingly difficult and time intensive. The high levels of genetic and environmental 
heterogeneity make the influences of aging hard to isolate and interpret. Furthermore, humans 
have a relatively long lifespan, making longitudinal studies difficult. Cross-sectional studies have 
been used but have their own inherent flaws when making inferences from the data. For these 
reasons, there currently is insufficient understanding of the variability in how human bones 
age. The murine model of variation in aging presented in this thesis is an attempt to 
demonstrate the need for further study of differences within a species.  
Mouse models provide reduction in confounding variables and high levels of 
experimental control, however, using mice as a proxy for human aging is an imperfect approach 
as variable patterns of aging have been recorded even within littermates [31]. These models fall 
                                                          
12 The terms “men” and “women” are used here to describe chromosomal sex and are used for clarity when 
referencing humans and not animal models. 
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short based on the quite obvious fact that mice and humans are not synonymous. Aging studies 
often use species with short lifespans due to the increased rate of senescence. Yet the very 
reason these models are so attractive to researchers is also why they are not necessarily 
indicative of human aging. Wild mice have evolved under extreme predation pressures and 
therefore have a life history pattern of rapid maturation with large and early investment in 
offspring until death. For this reason, mice have not evolved with a need to conserve resources 
for later in life. Investigators must approach murine models of geriatric studies with caution, 
recognizing the inherent differences between the physiologies of the species that arose due to 
very different selective pressures.  
The goal of the first aim of this thesis was to determine if the femora of four different 
inbred strains of mice change differently with age, with the intent to provide models of 
intraspecies aging variation. We found that two of the strains, BALB/c and C57Bl/6 have lower 
mean ultimate loads under 4-point bending in the 18-month mice compared to the 3-month 
mice. The CBA/J strain had higher mean ultimate loads in the 18-month group when compared 
to the 3-month group. The fourth strain, DBA/2, had no difference in mean ultimate load values 
between the two age groups.  
 In the BALB/c strain, the combination of mechanical and morphological data indicates a 
loss of strength due to non-geometric changes. The reduced strength is due to the lower 
mineralization and matrix changes reducing post-yield properties. In the C57Bl/6 old mice, 
mechanical data demonstrate a reduction in strength, stiffness, and ductility. The loss of 
strength can be attributed to both the mineralization and matrix changes, as in BALB/c, but also 
to geometric changes. The loss of strength and stiffness is partly due to the marrow expansion 
without adequate periosteal compensation. In contrast to the first two strains, the CBA/J mice 
increase ultimate load with age. Stiffness is also greater in the older animals compared to the 3-
month mice. The mineralization, matrix, and endosteal changes are compensated for by 
periosteal expansion in CBA/J aging. Lastly, the DBA/2 mice had no change in ultimate load with 
aging. As with the CBA/J mice, stiffness was greater in the older animals. Unique to the DBA/J 
mice, the older animals did not experience altered PYD or TMD. This indicates minimal changes 
to the composition of the bone throughout the aging process. Similar to the CBA/J mice, the 
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DBA/2 strain is able to compensate for the endosteal resorption by adding bone to the 
periosteal surface.  
 With respect to bone aging, specifically, there are additional reasons for caution in using 
mouse models. There is the obvious issue of difference in locomotor patters. Latimer argues 
that the shift to bipedality has, in fact, increased our risk of age-induced fragility due to a 
greater need for trabecular bone which is easily resorbed later in life [32]. So we cannot assume 
the same functional demands in mice and humans. Mice do not employ BMU-based remodeling 
as do larger mammals [33]. Bone fragility in older humans is largely a product of unbalanced 
remodeling [21] and this could provide concerns with inferences taken from mouse studies of 
aging.  
 Despite the inevitable drawbacks to using rodent models as a proxy for human biology, 
the ability to compare inbred strains provides insight into the energetic and life history 
approach to aging. The use of mice allows researchers to investigate the intraspecies variation 
and how genetic and environmental factors influence aging. In the C57Bl/6 and CBA/J strains, 
the C57Bl/6 mice have significantly longer average lifespans [34, 35]. Applying the resource 
investment approach, it is not surprising that the C57Bl/6 mice also experience reduced bone 
strength due to unbalanced remodeling. The wide and thin diaphysis of the C57Bl/6 long bones 
provides greater surface area for endosteal resorption, providing more rapid access to 
resources required to sustain the animal. Conversely, the maintenance of bone in the CBA/J 
strain may come at the expense of life span.  
The second aim of this work was to look more closely at the C57Bl/6 and CBA/J strains, 
and determine when age-related changes initiate. In addition to this question, we sought to 
determine if aging changes of the femur are the same in the tibia. The final goal of this section 
was to correlate changes in the cortical bone to changes in the trabecular region with age. 
C57Bl/6 mice experience a steady decline in ultimate load and stiffness after 10 months. Unlike 
the C57Bl/6 femoral patterns, the tibial decrease in ultimate load is independent of changes to 
stiffness. The lack of change in stiffness is suggestive of matrix compositional and organizational 
changes reducing bone strength in the tibia.  The CBA/J strain does not elicit changes in 
ultimate load or stiffness in 18 months. The consistent mechanical properties are due to a 
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rearrangement of tissue to increase Iy, compensating for loss of mineralization and marrow 
expansion. The C57Bl/6 strain experienced less bone loss in the trabecular regions than the 
CBA/J mice. This pattern may represent a trade-off between periosteal deposition and 
trabecular resorption in the CBA/J mice. The C57Bl/6 strain experiences bone loss in both the 
cortical and trabecular region and may represent a strategy to disperse the bone loss between 
the compartments. 
Both mouse strains have developmental patterns that produce operational bone 
phenotypes. Without selection acting on the older animals, these phenotypes are optimized for 
younger life stages and may be suboptimal upon senescence.  The initial shape of the C57Bl/6 
diaphyseal bone provides greater endosteal surface area for potential resorption. In order to 
not over tax this region of bone, some resorption occurs in the trabecular regions, as well. Upon 
reaching senescence in the CBA/J mice, due to low surface area on the marrow side, less 
resorption can take place leading to less severe bone loss. This strain also appears to continue 
periosteal deposition on bone throughout aging. The addition of bone may come at the 
expense of the already sparse trabecular bone. These represent two very different strategies to 
maintain bone function during aging that is partly regulated by the morphology of the bones 
while young. 
Young adult bones of humans and mice are designed to be responsive to environmental 
stimuli. Just as humans have evolved in highly heterogeneous environments, mice also live on 
every continent except Antarctica [36, 37]. Thus, mice provide a good model in the sense that 
they also have evolved with the need for acclimation to various environments. Human fragility 
fractures are in large part due to the unbalanced resorption and deposition of bone [2, 21, 22, 
23]. As in humans [15, 16, 17, 18], mice are able to alter bone phenotype in response to various 
stressors. One of the best studied demand for remodeling is the responsiveness to changes in 
mechanical loading [38, 39]. 
 The third aim acts as a preliminary study approaching the question of how changes in 
the mechanoresponse could be influencing the variable bone aging patterns in C57Bl/6 and 
CBA/J strains. A method of axial tibial loading was employed and rtPCR used to measure the 
difference in responsiveness to load in the various age groups. Due to the continued periosteal 
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expansion, we predicted that CBA/J mice would experience a consistent response to loading 
regardless of age in the periosteal and cortical regions. The lack of periosteal expansion in the 
C57Bl/6 mice led to our prediction that the response in these regions would be lost with age. In 
the trabecular region, the C57Bl/6 mice had less dramatic trabecular bone loss than the CBA/J, 
leading to our prediction that C57Bl/6 mice would retain trabecular responsiveness better than 
CBA/J mice.  
 No difference in expression of mechanoresponsive genes was measured in the cortical 
and marrow regions. The CBA/J 18-month animals had a significant increase in response in the 
periosteum. The C57Bl/6 mice had an increase in expression in the 18-month epiphyseal 
sample. The predictions were correct by estimating a greater response in the periosteum of the 
CBA/J and epiphysis of the C57Bl/6. However, the original prediction of not losing response was 
not supported. Instead of maintaining response with age, the regions increased response in the 
18-month groups. The increased response might provide a buffer preventing more severe bone 
loss. Future work must look at the down-stream effects of these response patterns.  
 
Future Work 
 This work has contributed to the understanding of phenotypic variability within a single 
species with respect to bone aging. To add to the confidence in the outcomes, the next step 
should be to include female mice in the study, as well as run the analyses conducted in Aim 2 
on all four strains and in both sexes. Additionally, functional measures from trabecular 
compression tests should be included. This study utilized very distinct mouse phenotypes by 
looking at inbred strains. However, the continuum of variation provided by a heterogeneous 
mouse population would allow increased resolution of correlated factors. 
The work here demonstrates the variance in aging, but this study is primarily 
phenomenological in nature. Future studies should advance on the results demonstrating the 
variable aging patterns. The model for known aging differences will allow experimental designs 
aimed at investigating the physiological mechanisms underlying the aging variability. Broadly, 
comparisons between the strains could be made looking for patterns of aging associated with 
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genetics13, nutrition, activity, hormones, and drug treatments. The different variables could 
influence bone aging differently in the various strains. Hypothetically, an experiment could be 
run comparing exercise-based fracture prevention protocols in the C57Bl/6 and CBA/J strains. If 
one strain reacts well to the protocol and the other does not, it may indicate that exercise 
treatments are not suitable for all aging humans, as well.  
Aim 3 was an attempt to begin to investigate the mechanisms behind the aging 
differences. Useful information was gained by measuring short-term response and how it 
differs by strain and location. However, in order to fully comprehend the functional implications 
of these differences, long-term loading studies must be undertaken. These studies should look 
at gene regulation following consistent loading protocols to assess bone anabolic response. 
More importantly, the functional understanding of these responses demands dynamic 
histomorphometric comparisons of young and old adults, as well as mechanical tests following 
loading. These results will provide a more comprehensive view of the actual physiologic 
outcomes of this variation.  
Future work should also look more closely at the role of periosteal tissue in the 
remodeling and aging processes. It is clear from these data that periosteum is a mechanically 
responsive tissue under some conditions. However, little work has focused on the whole-bone 
and micro-level periosteum mechanics. Additional studies concerning variation in cellular 
response and function with aging between the strains would be enlightening, as well. This 
would require in vitro methods. On top of the variation in cell response to aging, the role of 
ECM aging change on the cellular functionality would provide insight into how cell senescence 
and the protein-mineral changes with age influence aging independently and in concert.  
Finally, more investigation into the amount and sources of variability in human aging is 
recommended. Currently, diagnostics and treatments are conducted and administered 
universally. However, there is likely a large degree of variation that these broad-spectrum 
approaches overlook. People with different bone phenotypes following maturation may require 
variant preventative and treatment protocols to reduce the risk of fragility fractures in each 
                                                          
13 See Appendix Table 3 for list of SNPs. 
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individual. Once the degree of variability has been established, the mouse models can be 
utilized to prescribe approaches more specific to individual physiologies.  
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APPENDIX 
 
Table A. 1 - Mean fold change in gene expression 
From Chapter IV: Fold change is calculated using x=2ΔΔc(T) with β2m as housekeeping and left (unloaded) 
limb as control. 
Tissue Gene 
C57Bl/6 Fold Change CBA/J Fold Change 
3 
month 
10 
month 
18 
month 
p-value 3 
month 
10 
month 
18 
month 
p-value 
Periosteal 
c-Fos 
1.32 
±1.23 
0.99 
±0.99 
2.8 ±2.02 0.026 1.45 
±1.59 
1.75 
±1.71 
8.03 
±6.97 
0.003 
COX-2 
----- 0.91 
±1.22 
2.25 
±2.65 
0.166 2.47 
±2.12 
1.99 
±2.31 
4.57 
±3.84 
0.174 
eNOS 
1.29 
±2.07 
0.83 
±0.97 
1.63 
±2.38 
0.646 1.81 
±3.03 
2.28 
±3.48 
2.20 
±1.52 
0.929 
Cx43 
0.86 
±1.11 
0.57 
±0.60 
1.61 
±2317 
0.268 0.98 
±1.23 
1.56 
±1.67 
2.68 
±2.43 
0.151 
Cortical 
c-Fos 
2.18 
±1.61 
1.08 
±0.56 
1.92 
±1.28 
0.133 3.51 
±3.55 
1.97 
±1.63 
1.91 
±0.72 
0.228 
COX-2 
2.67 
±2.75 
1.17 
±0.64 
2.28 
±1.23 
0.167 2.98 
±2.74 
2.19 
±1.51 
3.06 
±4.44 
0.794 
eNOS 
1.00 
±0.57 
0.99 
±0.51 
1.10 
±0.61 
0.896 1.21 
±1.16 
1.64 
±1.38 
1.24 
±0.83 
0.643 
Cx43 
0.84 
±0.40 
1.02 
±0.41 
1.04 
±0.37 
0.472 1.51 
±1.52 
1.49 
±1.27 
1.37 
±1.08 
0.968 
Marrow 
c-Fos 
1.66 
±0.98 
1.18 
±0.38 
1.52 
±0.54 
0.328 1.61 
±0.89 
1.25 
±0.39 
1.22 
±0.58 
0.339 
COX-2 
1.85 
±0.89 
1.45 
±0.71 
1.76 
±0.81 
0.552 2.44 
±1.82 
1.25 
±0.46 
1.69 
±1.02 
0.112 
eNOS 
1.16 
±0.63 
1.21 
±0.52 
1.20 
±0.46 
0.976 0.88 
±0.43 
1.02 
±0.20 
1.25 
±0.87 
0.363 
Cx43 
1.37 
±0.67 
1.30 
±0.63 
1.22 
±0.33 
0.842 0.93 
±0.33 
1.15 
±0.21 
1.08 
±0.28 
0.219 
Epiphysis 
c-Fos 
2.63 
±1.22 
1.92 
±1.22 
5.16 
±4.88 
0.056 1.86 
±0.32 
2.36 
±2.19 
3.11 
±2.15 
0.368 
COX-2 
2.63 
±1.70 
1.98 
±0.76 
13.17 
±16.9 
0.028 2.27 
±1.32 
2.93 
±2.53 
2.99 
±2.50 
0.743 
eNOS 
1.00 
±0.53 
1.33 
±0.52 
2.39 
±1.92 
0.039 0.68 
±0.39 
1.23 
±0.65 
1.78 
±1.81 
0.143 
Cx43 
0.90 
±0.35 
1.09 
±0.27 
1.28 
±0.60 
0.169 0.74 
±0.24 
0.98 
±0.38 
1.28 
±0.26 
0.025 
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Table A. 2 - Tibial dynamic histomorphometry data 
From Chapter IV: Mean values for dynamic histomorphometry in long-term adaptive loading pilot. 
 
 
 
 
 
 
 
 
 
 C57Bl/6 CBA/J 
Region Measurement Control Loaded p-value Control Loaded p-value 
Periosteal 
Mineralizing surface 
(µm) 
918.93 
(±437.68) 
1006.6 
(±620.94) 
0.702 539.93 
(±293.67) 
740.24 
(±251.83) 
0.048 
Mineralizing 
surface/Bone 
surface 
0.209 
(±0.103) 
0.202 
(±0.114) 
0.849 0.141 
(±0.08) 
0.175 
(±0.058) 
0.295 
Endosteal 
Mineralizing surface 
(µm) 
1204.92 
(±273.55) 
980.76 
(±218.03) 
0.042 306.93 
(±156.49) 
573.88 
(±207.51) 
0.021 
Mineralizing 
surface/Bone 
surface  
0.534 
(±0.107) 
0.434 
(±0.085) 
0.053 0.185 
(±0.09) 
0.345 
(±0.14) 
0.028 
Mineral apposition 
rate (µm/day) 
0.902 
(±0.337) 
1.124 
(±0.138) 
0.264 0.322 
(±0.304) 
1.393 
(±0.548) 
0.031 
Bone formation rate 
(µm/day) 
1060.1 
(±449.17) 
1123.39 
(±373.43) 
0.693 131.73 
(±130.25) 
724.97 
(±183.91) 
0.001 
Trabecular 
Mineralizing 
surface/Bone 
surface  
0.185 
(±0.093) 
0.226 
(±0.071) 
0.071 0.338 
±0.095) 
0.331 
(±0.029) 
0.897 
Mineral apposition 
rate (µm/day) 
0.851 
(±0.157) 
1.100 
(±0.220) 
0.092 0.739 
(±0.092) 
0.952 
(±0.099) 
0.015 
Bone formation rate 
(µm/day) 
0.165 
(±0.10) 
0.257 
(±0.114) 
0.019 0.254 
(±0.101) 
0.316 
(±0.061) 
0.275 
